29579-0
Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria
Active
20373-7 Amikacin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15005-9 Amikacin
A broad-spectrum antibiotic derived from kanamycin. It is reno- and oto-toxic like the other aminoglycoside antibiotics. No longer used widely but when used, serum levels will often be monitored.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Amikacin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Amikacin Islt SlowMyco
- Display Name
- Amikacin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Amikacin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0m
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 14101
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG40986-8 | AmikacinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Amikacin: |
| es-AR | Spanish (Argentina) | micobacterias.lentas: |
| es-MX | Spanish (Mexico) | Amikacina: |
| es-ES | Spanish (Spain) | Amikacina: |
| fr-CA | French (Canada) | Amikacine: |
| fr-BE | French (Belgium) | Amikacine: |
| fr-FR | French (France) | Amikacine: |
| it-IT | Italian (Italy) | Amicacina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 아미카신: |
| nl-NL | Dutch (Netherlands) | amikacine: |
| pt-BR | Portuguese (Brazil) | Amicacina: Synonyms: Amikin; |
| tr-TR | Turkish (Turkey) | Amikasin: |
| zh-CN | Chinese (China) | 丁胺卡那霉素: Synonyms: 分离物; |
48169-7 Amikacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15005-9 Amikacin
A broad-spectrum antibiotic derived from kanamycin. It is reno- and oto-toxic like the other aminoglycoside antibiotics. No longer used widely but when used, serum levels will often be monitored.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Amikacin 1.5 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Amikacin 1.5 ug/mL Islt SlowMyco
- Display Name
- Amikacin 1.5 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Amikacin 1.5 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.21
- Last Updated
- Version 2.40
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Amikacin 1,5 µg/mL: |
| es-ES | Spanish (Spain) | Amikacina 1.5 ug/mL: |
| es-MX | Spanish (Mexico) | Amikacina 1,5 ug / mL: |
| fr-CA | French (Canada) | Amikacine, 1,5 mg/L: |
| fr-BE | French (Belgium) | Amikacine 1,5 mg/L: |
| fr-FR | French (France) | Amikacine 1,5mg/L: |
| it-IT | Italian (Italy) | Amicacina 1,5 ug/mL: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | amikacine 1,5 ug/mL: |
| pt-BR | Portuguese (Brazil) | Amicacina 1.5 ug/ml: Synonyms: Amikin; |
| tr-TR | Turkish (Turkey) | Amikasin 1.5 ug/mL: |
| zh-CN | Chinese (China) | 丁胺卡那霉素 1.5 微克/毫升: Synonyms: 1.5 ug/mL ug μg 分离物; |
42642-9 Amikacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15005-9 Amikacin
A broad-spectrum antibiotic derived from kanamycin. It is reno- and oto-toxic like the other aminoglycoside antibiotics. No longer used widely but when used, serum levels will often be monitored.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Amikacin 2.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Amikacin 2 ug/mL Islt SlowMyco
- Display Name
- Amikacin 2 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Amikacin 2 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.16
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Amikacin 2,0 µg/mL: |
| es-ES | Spanish (Spain) | Amikacina 2 ug/mL: |
| es-MX | Spanish (Mexico) | Amikacina 2,0 ug / mL: |
| fr-CA | French (Canada) | Amikacine, 2,0 mg/L: |
| fr-BE | French (Belgium) | Amikacine 2,0 mg/L: |
| fr-FR | French (France) | Amikacine 2mg/L: |
| it-IT | Italian (Italy) | Amicacina, 2,0 ug/mL: Synonyms: 2 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 아미카신 2.0ug/mL: |
| nl-NL | Dutch (Netherlands) | amikacine 2,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Amicacina 2.0 ug/ml: Synonyms: Amikin; |
| tr-TR | Turkish (Turkey) | Amikasin 2.0 ug/mL: |
| zh-CN | Chinese (China) | 丁胺卡那霉素 2.0 微克/毫升: Synonyms: 2 ug/mL; |
25179-3 Amikacin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15005-9 Amikacin
A broad-spectrum antibiotic derived from kanamycin. It is reno- and oto-toxic like the other aminoglycoside antibiotics. No longer used widely but when used, serum levels will often be monitored.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Amikacin 6.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Amikacin 6 ug/mL Islt SlowMyco
- Display Name
- Amikacin 6 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Amikacin 6 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 15549
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Amikacin 6,0 µg/mL: |
| es-ES | Spanish (Spain) | Amikacina 6 ug/mL: |
| es-AR | Spanish (Argentina) | amicacina 6.0 ug/ml: |
| es-MX | Spanish (Mexico) | Amikacina 6.0 ug / mL: |
| fr-CA | French (Canada) | Amikacine, 6,0 mg/L: |
| fr-BE | French (Belgium) | Amikacine 6,0 mg/L: |
| fr-FR | French (France) | Amikacine 6mg/L: |
| it-IT | Italian (Italy) | Amicacina 6,0 ug/mL: Synonyms: 6 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 아미카신 6.0ug/mL: |
| nl-NL | Dutch (Netherlands) | amikacine 6,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Amicacina 6.0 ug/ml: Synonyms: Amikin; |
| tr-TR | Turkish (Turkey) | Amikasin 6.0 ug/mL: |
| zh-CN | Chinese (China) | 丁胺卡那霉素 6.0 微克/毫升: Synonyms: 6 ug/mL; |
25174-4 Amikacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15005-9 Amikacin
A broad-spectrum antibiotic derived from kanamycin. It is reno- and oto-toxic like the other aminoglycoside antibiotics. No longer used widely but when used, serum levels will often be monitored.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Amikacin 8.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Amikacin 8 ug/mL Islt SlowMyco
- Display Name
- Amikacin 8 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Amikacin 8 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 19061
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Amikacin 8,0 µg/mL: |
| es-ES | Spanish (Spain) | Amikacina 8 ug/mL: |
| es-AR | Spanish (Argentina) | amicacina 8.0 ug/ml: |
| es-MX | Spanish (Mexico) | Amikacina 8.0 ug / mL: |
| fr-BE | French (Belgium) | Amikacine 8,0 mg/L: |
| fr-CA | French (Canada) | Amikacine, 8,0 mg/L: |
| fr-FR | French (France) | Amikacine 8mg/L: |
| it-IT | Italian (Italy) | Amicacina, 8,0 ug/mL: Synonyms: 8 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 아미카신 8.0ug/mL: |
| nl-NL | Dutch (Netherlands) | amikacine 8,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Amicacina 8.0 ug/ml: Synonyms: Amikin; |
| tr-TR | Turkish (Turkey) | Amikasin 8.0 ug/mL: |
| zh-CN | Chinese (China) | 丁胺卡那霉素 8.0 微克/毫升: Synonyms: 8 ug/mL; |
25177-7 Amikacin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15005-9 Amikacin
A broad-spectrum antibiotic derived from kanamycin. It is reno- and oto-toxic like the other aminoglycoside antibiotics. No longer used widely but when used, serum levels will often be monitored.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Amikacin 12.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Amikacin 12 ug/mL Islt SlowMyco
- Display Name
- Amikacin 12 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Amikacin 12 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Amikacin 12,0 µg/mL: |
| es-ES | Spanish (Spain) | Amikacina 12 ug/mL: |
| es-AR | Spanish (Argentina) | amicacina 12.0 ug/ml: |
| es-MX | Spanish (Mexico) | Amikacina 12,0 ug / mL: |
| fr-CA | French (Canada) | Amikacine, 12,0 mg/L: |
| fr-BE | French (Belgium) | Amikacine 12,0 mg/L: |
| fr-FR | French (France) | Amikacine 12mg/L: |
| it-IT | Italian (Italy) | Amicacina 12,0 ug/mL: Synonyms: 12 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 아미카신 12.0ug/mL: |
| nl-NL | Dutch (Netherlands) | amikacine 12,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Amicacina 12.0 ug/ml: Synonyms: Amikin; |
| tr-TR | Turkish (Turkey) | Amikasin 12.0 ug/mL: |
| zh-CN | Chinese (China) | 丁胺卡那霉素 12.0 微克/毫升: Synonyms: 12 ug/mL; |
25175-1 Amikacin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15005-9 Amikacin
A broad-spectrum antibiotic derived from kanamycin. It is reno- and oto-toxic like the other aminoglycoside antibiotics. No longer used widely but when used, serum levels will often be monitored.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Amikacin 16.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Amikacin 16 ug/mL Islt SlowMyco
- Display Name
- Amikacin 16 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Amikacin 16 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 18135
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Amikacin 16,0 µg/mL: |
| es-ES | Spanish (Spain) | Amikacina 16 ug/mL: |
| es-AR | Spanish (Argentina) | amicacina 16.0 ug/ml: |
| es-MX | Spanish (Mexico) | Amikacina 16,0 ug / mL: |
| fr-BE | French (Belgium) | Amikacine 16,0 mg/L: |
| fr-CA | French (Canada) | Amikacine, 16,0 mg/L: |
| fr-FR | French (France) | Amikacine 16mg/L: |
| it-IT | Italian (Italy) | Amicacina 16,0 ug/mL: Synonyms: 16 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 아미카신 16.0ug/mL: |
| nl-NL | Dutch (Netherlands) | amikacine 16,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Amicacina 16.0 ug/ml: Synonyms: Amikin; |
| tr-TR | Turkish (Turkey) | Amikasin 16.0 ug/mL: |
| zh-CN | Chinese (China) | 丁胺卡那霉素 16.0 微克/毫升: Synonyms: 16 ug/mL; |
25178-5 Amikacin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15005-9 Amikacin
A broad-spectrum antibiotic derived from kanamycin. It is reno- and oto-toxic like the other aminoglycoside antibiotics. No longer used widely but when used, serum levels will often be monitored.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Amikacin 30.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Amikacin 30 ug/mL Islt SlowMyco
- Display Name
- Amikacin 30 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Amikacin 30 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Amikacin 30,0 µg/mL: |
| es-ES | Spanish (Spain) | Amikacina 30 ug/mL: |
| es-AR | Spanish (Argentina) | amicacina 30.0 ug/ml: |
| es-MX | Spanish (Mexico) | Amikacina 30,0 ug / mL: |
| fr-CA | French (Canada) | Amikacine, 30,0 mg/L: |
| fr-BE | French (Belgium) | Amikacine 30,0 mg/L: |
| fr-FR | French (France) | Amikacine 30mg/L: |
| it-IT | Italian (Italy) | Amicacina 30,0 ug/mL: Synonyms: 30 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 아미카신 30.0ug/mL: |
| nl-NL | Dutch (Netherlands) | amikacine 30,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Amicacina 30.0 ug/ml: Synonyms: Amikin; |
| tr-TR | Turkish (Turkey) | Amikasin 30.0 ug/mL: |
| zh-CN | Chinese (China) | 丁胺卡那霉素 30.0 微克/毫升: Synonyms: 30 ug/mL; |
25176-9 Amikacin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15005-9 Amikacin
A broad-spectrum antibiotic derived from kanamycin. It is reno- and oto-toxic like the other aminoglycoside antibiotics. No longer used widely but when used, serum levels will often be monitored.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Amikacin 32.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Amikacin 32 ug/mL Islt SlowMyco
- Display Name
- Amikacin 32 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Amikacin 32 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 17225
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Amikacin 32,0 µg/mL: |
| es-ES | Spanish (Spain) | Amikacina 32 ug/mL: |
| es-AR | Spanish (Argentina) | amicacina 32.0 ug/ml: |
| es-MX | Spanish (Mexico) | Amikacina 32,0 ug / mL: |
| fr-BE | French (Belgium) | Amikacine 32,0 mg/L: |
| fr-CA | French (Canada) | Amikacine, 32,0 mg/L: |
| fr-FR | French (France) | Amikacine 32mg/L: |
| it-IT | Italian (Italy) | Amicacina 32,0 ug/mL: Synonyms: 32 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 아미카신 32.0ug/mL: |
| nl-NL | Dutch (Netherlands) | amikacine 32,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Amicacina 32.0 ug/ml: Synonyms: Amikin; |
| tr-TR | Turkish (Turkey) | Amikasin 32.0 ug/mL: |
| zh-CN | Chinese (China) | 丁胺卡那霉素 32.0 微克/毫升: Synonyms: 32 ug/mL; |
25310-4 Amoxicillin+Clavulanate [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15420-0 Amoxicillin+Clavulanate
The combination of Amoxicillin and clavulanate -- also known as Augmentin -- is an oral antibacterial combination consisting of the semisynthetic antibiotic amoxicillin and the -lactamase inhibitor, clavulanate . It is used in the treatment of otitis media, sinusitis, and infections caused by susceptible organisms involving the lower respiratory tract, skin and skin structure, and urinary tract; spectrum same as amoxicillin with additional coverage of beta-lactamase producing B. catarrhalis, H. influenzae, N. gonorrhoeae, and S. aureus (not MRSA). The expanded coverage of this combination makes it a useful alternative when penicillin resistance is present and patients cannot tolerate alternative treatments.
Source: Regenstrief Institute
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Amoxicillin+Clavulanate
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Amoxicillin+Clav Islt SlowMyco
- Display Name
- Amoxicillin+Clavulanate Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Amoxicillin+Clavulanate
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41009-8 | Amoxicillin+ClavulanateSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Amoxicillin+Clavulanat: |
| es-ES | Spanish (Spain) | Amoxicilina+Clavulánico: |
| es-AR | Spanish (Argentina) | amoxicilina+clavulanato: |
| es-MX | Spanish (Mexico) | Amoxicilina + Clavulanato: |
| fr-CA | French (Canada) | Amoxicilline+clavulanate: |
| fr-BE | French (Belgium) | Amoxicilline+clavulanate: |
| fr-FR | French (France) | Amoxicilline+clavulanate: |
| it-IT | Italian (Italy) | Amoxicillina+Acido clavulanico: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 아목시실린+클라부라네이트: |
| nl-NL | Dutch (Netherlands) | amoxicilline + clavulanaat: |
| pt-BR | Portuguese (Brazil) | Amoxicilina+Clavulanato de Potássio: Synonyms: Clav; |
| tr-TR | Turkish (Turkey) | Amoksisilin+Klavulanat: |
| zh-CN | Chinese (China) | 羟氨苄青霉素+棒酸: Synonyms: β-内酰胺酶抑制剂; |
20374-5 Ampicillin+Sulbactam [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15937-3 Ampicillin+Sulbactam
Ampicillin/sulbactam is a combination of the common penicillin-derived antibiotic ampicillin and sulbactam, an inhibitor of bacterial beta-lactamase. Two different forms of the drug exist. The first, developed in 1987 and marketed in the United States under the tradename Unasyn, is an intravenous antibiotic. The second, an oral form called sultamicillin, is marketed under the trade name Ampictam outside of the United States. Ampicillin/sulbactam is used to treat infections caused by bacteria resistant to beta-lactam antibiotics. Sulbactam blocks the enzyme which breaks down ampicillin and thereby allows ampicillin to attack and kill the bacteria.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ampicillin+Sulbactam
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ampicillin+Sulbactam
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ampicillin+Sulbac Islt SlowMyco
- Display Name
- Ampicillin+Sulbactam Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ampicillin+Sulbactam
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0m
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41012-2 | Ampicillin+SulbactamSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ampicillin+Sulbactam: |
| es-AR | Spanish (Argentina) | micobacterias.lentas: |
| es-MX | Spanish (Mexico) | Ampicilina + Sulbactam: |
| es-ES | Spanish (Spain) | Ampicilina + Sulbactam: |
| fr-CA | French (Canada) | Ampicilline+sulbactame: Synonyms: #REF! |
| fr-BE | French (Belgium) | Ampicilline+sulbactame: |
| fr-FR | French (France) | Ampicilline+sulbactam: |
| it-IT | Italian (Italy) | Ampicillina+Sulbactam: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 암피실린+설박탐: |
| nl-NL | Dutch (Netherlands) | ampicilline + sulbactam: |
| pt-BR | Portuguese (Brazil) | Ampicilina+Sulbactam: Synonyms: Sulb; |
| tr-TR | Turkish (Turkey) | Ampisilin+sulbaktam: |
| zh-CN | Chinese (China) | 氨苄青霉素+舒巴坦: Synonyms: 分离物; |
23612-5 Azithromycin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16090-0 Azithromycin
Azithromycin is an azalide, a subclass of macrolide antibiotics. Azithromycin (brand names Zithromax ® in Italy; Zmax ®; Sumamed ®; Aztrin ®) is one of the world's best-selling antibiotics, and is derived from erythromycin ; however, it differs chemically from erythromycin in that a methyl -substituted nitrogen atom is incorporated into the lactone ring, thus making the lactone ring 15-membered. Azithromycin is used to treat certain bacterial infections, most often bacteria causing middle ear infections, tonsillitis, throat infections, laryngitis, bronchitis, pneumonia and sinusitis. It is also effective against certain sexually transmitted infectious diseases, such as non-gonococcal urethritis and cervicitis. Recent studies have also shown it to be effective against late-onset asthma, but these findings are controversial and not widely accepted as of yet.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Azithromycin (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Azithromycin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Azithromycin Islt SlowMyco
- Display Name
- Azithromycin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Azithromycin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0n
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41013-0 | AzithromycinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Azithromycin: |
| es-MX | Spanish (Mexico) | Azitromicina: |
| es-ES | Spanish (Spain) | Azitromicina: |
| es-AR | Spanish (Argentina) | azitromicina: |
| fr-BE | French (Belgium) | Azithromycine: |
| fr-CA | French (Canada) | Azithromycine: |
| fr-FR | French (France) | Azithromycine: |
| it-IT | Italian (Italy) | Azitromicina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 아지트로마이신: |
| nl-NL | Dutch (Netherlands) | azitromycine: |
| pt-BR | Portuguese (Brazil) | Azitromicina: Synonyms: Zithromax; |
| tr-TR | Turkish (Turkey) | Azitromisin: |
| zh-CN | Chinese (China) | 阿齐霉素: Synonyms: 分离物; |
23607-5 Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16787-1 Capreomycin
Capreomycin is a peptide antibiotic which is given in combination with other antibiotics for tuberculosis. Adverse effects include nephrotoxicity and 8th cranial nerve toxicity.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Capreomycin (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Capreomycin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Capreomycin Islt SlowMyco
- Display Name
- Capreomycin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Capreomycin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0n
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 8972
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41019-7 | CapreomycinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Capreomycin: |
| es-ES | Spanish (Spain) | Capreomicina: |
| es-AR | Spanish (Argentina) | capreomicina: |
| es-MX | Spanish (Mexico) | Capreomicina: |
| fr-BE | French (Belgium) | Capréomycine: |
| fr-CA | French (Canada) | Capréomycine: |
| fr-FR | French (France) | Capréomycine: |
| it-IT | Italian (Italy) | Capreomicina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 카프레오마이신: |
| nl-NL | Dutch (Netherlands) | capreomycine: |
| pt-BR | Portuguese (Brazil) | Capreomicina: Synonyms: CAPASTAT; |
| tr-TR | Turkish (Turkey) | Kapreomisin: |
| zh-CN | Chinese (China) | 卷曲霉素: Synonyms: 分离物; |
48170-5 Capreomycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16787-1 Capreomycin
Capreomycin is a peptide antibiotic which is given in combination with other antibiotics for tuberculosis. Adverse effects include nephrotoxicity and 8th cranial nerve toxicity.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Capreomycin (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Capreomycin 3.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Capreomycin 3 ug/mL Islt SlowMyco
- Display Name
- Capreomycin 3 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Capreomycin 3 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.21
- Last Updated
- Version 2.26
- Order vs. Observation
- Both
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Capreomycin 3,0 µg/mL: |
| es-ES | Spanish (Spain) | Capreomicina 3 ug/mL: |
| es-MX | Spanish (Mexico) | Capreomicina 3,0 ug / mL: |
| fr-CA | French (Canada) | Capréomycine, 3,0 mg/L: |
| fr-BE | French (Belgium) | Capréomycine 3,0 mg/L: |
| fr-FR | French (France) | Capréomycine 3mg/L: |
| it-IT | Italian (Italy) | Capreomicina, 3,0 ug/mL: Synonyms: 3 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | capreomycine 3,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Capreomicina 3.0 ug/mL: Synonyms: CAPASTAT; |
| tr-TR | Turkish (Turkey) | Kapreomisin 3.0 ug/mL: |
| zh-CN | Chinese (China) | 卷曲霉素 3.0 微克/毫升: Synonyms: 3 ug/mL; |
25210-6 Capreomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16787-1 Capreomycin
Capreomycin is a peptide antibiotic which is given in combination with other antibiotics for tuberculosis. Adverse effects include nephrotoxicity and 8th cranial nerve toxicity.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Capreomycin (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Capreomycin 10.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Capreomycin 10 ug/mL Islt SlowMyco
- Display Name
- Capreomycin 10 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Capreomycin 10 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 17439
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41188-0 | Capreomycin 10.0 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Capreomycin 10,0 µg/mL: |
| es-ES | Spanish (Spain) | Capreomicina 10 ug/mL: |
| es-AR | Spanish (Argentina) | capreomicina 10,0 ug/ml: |
| es-MX | Spanish (Mexico) | Capreomicina 10.0 ug / mL: |
| fr-CA | French (Canada) | Capréomycine, 10,0 mg/L: |
| fr-BE | French (Belgium) | Capréomycine 10,0 mg/L: |
| fr-FR | French (France) | Capréomycine 10mg/L: |
| it-IT | Italian (Italy) | Capreomicina 10,0 ug/mL: Synonyms: 10 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 카프레오마이신 10.0ug/mL: |
| nl-NL | Dutch (Netherlands) | capreomycine 10,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Capreomicina 10.0 ug/mL: Synonyms: CAPASTAT; |
| tr-TR | Turkish (Turkey) | Kapreomisin 10.0 ug/mL: |
| zh-CN | Chinese (China) | 卷曲霉素 10.0 微克/毫升: Synonyms: 10 ug/mL; |
25211-4 Capreomycin 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16787-1 Capreomycin
Capreomycin is a peptide antibiotic which is given in combination with other antibiotics for tuberculosis. Adverse effects include nephrotoxicity and 8th cranial nerve toxicity.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Capreomycin (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Capreomycin 20.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Capreomycin 20 ug/mL Islt SlowMyco
- Display Name
- Capreomycin 20 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Capreomycin 20 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Capreomycin 20,0 µg/mL: |
| es-ES | Spanish (Spain) | Capreomicina 20 ug/mL: |
| es-AR | Spanish (Argentina) | capreomicina 20,0 ug/ml: |
| es-MX | Spanish (Mexico) | Capreomicina 20,0 ug / mL: |
| fr-CA | French (Canada) | Capréomycine, 20,0 mg/L: |
| fr-BE | French (Belgium) | Capréomycine 20,0 mg/L: |
| fr-FR | French (France) | Capréomycine 20mg/L: |
| it-IT | Italian (Italy) | Capreomicina 20,0 ug/mL: Synonyms: 20 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 카프레오마이신 20.0ug/mL: |
| nl-NL | Dutch (Netherlands) | capreomycine 20,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Capreomicina 20.0 ug/mL: Synonyms: CAPASTAT; |
| tr-TR | Turkish (Turkey) | Kapreomisin 20.0 ug/mL: |
| zh-CN | Chinese (China) | 卷曲霉素 20.0 微克/毫升: Synonyms: 20 ug/mL; |
25212-2 Capreomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16787-1 Capreomycin
Capreomycin is a peptide antibiotic which is given in combination with other antibiotics for tuberculosis. Adverse effects include nephrotoxicity and 8th cranial nerve toxicity.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Capreomycin (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Capreomycin 30.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Capreomycin 30 ug/mL Islt SlowMyco
- Display Name
- Capreomycin 30 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Capreomycin 30 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Capreomycin 30,0 µg/mL: |
| es-ES | Spanish (Spain) | Capreomicina 30 ug/mL: |
| es-AR | Spanish (Argentina) | capreomicina 30,0 ug/ml: |
| es-MX | Spanish (Mexico) | Capreomicina 30,0 ug / mL: |
| fr-CA | French (Canada) | Capréomycine, 30,0 mg/L: |
| fr-BE | French (Belgium) | Capréomycine 30,0 mg/L: |
| fr-FR | French (France) | Capréomycine 30mg/L: |
| it-IT | Italian (Italy) | Capreomicina 30,0 ug/mL: Synonyms: 30 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 카프레오마이신 30.0ug/mL: |
| nl-NL | Dutch (Netherlands) | capreomycine 30,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Capreomicina 30.0 ug/mL: Synonyms: CAPASTAT; |
| tr-TR | Turkish (Turkey) | Kapreomisin 30.0 ug/mL: |
| zh-CN | Chinese (China) | 卷曲霉素 30.0 微克/毫升: Synonyms: 30 ug/mL; |
50631-1 Cefepime [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP17165-9 Cefepime
Cefepime is a fourth-generation cephalosporin antibiotic developed in 1994. It has an extended spectrum of activity against Gram-positive and Gram-negative bacteria. Cefepime hydrochloride was first introduced in 1994 and is currently marketed under various trade names including Maxipime (Elan Pharma, Maxcef, Cepimax, Cepimex, and Axepim).
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Cefepime (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Cefepime
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Cefepime Islt SlowMyco
- Display Name
- Cefepime Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Cefepime
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.22
- Last Updated
- Version 2.26
- Order vs. Observation
- Both
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41026-2 | CefepimeSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Cefepim: |
| es-ES | Spanish (Spain) | Cefepima: |
| es-MX | Spanish (Mexico) | Cefepima: |
| fr-CA | French (Canada) | Céfépime: |
| fr-BE | French (Belgium) | Céfépime: |
| fr-FR | French (France) | Céfépime: |
| it-IT | Italian (Italy) | Cefepima: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | cefepime: |
| pt-BR | Portuguese (Brazil) | Cefepima: Synonyms: Maxipime; |
| tr-TR | Turkish (Turkey) | Sefepim: |
| zh-CN | Chinese (China) | 头孢吡肟: Synonyms: 分离物; |
25222-1 Cefmetazole 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP17800-1 Cefmetazole
A semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms. It has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Cefmetazole 30.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Cefmetazole 30 ug/mL Islt SlowMyco
- Display Name
- Cefmetazole 30 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Cefmetazole 30 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Cefmetazol 30,0 µg/mL: |
| es-ES | Spanish (Spain) | Cefmetazol 30 ug/mL: |
| es-AR | Spanish (Argentina) | cefmetazol 30,0 ug/ml: |
| es-MX | Spanish (Mexico) | Cefmetazol 30,0 ug / mL: |
| fr-CA | French (Canada) | Cefmétazole, 30,0 mg/L: |
| fr-BE | French (Belgium) | Cefmétazole 30,0 mg/L: |
| fr-FR | French (France) | Cefmétazole 30mg/L: |
| it-IT | Italian (Italy) | Cefmetazolo 30,0 ug/mL: Synonyms: 30 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 세프메타졸 30.0ug/mL: |
| nl-NL | Dutch (Netherlands) | cefmetazol 30,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Cefmetazole 30.0 ug/mL: Synonyms: Cefmetazon; |
| tr-TR | Turkish (Turkey) | Sefmetazol 30.0 ug/mL: |
| zh-CN | Chinese (China) | 头孢美唑 30.0 微克/毫升: Synonyms: 30 ug/mL; |
50632-9 Cefotaxime [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP14831-9 Cefotaxime
Cefotaxime is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram positive and Gram negative bacteria. In most cases, it is equivalent to ceftriaxone in terms of safety and efficacy. Cefotaxime sodium is marketed under various trade names including Claforan (Sanofi-Aventis).
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Cefotaxime (Wikipedia)
LP14831-9 Cefotaxime
Semisynthetic broad-spectrum cephalosporin.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Cefotaxime
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Cefotaxime Islt SlowMyco
- Display Name
- Cefotaxime Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Cefotaxime
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.22
- Last Updated
- Version 2.26
- Order vs. Observation
- Both
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41031-2 | CefotaximeSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Cefotaxim: |
| es-ES | Spanish (Spain) | Cefotaxima: |
| es-MX | Spanish (Mexico) | Cefotaxima: |
| fr-CA | French (Canada) | Céfotaxime: |
| fr-BE | French (Belgium) | Céfotaxime: |
| fr-FR | French (France) | Céfotaxime: |
| it-IT | Italian (Italy) | Cefotaxima: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | cefotaxime: |
| pt-BR | Portuguese (Brazil) | Cefotaxima: Synonyms: Claforan; |
| tr-TR | Turkish (Turkey) | Sefotaksim: |
| zh-CN | Chinese (China) | 头孢噻肟: Synonyms: 分离物; |
25366-6 cefOXitin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15205-5 cefOXitin
A semisynthetic cephamycin antibiotic resistant to beta-lactamase.
Source: National Library of Medicine, MeSH 2006
LP15205-5 cefOXitin
Cefoxitin is a second generation Cephalosporin. Less active against staphylococci and streptococci than first generation cephalosporins, but active against anaerobes including Bacteroides fragilis; active against gram-negative enteric bacilli including E. coli, Klebsiella, and Proteus; used predominantly for respiratory tract, skin and skin structure, bone and joint, urinary tract and gynecologic as well as septicemia; surgical prophylaxis; intra-abdominal infections and other mixed infections; indicated for bacterial Eikenella corrodens infections.
Source: Regenstrief Institute
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- cefOXitin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- cefOXitin Islt SlowMyco
- Display Name
- cefOXitin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to cefOXitin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 14500
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG40981-9 | CefoxitinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Cefoxitin: |
| es-ES | Spanish (Spain) | Cefoxitina: |
| es-AR | Spanish (Argentina) | cefoxitina: |
| es-MX | Spanish (Mexico) | cefOXitina: |
| fr-CA | French (Canada) | Céfoxitine: |
| fr-BE | French (Belgium) | Céfoxitine: |
| fr-FR | French (France) | Céfoxitine: |
| it-IT | Italian (Italy) | Cefoxitina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 세폭시틴: |
| nl-NL | Dutch (Netherlands) | cefoxitine: |
| pt-BR | Portuguese (Brazil) | Cefoxitina: Synonyms: Mefoxin; |
| tr-TR | Turkish (Turkey) | Sefoksitin: |
| zh-CN | Chinese (China) | 头孢甲氧霉素: Synonyms: 分离物; |
25220-5 cefOXitin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15205-5 cefOXitin
A semisynthetic cephamycin antibiotic resistant to beta-lactamase.
Source: National Library of Medicine, MeSH 2006
LP15205-5 cefOXitin
Cefoxitin is a second generation Cephalosporin. Less active against staphylococci and streptococci than first generation cephalosporins, but active against anaerobes including Bacteroides fragilis; active against gram-negative enteric bacilli including E. coli, Klebsiella, and Proteus; used predominantly for respiratory tract, skin and skin structure, bone and joint, urinary tract and gynecologic as well as septicemia; surgical prophylaxis; intra-abdominal infections and other mixed infections; indicated for bacterial Eikenella corrodens infections.
Source: Regenstrief Institute
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- cefOXitin 30.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- cefOXitin 30 ug/mL Islt SlowMyco
- Display Name
- cefOXitin 30 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to cefOXitin 30 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Cefoxitin 30,0 µg/mL: |
| es-ES | Spanish (Spain) | Cefoxitina 30 ug/mL: |
| es-AR | Spanish (Argentina) | cefoxitina 30,0 ug/ml: |
| es-MX | Spanish (Mexico) | cefOXitina 30,0 ug / mL: |
| fr-CA | French (Canada) | Céfoxitine, 30,0 mg/L: |
| fr-BE | French (Belgium) | Céfoxitine 30,0 mg/L: |
| fr-FR | French (France) | Céfoxitine 30mg/L: |
| it-IT | Italian (Italy) | Cefoxitina 30,0 ug/mL: Synonyms: 30 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 세폭시틴 30.0ug/mL: |
| nl-NL | Dutch (Netherlands) | cefoxitine 30,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Cefoxitina 30.0 ug/mL: Synonyms: Mefoxin; |
| tr-TR | Turkish (Turkey) | Sefoksitin 30.0 ug/mL: |
| zh-CN | Chinese (China) | 头孢甲氧霉素 30.0 微克/毫升: Synonyms: 30 ug/mL; |
20378-6 Ceftizoxime [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15253-5 Ceftizoxime
A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ceftizoxime
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ceftizoxime Islt SlowMyco
- Display Name
- Ceftizoxime Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ceftizoxime
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0m
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41035-3 | CeftizoximeSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ceftizoxim: |
| es-ES | Spanish (Spain) | Ceftizoxima: |
| es-AR | Spanish (Argentina) | micobacterias.lentas: |
| es-MX | Spanish (Mexico) | Ceftizoxima: |
| fr-CA | French (Canada) | Ceftizoxime: |
| fr-BE | French (Belgium) | Ceftizoxime: |
| fr-FR | French (France) | Ceftizoxime: |
| it-IT | Italian (Italy) | Ceftizoxime: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 세프티족심: |
| nl-NL | Dutch (Netherlands) | ceftizoxime: |
| pt-BR | Portuguese (Brazil) | Ceftizoxima: Synonyms: Cefizox; |
| tr-TR | Turkish (Turkey) | Seftizoksim: |
| zh-CN | Chinese (China) | 头孢唑肟: Synonyms: 分离物; |
25367-4 cefTRIAXone [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15260-0 cefTRIAXone
Ceftriaxone is a third-generation cephalosporin antibiotic. It is effective against both Gram positive and Gram negative bacteria and in terms of safety and efficacy, it is equivalent to cefotaxime. Ceftriaxone sodium is marketed by Hoffman-La Roche under the trade name Rocephin.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ceftriaxone (Wikipedia)
LP15260-0 cefTRIAXone
A broad-spectrum cephalosporin antibiotic with a very long half-life and high penetrability to meninges, eyes and inner ears.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- cefTRIAXone
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- cefTRIAXone Islt SlowMyco
- Display Name
- cefTRIAXone Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to cefTRIAXone
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41036-1 | CeftriaxoneSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ceftriaxon: |
| es-ES | Spanish (Spain) | Ceftriaxona: |
| es-AR | Spanish (Argentina) | ceftriaxona: |
| es-MX | Spanish (Mexico) | cefTRIAXone: |
| fr-CA | French (Canada) | Ceftriaxone: |
| fr-BE | French (Belgium) | Ceftriaxone: |
| fr-FR | French (France) | Ceftriaxone: |
| it-IT | Italian (Italy) | Ceftriaxone: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 세프트리악손: |
| nl-NL | Dutch (Netherlands) | ceftriaxon: |
| pt-BR | Portuguese (Brazil) | Ceftriaxona: Synonyms: Rocephin; |
| tr-TR | Turkish (Turkey) | Seftriakzon: |
| zh-CN | Chinese (China) | 头孢三嗪: Synonyms: ROCJ; |
20377-8 Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15380-6 Ciprofloxacin
Ciprofloxacin is the generic international name for the synthetic antibiotic manufactured and sold by Bayer Pharmaceutical under the brand names Cipro® and Ciproxin®. It belongs to a group called fluoroquinolones, is bactericidal. Its mode of action depends upon blocking bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ciprofloxacin (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ciprofloxacin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ciprofloxacin Islt SlowMyco
- Display Name
- Ciprofloxacin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ciprofloxacin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0m
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 14103
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41003-1 | CiprofloxacinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ciprofloxacin: |
| es-AR | Spanish (Argentina) | micobacterias.lentas: |
| es-MX | Spanish (Mexico) | Ciprofloxacina: |
| es-ES | Spanish (Spain) | Ciprofloxacino: |
| fr-CA | French (Canada) | Ciprofloxacine: |
| fr-BE | French (Belgium) | Ciprofloxacine: |
| fr-FR | French (France) | Ciprofloxacine: |
| it-IT | Italian (Italy) | Ciprofloxacina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 사이프로프록사신: |
| nl-NL | Dutch (Netherlands) | ciprofloxacine: |
| pt-BR | Portuguese (Brazil) | Ciprofloxacina: Synonyms: Ciprofloxacn; |
| tr-TR | Turkish (Turkey) | Ciproflokzasin: |
| zh-CN | Chinese (China) | 环丙沙星: Synonyms: 分离物; |
55194-5 Ciprofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15380-6 Ciprofloxacin
Ciprofloxacin is the generic international name for the synthetic antibiotic manufactured and sold by Bayer Pharmaceutical under the brand names Cipro® and Ciproxin®. It belongs to a group called fluoroquinolones, is bactericidal. Its mode of action depends upon blocking bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ciprofloxacin (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ciprofloxacin 1.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ciprofloxacin 1 ug/mL Islt SlowMyco
- Display Name
- Ciprofloxacin 1 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ciprofloxacin 1 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.27
- Last Updated
- Version 2.29
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ciprofloxacin 1,0 µg/mL: |
| es-ES | Spanish (Spain) | Ciprofloxacino 1 ug/mL: |
| es-MX | Spanish (Mexico) | Ciprofloxacina 1.0 ug / mL: |
| fr-CA | French (Canada) | Ciprofloxacine, 1,0 mg/L: |
| fr-BE | French (Belgium) | Ciprofloxacine 1,0 mg/L: |
| fr-FR | French (France) | Ciprofloxacine 1mg/L: |
| it-IT | Italian (Italy) | Ciprofloxacina 1,0 ug/mL: Synonyms: 1 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | ciprofloxacine 1,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Ciprofloxacina 1.0 ug/mL: Synonyms: Ciprofloxacn; |
| tr-TR | Turkish (Turkey) | Ciproflokzasin 1.0 ug/mL: |
| zh-CN | Chinese (China) | 环丙沙星 1.0 微克/毫升: Synonyms: 1 ug/mL; |
25180-1 Ciprofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15380-6 Ciprofloxacin
Ciprofloxacin is the generic international name for the synthetic antibiotic manufactured and sold by Bayer Pharmaceutical under the brand names Cipro® and Ciproxin®. It belongs to a group called fluoroquinolones, is bactericidal. Its mode of action depends upon blocking bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ciprofloxacin (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ciprofloxacin 2.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ciprofloxacin 2 ug/mL Islt SlowMyco
- Display Name
- Ciprofloxacin 2 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ciprofloxacin 2 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 18562
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41160-9 | Ciprofloxacin 2.0 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ciprofloxacin 2,0 µg/mL: |
| es-ES | Spanish (Spain) | Ciprofloxacino 2 ug/mL: |
| es-AR | Spanish (Argentina) | ciprofloxacina 2.0 ug/ml: |
| es-MX | Spanish (Mexico) | Ciprofloxacina 2,0 ug / mL: |
| fr-CA | French (Canada) | Ciprofloxacine, 2,0 mg/L: |
| fr-BE | French (Belgium) | Ciprofloxacine 2,0 mg/L: |
| fr-FR | French (France) | Ciprofloxacine 2mg/L: |
| it-IT | Italian (Italy) | Ciprofloxacina, 2,0 ug/mL: Synonyms: 2 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 사이프로프록사신 2.0ug/mL: |
| nl-NL | Dutch (Netherlands) | ciprofloxacine 2,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Ciprofloxacina 2.0 ug/mL: Synonyms: Ciprofloxacn; |
| tr-TR | Turkish (Turkey) | Ciproflokzasin 2.0 ug/mL: |
| zh-CN | Chinese (China) | 环丙沙星 2.0 微克/毫升: Synonyms: 2 ug/mL; |
25181-9 Ciprofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15380-6 Ciprofloxacin
Ciprofloxacin is the generic international name for the synthetic antibiotic manufactured and sold by Bayer Pharmaceutical under the brand names Cipro® and Ciproxin®. It belongs to a group called fluoroquinolones, is bactericidal. Its mode of action depends upon blocking bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ciprofloxacin (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ciprofloxacin 4.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ciprofloxacin 4 ug/mL Islt SlowMyco
- Display Name
- Ciprofloxacin 4 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ciprofloxacin 4 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 18466
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ciprofloxacin 4,0 µg/mL: |
| es-ES | Spanish (Spain) | Ciprofloxacino 4 ug/mL: |
| es-AR | Spanish (Argentina) | ciprofloxacina 4.0 ug/ml: |
| es-MX | Spanish (Mexico) | Ciprofloxacina 4.0 ug / mL: |
| fr-CA | French (Canada) | Ciprofloxacine, 4,0 mg/L: |
| fr-BE | French (Belgium) | Ciprofloxacine 4,0 mg/L: |
| fr-FR | French (France) | Ciprofloxacine 4mg/L: |
| it-IT | Italian (Italy) | Ciprofloxacina, 4,0 ug/mL: Synonyms: 4 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 사이프로프록사신 4.0ug/mL: |
| nl-NL | Dutch (Netherlands) | ciprofloxacine 4,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Ciprofloxacina 4.0 ug/mL: Synonyms: Ciprofloxacn; |
| tr-TR | Turkish (Turkey) | Ciproflokzasin 4.0 ug/mL: |
| zh-CN | Chinese (China) | 环丙沙星 4.0 微克/毫升: Synonyms: 4 ug/mL; |
25189-2 Ciprofloxacin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15380-6 Ciprofloxacin
Ciprofloxacin is the generic international name for the synthetic antibiotic manufactured and sold by Bayer Pharmaceutical under the brand names Cipro® and Ciproxin®. It belongs to a group called fluoroquinolones, is bactericidal. Its mode of action depends upon blocking bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ciprofloxacin (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ciprofloxacin 5.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ciprofloxacin 5 ug/mL Islt SlowMyco
- Display Name
- Ciprofloxacin 5 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ciprofloxacin 5 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ciprofloxacin 5,0 µg/mL: |
| es-ES | Spanish (Spain) | Ciprofloxacino 5 ug/mL: |
| es-AR | Spanish (Argentina) | ciprofloxacina 5.0 ug/ml: |
| es-MX | Spanish (Mexico) | Ciprofloxacina 5,0 ug / mL: |
| fr-CA | French (Canada) | Ciprofloxacine, 5,0 mg/L: |
| fr-BE | French (Belgium) | Ciprofloxacine 5,0 mg/L: |
| fr-FR | French (France) | Ciprofloxacine 5mg/L: |
| it-IT | Italian (Italy) | Ciprofloxacina, 5,0 ug/mL: Synonyms: 5 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 사이프로프록사신 5.0ug/mL: |
| nl-NL | Dutch (Netherlands) | ciprofloxacine 5,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Ciprofloxacina 5.0 ug/mL: Synonyms: Ciprofloxacn; |
| tr-TR | Turkish (Turkey) | Ciproflokzasin 5.0 ug/mL: |
| zh-CN | Chinese (China) | 环丙沙星 5.0 微克/毫升: Synonyms: 5 ug/mL; |
25188-4 Ciprofloxacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15380-6 Ciprofloxacin
Ciprofloxacin is the generic international name for the synthetic antibiotic manufactured and sold by Bayer Pharmaceutical under the brand names Cipro® and Ciproxin®. It belongs to a group called fluoroquinolones, is bactericidal. Its mode of action depends upon blocking bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ciprofloxacin (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ciprofloxacin 8.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ciprofloxacin 8 ug/mL Islt SlowMyco
- Display Name
- Ciprofloxacin 8 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ciprofloxacin 8 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 17508
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ciprofloxacin 8,0 µg/mL: |
| es-ES | Spanish (Spain) | Ciprofloxacino 8 ug/mL: |
| es-AR | Spanish (Argentina) | ciprofloxacina 8.0 ug/ml: |
| es-MX | Spanish (Mexico) | Ciprofloxacina 8.0 ug / mL: |
| fr-CA | French (Canada) | Ciprofloxacine, 8,0 mg/L: |
| fr-BE | French (Belgium) | Ciprofloxacine 8,0 mg/L: |
| fr-FR | French (France) | Ciprofloxacine 8mg/L: |
| it-IT | Italian (Italy) | Ciprofloxacina, 8,0 ug/mL: Synonyms: 8 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 사이프로프록사신 8.0ug/mL: |
| nl-NL | Dutch (Netherlands) | ciprofloxacine 8,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Ciprofloxacina 8.0 ug/mL: Synonyms: Ciprofloxacn; |
| tr-TR | Turkish (Turkey) | Ciproflokzasin 8.0 ug/mL: |
| zh-CN | Chinese (China) | 环丙沙星 8.0 微克/毫升: Synonyms: 8 ug/mL; |
20375-2 Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15406-9 Clarithromycin
Clarithromycin is a macrolide antibiotic used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia (especially atypical pneumonias associated with Chlamydia pneumoniae or TWAR), skin and skin structure infections, and, in HIV and AIDS patients to prevent, and to treat, disseminated Mycobacterium avium complex or MAC. In addition, it is sometimes used to treat Legionellosis. Clarithromycin is available under several brand names, for example Biaxin, Klacid, and Claripen.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Clarithromycin (Wikipedia)
LP15406-9 Clarithromycin
A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit protein synthesis in bacteria by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Clarithromycin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Clarithro Islt SlowMyco
- Display Name
- Clarithromycin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Clarithromycin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0m
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 14102
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41004-9 | ClarithromycinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Clarithromycin: |
| es-AR | Spanish (Argentina) | micobacterias.lentas: |
| es-MX | Spanish (Mexico) | Claritromicina: |
| es-ES | Spanish (Spain) | Claritromicina: |
| fr-CA | French (Canada) | Clarithromycine: |
| fr-BE | French (Belgium) | Clarithromycine: |
| fr-FR | French (France) | Clarithromycine: |
| it-IT | Italian (Italy) | Claritromicina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 클라리스로마이신: |
| nl-NL | Dutch (Netherlands) | clarithromycine: |
| pt-BR | Portuguese (Brazil) | Claritromicina: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Klaritromisin: |
| zh-CN | Chinese (China) | 克拉霉素: Synonyms: 分离物; |
43990-1 Clarithromycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15406-9 Clarithromycin
Clarithromycin is a macrolide antibiotic used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia (especially atypical pneumonias associated with Chlamydia pneumoniae or TWAR), skin and skin structure infections, and, in HIV and AIDS patients to prevent, and to treat, disseminated Mycobacterium avium complex or MAC. In addition, it is sometimes used to treat Legionellosis. Clarithromycin is available under several brand names, for example Biaxin, Klacid, and Claripen.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Clarithromycin (Wikipedia)
LP15406-9 Clarithromycin
A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit protein synthesis in bacteria by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Clarithromycin 3.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Clarithro 3 ug/mL Islt SlowMyco
- Display Name
- Clarithromycin 3 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Clarithromycin 3 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.17
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Clarithromycin 3,0 µg/mL: |
| es-ES | Spanish (Spain) | Claritromicina 3 ug/mL: |
| es-MX | Spanish (Mexico) | Claritromicina 3,0 ug / mL: |
| fr-CA | French (Canada) | Clarithromycine, 3,0 mg/L: |
| fr-BE | French (Belgium) | Clarithromycine 3,0 mg/L: |
| fr-FR | French (France) | Clarithromycine 3mg/L: |
| it-IT | Italian (Italy) | Claritromicina, 3,0 ug/mL: Synonyms: 3 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | clarithromycine 3,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Claritromicina 3.0 ug/mL: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Klaritromisin 3.0 ug/mL: |
| zh-CN | Chinese (China) | 克拉霉素 3.0 微克/毫升: Synonyms: 3 ug/mL; |
43991-9 Clarithromycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15406-9 Clarithromycin
Clarithromycin is a macrolide antibiotic used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia (especially atypical pneumonias associated with Chlamydia pneumoniae or TWAR), skin and skin structure infections, and, in HIV and AIDS patients to prevent, and to treat, disseminated Mycobacterium avium complex or MAC. In addition, it is sometimes used to treat Legionellosis. Clarithromycin is available under several brand names, for example Biaxin, Klacid, and Claripen.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Clarithromycin (Wikipedia)
LP15406-9 Clarithromycin
A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit protein synthesis in bacteria by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Clarithromycin 6.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Clarithro 6 ug/mL Islt SlowMyco
- Display Name
- Clarithromycin 6 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Clarithromycin 6 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.17
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Clarithromycin 6,0 µg/mL: |
| es-ES | Spanish (Spain) | Claritromicina 6 ug/mL: |
| es-MX | Spanish (Mexico) | Claritromicina 6.0 ug / mL: |
| fr-CA | French (Canada) | Clarithromycine, 6,0 mg/L: |
| fr-BE | French (Belgium) | Clarithromycine 6,0 mg/L: |
| fr-FR | French (France) | Clarithromycine 6mg/L: |
| it-IT | Italian (Italy) | Claritromicina 6,0 ug/mL: Synonyms: 6 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | clarithromycine 6,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Claritromicina 6.0 ug/mL: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Klaritromisin 6.0 ug/mL: |
| zh-CN | Chinese (China) | 克拉霉素 6.0 微克/毫升: Synonyms: 6 ug/mL; |
25190-0 Clarithromycin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15406-9 Clarithromycin
Clarithromycin is a macrolide antibiotic used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia (especially atypical pneumonias associated with Chlamydia pneumoniae or TWAR), skin and skin structure infections, and, in HIV and AIDS patients to prevent, and to treat, disseminated Mycobacterium avium complex or MAC. In addition, it is sometimes used to treat Legionellosis. Clarithromycin is available under several brand names, for example Biaxin, Klacid, and Claripen.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Clarithromycin (Wikipedia)
LP15406-9 Clarithromycin
A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit protein synthesis in bacteria by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Clarithromycin 8.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Clarithro 8 ug/mL Islt SlowMyco
- Display Name
- Clarithromycin 8 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Clarithromycin 8 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 19702
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Clarithromycin 8,0 µg/mL: |
| es-ES | Spanish (Spain) | Claritromicina 8 ug/mL: |
| es-AR | Spanish (Argentina) | claritromicina 8.0 ug/ml: |
| es-MX | Spanish (Mexico) | Claritromicina 8.0 ug / mL: |
| fr-CA | French (Canada) | Clarithromycine, 8,0 mg/L: |
| fr-BE | French (Belgium) | Clarithromycine 8,0 mg/L: |
| fr-FR | French (France) | Clarithromycine 8mg/L: |
| it-IT | Italian (Italy) | Claritromicina, 8,0 ug/mL: Synonyms: 8 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 클라리스로마이신 8.0ug/mL: |
| nl-NL | Dutch (Netherlands) | clarithromycine 8,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Claritromicina 8.0 ug/mL: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Klaritromisin 8.0 ug/mL: |
| zh-CN | Chinese (China) | 克拉霉素 8.0 微克/毫升: Synonyms: 8 ug/mL; |
43987-7 Clarithromycin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15406-9 Clarithromycin
Clarithromycin is a macrolide antibiotic used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia (especially atypical pneumonias associated with Chlamydia pneumoniae or TWAR), skin and skin structure infections, and, in HIV and AIDS patients to prevent, and to treat, disseminated Mycobacterium avium complex or MAC. In addition, it is sometimes used to treat Legionellosis. Clarithromycin is available under several brand names, for example Biaxin, Klacid, and Claripen.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Clarithromycin (Wikipedia)
LP15406-9 Clarithromycin
A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit protein synthesis in bacteria by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Clarithromycin 12.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Clarithro 12 ug/mL Islt SlowMyco
- Display Name
- Clarithromycin 12 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Clarithromycin 12 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.17
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Clarithromycin 12,0 µg/mL: |
| es-ES | Spanish (Spain) | Claritromicina 12 ug/mL: |
| es-MX | Spanish (Mexico) | Claritromicina 12,0 ug / mL: |
| fr-CA | French (Canada) | Clarithromycine, 12,0 mg/L: |
| fr-BE | French (Belgium) | Clarithromycine 12,0 mg/L: |
| fr-FR | French (France) | Clarithromycine 12mg/L: |
| it-IT | Italian (Italy) | Claritromicina 12,0 ug/mL: Synonyms: 12 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | clarithromycine 12,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Claritromicina 12.0 ug/mL: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Klaritromisin 12.0 ug/mL: |
| zh-CN | Chinese (China) | 克拉霉素 12.0 微克/毫升: Synonyms: 12 ug/mL; |
25191-8 Clarithromycin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15406-9 Clarithromycin
Clarithromycin is a macrolide antibiotic used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia (especially atypical pneumonias associated with Chlamydia pneumoniae or TWAR), skin and skin structure infections, and, in HIV and AIDS patients to prevent, and to treat, disseminated Mycobacterium avium complex or MAC. In addition, it is sometimes used to treat Legionellosis. Clarithromycin is available under several brand names, for example Biaxin, Klacid, and Claripen.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Clarithromycin (Wikipedia)
LP15406-9 Clarithromycin
A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit protein synthesis in bacteria by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Clarithromycin 16.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Clarithro 16 ug/mL Islt SlowMyco
- Display Name
- Clarithromycin 16 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Clarithromycin 16 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 16833
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Clarithromycin 16,0 µg/mL: |
| es-ES | Spanish (Spain) | Claritromicina 16 ug/mL: |
| es-AR | Spanish (Argentina) | claritromicina 16.0 ug/ml: |
| es-MX | Spanish (Mexico) | Claritromicina 16,0 ug / mL: |
| fr-CA | French (Canada) | Clarithromycine, 16,0 mg/L: |
| fr-BE | French (Belgium) | Clarithromycine 16,0 mg/L: |
| fr-FR | French (France) | Clarithromycine 16mg/L: |
| it-IT | Italian (Italy) | Claritromicina 16,0 ug/mL: Synonyms: 16 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 클라리스로마이신 16.0ug/mL: |
| nl-NL | Dutch (Netherlands) | clarithromycine 16,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Claritromicina 16.0 ug/mL: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Klaritromisin 16.0 ug/mL: |
| zh-CN | Chinese (China) | 克拉霉素 16.0 微克/毫升: Synonyms: 16 ug/mL; |
25192-6 Clarithromycin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15406-9 Clarithromycin
Clarithromycin is a macrolide antibiotic used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia (especially atypical pneumonias associated with Chlamydia pneumoniae or TWAR), skin and skin structure infections, and, in HIV and AIDS patients to prevent, and to treat, disseminated Mycobacterium avium complex or MAC. In addition, it is sometimes used to treat Legionellosis. Clarithromycin is available under several brand names, for example Biaxin, Klacid, and Claripen.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Clarithromycin (Wikipedia)
LP15406-9 Clarithromycin
A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit protein synthesis in bacteria by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Clarithromycin 32.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Clarithro 32 ug/mL Islt SlowMyco
- Display Name
- Clarithromycin 32 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Clarithromycin 32 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 18199
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Clarithromycin 32,0 µg/mL: |
| es-ES | Spanish (Spain) | Claritromicina 32 ug/mL: |
| es-AR | Spanish (Argentina) | claritromicina 32.0 ug/ml: |
| es-MX | Spanish (Mexico) | Claritromicina 32,0 ug / mL: |
| fr-CA | French (Canada) | Clarithromycine, 32,0 mg/L: |
| fr-BE | French (Belgium) | Clarithromycine 32,0 mg/L: |
| fr-FR | French (France) | Clarithromycine 32mg/L: |
| it-IT | Italian (Italy) | Claritromicina 32,0 ug/mL: Synonyms: 32 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 클라리스로마이신 32.0ug/mL: |
| nl-NL | Dutch (Netherlands) | clarithromycine 32,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Claritromicina 32.0 ug/mL: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Klaritromisin 32.0 ug/mL: |
| zh-CN | Chinese (China) | 克拉霉素 32.0 微克/毫升: Synonyms: 32 ug/mL; |
20376-0 Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP18924-8 Clofazimine
Clofazimine is a fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619).
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Clofazimine (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Clofazimine
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Clofazamine Islt SlowMyco
- Display Name
- Clofazimine Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Clofazimine
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0m
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41129-4 | ClofazimineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Clofazimin: |
| es-AR | Spanish (Argentina) | micobacterias.lentas: |
| es-MX | Spanish (Mexico) | Clofazimina: |
| es-ES | Spanish (Spain) | Clofazimina: |
| fr-CA | French (Canada) | Clofazimine: |
| fr-BE | French (Belgium) | Clofazimine: |
| fr-FR | French (France) | Clofazimine: |
| it-IT | Italian (Italy) | Clofazimina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 클로파지민: |
| nl-NL | Dutch (Netherlands) | clofazimine: |
| pt-BR | Portuguese (Brazil) | Clofazimina: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Klofazimine: |
| zh-CN | Chinese (China) | 氯法齐明: Synonyms: B663; |
43988-5 Clofazimine 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP18924-8 Clofazimine
Clofazimine is a fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619).
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Clofazimine (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Clofazimine 0.5 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Clofazamine 0.5 ug/mL Islt SlowMyco
- Display Name
- Clofazimine 0.5 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Clofazimine 0.5 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.17
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Clofazimin 0,5 µg/mL: |
| es-ES | Spanish (Spain) | Clofazimina 0.5 ug/mL: |
| es-MX | Spanish (Mexico) | Clofazimina 0,5 ug / mL: |
| fr-CA | French (Canada) | Clofazimine, 0,5 mg/L: |
| fr-BE | French (Belgium) | Clofazimine 0,5 ug/mL: |
| fr-FR | French (France) | Clofazimine 0,5mg/L: |
| it-IT | Italian (Italy) | Clofazimina 0,5 ug/mL: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | clofazimine 0,5 ug/mL: |
| pt-BR | Portuguese (Brazil) | Clofazimina 0.5 ug/mL: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Klofazimine 0.5 ug/mL: |
| zh-CN | Chinese (China) | 氯法齐明 0.5 微克/毫升: Synonyms: 0.5 ug/mL B663; |
43989-3 Clofazimine 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP18924-8 Clofazimine
Clofazimine is a fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619).
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Clofazimine (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Clofazimine 1.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Clofazamine 1 ug/mL Islt SlowMyco
- Display Name
- Clofazimine 1 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Clofazimine 1 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.17
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Clofazimin 1,0 µg/mL: |
| es-ES | Spanish (Spain) | Clofazimina 1 ug/mL: |
| es-MX | Spanish (Mexico) | Clofazimina 1.0 ug / mL: |
| fr-CA | French (Canada) | Clofazimine, 1,0 mg/L: |
| fr-BE | French (Belgium) | Clofazimine 1,0 mg/L: |
| fr-FR | French (France) | Clofazimine 1mg/L: |
| it-IT | Italian (Italy) | Clofazimina 1,0 ug/mL: Synonyms: 1 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | clofazimine 1,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Clofazimina 1.0 ug/mL: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Klofazimine 1.0 ug/mL: |
| zh-CN | Chinese (China) | 氯法齐明 1.0 微克/毫升: Synonyms: 1 ug/mL; |
43986-9 Clofazimine 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP18924-8 Clofazimine
Clofazimine is a fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619).
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Clofazimine (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Clofazimine 2.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Clofazamine 2 ug/mL Islt SlowMyco
- Display Name
- Clofazimine 2 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Clofazimine 2 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.17
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Clofazimin 2,0 µg/mL: |
| es-ES | Spanish (Spain) | Clofazimina 2 ug/mL: |
| es-MX | Spanish (Mexico) | Clofazimina 2,0 ug / mL: |
| fr-CA | French (Canada) | Clofazimine, 2,0 mg/L: |
| fr-BE | French (Belgium) | Clofazimine 2,0 mg/L: |
| fr-FR | French (France) | Clofazimine 2mg/L: |
| it-IT | Italian (Italy) | Clofazimina, 2,0 ug/mL: Synonyms: 2 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | clofazimine 2,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Clofazimina 2.0 ug/mL: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Klofazimine 2.0 ug/mL: |
| zh-CN | Chinese (China) | 氯法齐明 2.0 微克/毫升: Synonyms: 2 ug/mL; |
23608-3 cycloSERINE [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15501-7 cycloSERINE
Is an oral broad spectrum antibiotic effective against tuberculosis, it inhibits cell wall synthesis of TB bacilli at early stage of peptidoglycan synthesis. Being trialed for treatment of phobias as well as an adjuvant to conventional treatments for depression and schizophrenia. Side effects mainly CNS manifestations i.e. headache, irritability, depression, convulsions. Co-administration of pyridoxine can reduce the incidence of some of the CNS side effects(e.g. convulsions). These psychotropic responses are related to D-cycloserine's action as a partial agonist of the neuronal NMDA receptor for glutamate and have been examined in implications with sensory-related fear extinction in the amygdala. See Michael Davis, Barbara Rothbaum, Kerry Ressler et al. and their work with PTSD at Emory University 's School of Medicine.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Cycloserine (Wikipedia)
LP15501-7 cycloSERINE
Antibiotic substance produced by Streptomyces garyphalus.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- cycloSERINE
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- cycloSERINE Islt SlowMyco
- Display Name
- cycloSERINE Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to cycloSERINE
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0n
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 8632
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41046-0 | CycloserineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Cycloserin: |
| es-ES | Spanish (Spain) | Cicloserina: |
| es-AR | Spanish (Argentina) | cicloserina: |
| es-MX | Spanish (Mexico) | cicloSERINA: |
| fr-BE | French (Belgium) | Cyclosérine: |
| fr-CA | French (Canada) | Cyclosérine: Synonyms: #REF! |
| fr-FR | French (France) | Cyclosérine: |
| it-IT | Italian (Italy) | Cicloserina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 시클로세린: |
| nl-NL | Dutch (Netherlands) | cycloserine: |
| pt-BR | Portuguese (Brazil) | Cicloserina: Synonyms: Seromycine; |
| tr-TR | Turkish (Turkey) | Sikloserin: |
| zh-CN | Chinese (China) | 环丝氨酸: Synonyms: 分离物; |
25207-2 cycloSERINE 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15501-7 cycloSERINE
Is an oral broad spectrum antibiotic effective against tuberculosis, it inhibits cell wall synthesis of TB bacilli at early stage of peptidoglycan synthesis. Being trialed for treatment of phobias as well as an adjuvant to conventional treatments for depression and schizophrenia. Side effects mainly CNS manifestations i.e. headache, irritability, depression, convulsions. Co-administration of pyridoxine can reduce the incidence of some of the CNS side effects(e.g. convulsions). These psychotropic responses are related to D-cycloserine's action as a partial agonist of the neuronal NMDA receptor for glutamate and have been examined in implications with sensory-related fear extinction in the amygdala. See Michael Davis, Barbara Rothbaum, Kerry Ressler et al. and their work with PTSD at Emory University 's School of Medicine.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Cycloserine (Wikipedia)
LP15501-7 cycloSERINE
Antibiotic substance produced by Streptomyces garyphalus.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- cycloSERINE 10.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- cycloSERINE 10 ug/mL Islt SlowMyco
- Display Name
- cycloSERINE 10 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to cycloSERINE 10 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Cycloserin 10,0 µg/mL: |
| es-ES | Spanish (Spain) | Cicloserina 10 ug/mL: |
| es-AR | Spanish (Argentina) | cicloserina 10.0 ug/ml: |
| es-MX | Spanish (Mexico) | cicloSERINA 10.0 ug / mL: |
| fr-CA | French (Canada) | Cyclosérine, 10,0 mg/L: Synonyms: #REF! |
| fr-BE | French (Belgium) | Cyclosérine 10,0 mg/L: |
| fr-FR | French (France) | Cyclosérine 10mg/L: |
| it-IT | Italian (Italy) | Cicloserina 10,0 ug/mL: Synonyms: 10 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 시클로세린 10.0ug/mL: |
| nl-NL | Dutch (Netherlands) | cycloserine 10,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Cicloserina 10.0 ug/mL: Synonyms: Seromycine; |
| tr-TR | Turkish (Turkey) | Sikloserin 10.0 ug/mL: |
| zh-CN | Chinese (China) | 环丝氨酸 10.0 微克/毫升: Synonyms: 10 ug/mL; |
25208-0 cycloSERINE 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15501-7 cycloSERINE
Is an oral broad spectrum antibiotic effective against tuberculosis, it inhibits cell wall synthesis of TB bacilli at early stage of peptidoglycan synthesis. Being trialed for treatment of phobias as well as an adjuvant to conventional treatments for depression and schizophrenia. Side effects mainly CNS manifestations i.e. headache, irritability, depression, convulsions. Co-administration of pyridoxine can reduce the incidence of some of the CNS side effects(e.g. convulsions). These psychotropic responses are related to D-cycloserine's action as a partial agonist of the neuronal NMDA receptor for glutamate and have been examined in implications with sensory-related fear extinction in the amygdala. See Michael Davis, Barbara Rothbaum, Kerry Ressler et al. and their work with PTSD at Emory University 's School of Medicine.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Cycloserine (Wikipedia)
LP15501-7 cycloSERINE
Antibiotic substance produced by Streptomyces garyphalus.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- cycloSERINE 20.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- cycloSERINE 20 ug/mL Islt SlowMyco
- Display Name
- cycloSERINE 20 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to cycloSERINE 20 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Cycloserin 20,0 µg/mL: |
| es-ES | Spanish (Spain) | Cicloserina 20 ug/mL: |
| es-AR | Spanish (Argentina) | cicloserina 20.0 ug/ml: |
| es-MX | Spanish (Mexico) | cicloSERINA 20,0 ug / mL: |
| fr-CA | French (Canada) | Cyclosérine, 20,0 mg/L: Synonyms: #REF! |
| fr-BE | French (Belgium) | Cyclosérine 20,0 mg/L: |
| fr-FR | French (France) | Cyclosérine 20mg/L: |
| it-IT | Italian (Italy) | Cicloserina 20,0 ug/mL: Synonyms: 20 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 시클로세린 20.0ug/mL: |
| nl-NL | Dutch (Netherlands) | cycloserine 20,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Cicloserina 20.0 ug/mL: Synonyms: Seromycine; |
| tr-TR | Turkish (Turkey) | Sikloserin 20.0 ug/mL: |
| zh-CN | Chinese (China) | 环丝氨酸 20.0 微克/毫升: Synonyms: 20 ug/mL; |
25209-8 cycloSERINE 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15501-7 cycloSERINE
Is an oral broad spectrum antibiotic effective against tuberculosis, it inhibits cell wall synthesis of TB bacilli at early stage of peptidoglycan synthesis. Being trialed for treatment of phobias as well as an adjuvant to conventional treatments for depression and schizophrenia. Side effects mainly CNS manifestations i.e. headache, irritability, depression, convulsions. Co-administration of pyridoxine can reduce the incidence of some of the CNS side effects(e.g. convulsions). These psychotropic responses are related to D-cycloserine's action as a partial agonist of the neuronal NMDA receptor for glutamate and have been examined in implications with sensory-related fear extinction in the amygdala. See Michael Davis, Barbara Rothbaum, Kerry Ressler et al. and their work with PTSD at Emory University 's School of Medicine.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Cycloserine (Wikipedia)
LP15501-7 cycloSERINE
Antibiotic substance produced by Streptomyces garyphalus.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- cycloSERINE 30.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- cycloSERINE 30 ug/mL Islt SlowMyco
- Display Name
- cycloSERINE 30 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to cycloSERINE 30 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 17530
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Cycloserin 30,0 µg/mL: |
| es-ES | Spanish (Spain) | Cicloserina 30 ug/mL: |
| es-AR | Spanish (Argentina) | cicloserina 30.0 ug/ml: |
| es-MX | Spanish (Mexico) | cicloSERINA 30,0 ug / mL: |
| fr-CA | French (Canada) | Cyclosérine, 30,0 mg/L: Synonyms: #REF! |
| fr-BE | French (Belgium) | Cyclosérine 30,0 mg/L: |
| fr-FR | French (France) | Cyclosérine 30mg/L: |
| it-IT | Italian (Italy) | Cicloserina 30,0 ug/mL: Synonyms: 30 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 시클로세린 30.0ug/mL: |
| nl-NL | Dutch (Netherlands) | cycloserine 30,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Cicloserina 30.0 ug/mL: Synonyms: Seromycine; |
| tr-TR | Turkish (Turkey) | Sikloserin 30.0 ug/mL: |
| zh-CN | Chinese (China) | 环丝氨酸 30.0 微克/毫升: Synonyms: 30 ug/mL; |
20379-4 Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP14992-9 Doxycycline
Doxycycline is a member of the tetracycline antibiotics group and is commonly used to treat a variety of infections. Brand names include Monodox®, Periostat®, Vibramycin®, Vibra-Tabs®, Doryx®, Vibrox®, Adoxa®, Doxyhexal® and Atridox® (topical doxycycline hyclate for gum disease.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Doxycycline (Wikipedia)
LP14992-9 Doxycycline
A synthetic TETRACYCLINE derivative with similar antimicrobial activity. Animal studies suggest that it may cause less tooth staining than other tetracyclines. It is used in some areas for the treatment of chloroquine-resistant falciparum malaria (MALARIA, FALCIPARUM).
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Doxycycline
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Doxycycline Islt SlowMyco
- Display Name
- Doxycycline Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Doxycycline
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0m
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41049-4 | DoxycyclineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Doxycyclin: |
| es-ES | Spanish (Spain) | Doxiciclina: |
| es-AR | Spanish (Argentina) | micobacterias.lentas: |
| es-MX | Spanish (Mexico) | Doxiciclina: |
| fr-CA | French (Canada) | Doxycycline: |
| fr-BE | French (Belgium) | Doxycycline: |
| fr-FR | French (France) | Doxycycline: |
| it-IT | Italian (Italy) | Doxiciclina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 독시사이클린: |
| nl-NL | Dutch (Netherlands) | doxycycline: |
| pt-BR | Portuguese (Brazil) | Doxiciclina: Synonyms: c206; |
| tr-TR | Turkish (Turkey) | Doksisiklin: |
| zh-CN | Chinese (China) | 强力霉素: Synonyms: 分离物; |
25223-9 Doxycycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP14992-9 Doxycycline
Doxycycline is a member of the tetracycline antibiotics group and is commonly used to treat a variety of infections. Brand names include Monodox®, Periostat®, Vibramycin®, Vibra-Tabs®, Doryx®, Vibrox®, Adoxa®, Doxyhexal® and Atridox® (topical doxycycline hyclate for gum disease.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Doxycycline (Wikipedia)
LP14992-9 Doxycycline
A synthetic TETRACYCLINE derivative with similar antimicrobial activity. Animal studies suggest that it may cause less tooth staining than other tetracyclines. It is used in some areas for the treatment of chloroquine-resistant falciparum malaria (MALARIA, FALCIPARUM).
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Doxycycline 30.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Doxycycline 30 ug/mL Islt SlowMyco
- Display Name
- Doxycycline 30 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Doxycycline 30 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Doxycyclin 30,0 µg/mL: |
| es-ES | Spanish (Spain) | Doxiciclina 30 ug/mL: |
| es-AR | Spanish (Argentina) | doxiciclina 30,0 ug/ml: |
| es-MX | Spanish (Mexico) | Doxiciclina 30,0 ug / mL: |
| fr-CA | French (Canada) | Doxycycline, 30,0 mg/L: |
| fr-BE | French (Belgium) | Doxycycline 30,0 mg/L: |
| fr-FR | French (France) | Doxycycline 30mg/L: |
| it-IT | Italian (Italy) | Doxiciclina 30,0 ug/mL: Synonyms: 30 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 독시사이클린 30.0ug/mL: |
| nl-NL | Dutch (Netherlands) | doxycycline 30,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Doxiciclina 30.0 ug/mL: Synonyms: c206; |
| tr-TR | Turkish (Turkey) | Doksisiklin 30.0 ug/mL: |
| zh-CN | Chinese (China) | 强力霉素 30.0 微克/毫升: Synonyms: 30 ug/mL; |
20380-2 Erythromycin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15115-6 Erythromycin
A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Erythromycin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Erythromycin Islt SlowMyco
- Display Name
- Erythromycin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Erythromycin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0m
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41051-0 | ErythromycinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Erythromycin: |
| es-ES | Spanish (Spain) | Eritromicina: |
| es-AR | Spanish (Argentina) | micobacterias.lentas: |
| es-MX | Spanish (Mexico) | Eritromicina: |
| fr-CA | French (Canada) | Érythromycine: |
| fr-BE | French (Belgium) | Érythromycine: |
| fr-FR | French (France) | Érythromycine: |
| it-IT | Italian (Italy) | Eritromicina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 에리트로마이신: |
| nl-NL | Dutch (Netherlands) | erytromycine: |
| pl-PL | Polish (Poland) | Erytromycyna: Synonyms: wrażliwość (mikroorganizmów) |
| pt-BR | Portuguese (Brazil) | Eritromicina: Synonyms: Erythromycn; |
| tr-TR | Turkish (Turkey) | Eritromisin: |
| zh-CN | Chinese (China) | 红霉素: Synonyms: 分离物; |
25224-7 Erythromycin 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15115-6 Erythromycin
A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Erythromycin 15.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Erythromycin 15 ug/mL Islt SlowMyco
- Display Name
- Erythromycin 15 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Erythromycin 15 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Erythromycin 15,0 µg/mL: |
| es-ES | Spanish (Spain) | Eritromicina 15 ug/mL: |
| es-AR | Spanish (Argentina) | eritromicina 15.0 ug/ml: |
| es-MX | Spanish (Mexico) | Eritromicina 15,0 ug / mL: |
| fr-CA | French (Canada) | Érythromycine, 15,0 mg/L: |
| fr-BE | French (Belgium) | Érythromycine 15 mg/L: |
| fr-FR | French (France) | Érythromycine 15mg/L: |
| it-IT | Italian (Italy) | Eritromicina 15,0 ug/mL: Synonyms: 15 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 에리트로마이신 15.0ug/mL: |
| nl-NL | Dutch (Netherlands) | erytromycine 15,0 ug/mL: |
| pl-PL | Polish (Poland) | Erytromycyna 15,0 µg/mL: Synonyms: wrażliwość (mikroorganizmów) |
| pt-BR | Portuguese (Brazil) | Eritromicina 15.0 ug/mL: Synonyms: Erythromycn; |
| tr-TR | Turkish (Turkey) | Eritromisin 15.0 ug/mL: |
| zh-CN | Chinese (China) | 红霉素 15.0 微克/毫升: Synonyms: 15 ug/mL; |
20381-0 Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15625-4 Ethambutol
Ethambutol is a bacteriostatic antimycobacterial drug prescribed to treat tuberculosis (Mycobacterium tuberculosis). It is usually given in combination with other tuberculosis drugs. It is sold under the name Myambutol. Bacteriostatic against actively growing TB bacilli, it inhibits RNA synthesis and bacterial growth.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ethambutol (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ethambutol
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ethambutol Islt SlowMyco
- Display Name
- Ethambutol Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ethambutol
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0m
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41052-8 | EthambutolSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ethambutol: |
| es-ES | Spanish (Spain) | Etambutol: |
| es-AR | Spanish (Argentina) | micobacterias.lentas: |
| es-MX | Spanish (Mexico) | Etambutol: |
| fr-CA | French (Canada) | Éthambutol: |
| fr-BE | French (Belgium) | Éthambutol: |
| fr-FR | French (France) | Éthambutol: |
| it-IT | Italian (Italy) | Etambutolo: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 에탐부톨: |
| nl-NL | Dutch (Netherlands) | ethambutol: |
| pt-BR | Portuguese (Brazil) | Etambutol: Synonyms: Ethamb; |
| tr-TR | Turkish (Turkey) | Etambutol: |
| zh-CN | Chinese (China) | 乙胺丁醇: Synonyms: C10H24N2O2 分离物; |
55674-6 Ethambutol 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15625-4 Ethambutol
Ethambutol is a bacteriostatic antimycobacterial drug prescribed to treat tuberculosis (Mycobacterium tuberculosis). It is usually given in combination with other tuberculosis drugs. It is sold under the name Myambutol. Bacteriostatic against actively growing TB bacilli, it inhibits RNA synthesis and bacterial growth.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ethambutol (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ethambutol 2.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ethambutol 2 ug/mL Islt SlowMyco
- Display Name
- Ethambutol 2 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ethambutol 2 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.27
- Last Updated
- Version 2.27
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ethambutol 2,0 µg/mL: |
| es-ES | Spanish (Spain) | Etambutol 2 ug/mL: |
| es-MX | Spanish (Mexico) | Etambutol 2,0 ug / mL: |
| fr-CA | French (Canada) | Éthambutol, 2,0 mg/L: |
| fr-BE | French (Belgium) | Éthambutol 2,0 mg/L: |
| fr-FR | French (France) | Éthambutol 2mg/L: |
| it-IT | Italian (Italy) | Etambutolo, 2,0 ug/mL: Synonyms: 2 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | ethambutol 2,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Etambutol 2.0 ug/mL: Synonyms: Ethamb; |
| tr-TR | Turkish (Turkey) | Etambutol 2.0 ug/mL: |
| zh-CN | Chinese (China) | 乙胺丁醇 2.0 微克/毫升: Synonyms: 2 ug/mL; |
25230-4 Ethambutol 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15625-4 Ethambutol
Ethambutol is a bacteriostatic antimycobacterial drug prescribed to treat tuberculosis (Mycobacterium tuberculosis). It is usually given in combination with other tuberculosis drugs. It is sold under the name Myambutol. Bacteriostatic against actively growing TB bacilli, it inhibits RNA synthesis and bacterial growth.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ethambutol (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ethambutol 2.5 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ethambutol 2.5 ug/mL Islt SlowMyco
- Display Name
- Ethambutol 2.5 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ethambutol 2.5 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 18173
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ethambutol 2,5 µg/mL: |
| es-ES | Spanish (Spain) | Etambutol 2.5 ug/mL: |
| es-AR | Spanish (Argentina) | etambutol 2,5 ug/ml: |
| es-MX | Spanish (Mexico) | Etambutol 2,5 ug / mL: |
| fr-CA | French (Canada) | Éthambutol, 2,5 mg/L: |
| fr-BE | French (Belgium) | Éthambutol 2,5 mg/L: |
| fr-FR | French (France) | Éthambutol 2,5mg/L: |
| it-IT | Italian (Italy) | Etambutolo, 2,5 ug/mL: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 에탐부톨 2.5ug/mL: |
| nl-NL | Dutch (Netherlands) | ethambutol 2,5 ug/mL: |
| pt-BR | Portuguese (Brazil) | Etambutol 2.5 ug/mL: Synonyms: Ethamb; |
| tr-TR | Turkish (Turkey) | Etambutol 2.5 ug/mL: |
| zh-CN | Chinese (China) | 乙胺丁醇 2.5 微克/毫升: Synonyms: 2.5 ug/mL C10H24N2O2 ug μg 分离物; |
25194-2 Ethambutol 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15625-4 Ethambutol
Ethambutol is a bacteriostatic antimycobacterial drug prescribed to treat tuberculosis (Mycobacterium tuberculosis). It is usually given in combination with other tuberculosis drugs. It is sold under the name Myambutol. Bacteriostatic against actively growing TB bacilli, it inhibits RNA synthesis and bacterial growth.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ethambutol (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ethambutol 5.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ethambutol 5 ug/mL Islt SlowMyco
- Display Name
- Ethambutol 5 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ethambutol 5 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 10301
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41173-2 | Ethambutol 5.0 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ethambutol 5,0 µg/mL: |
| es-ES | Spanish (Spain) | Etambutol 5 ug/mL: |
| es-AR | Spanish (Argentina) | etambutol 5,0 ug/ml: |
| es-MX | Spanish (Mexico) | Etambutol 5,0 ug / mL: |
| fr-CA | French (Canada) | Éthambutol, 5,0 mg/L: |
| fr-BE | French (Belgium) | Éthambutol 5,0 mg/L: |
| fr-FR | French (France) | Éthambutol 5mg/L: |
| it-IT | Italian (Italy) | Etambutolo, 5,0 ug/mL: Synonyms: 5 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 에탐부톨 5.0ug/mL: |
| nl-NL | Dutch (Netherlands) | ethambutol 5,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Etambutol 5.0 ug/mL: Synonyms: Ethamb; |
| tr-TR | Turkish (Turkey) | Etambutol 5.0 ug/mL: |
| zh-CN | Chinese (China) | 乙胺丁醇 5.0 微克/毫升: Synonyms: 5 ug/mL; |
25187-6 Ethambutol 7.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15625-4 Ethambutol
Ethambutol is a bacteriostatic antimycobacterial drug prescribed to treat tuberculosis (Mycobacterium tuberculosis). It is usually given in combination with other tuberculosis drugs. It is sold under the name Myambutol. Bacteriostatic against actively growing TB bacilli, it inhibits RNA synthesis and bacterial growth.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ethambutol (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ethambutol 7.5 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ethambutol 7.5 ug/mL Islt SlowMyco
- Display Name
- Ethambutol 7.5 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ethambutol 7.5 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 17258
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ethambutol 7,5 µg/mL: |
| es-ES | Spanish (Spain) | Etambutol 7.5 ug/mL: |
| es-AR | Spanish (Argentina) | etambutol 7,5 ug/ml: |
| es-MX | Spanish (Mexico) | Etambutol 7.5 ug / mL: |
| fr-CA | French (Canada) | Éthambutol, 7,5 mg/L: |
| fr-BE | French (Belgium) | Éthambutol 7,5 mg/L: |
| fr-FR | French (France) | Éthambutol 7,5mg/L: |
| it-IT | Italian (Italy) | Etambutolo 7,5 ug/mL: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 에탐부톨 7.5ug/mL: |
| nl-NL | Dutch (Netherlands) | ethambutol 7,5 ug/mL: |
| pt-BR | Portuguese (Brazil) | Etambutol 7.5 ug/mL: Synonyms: Ethamb; |
| tr-TR | Turkish (Turkey) | Etambutol 7.5 ug/mL: |
| zh-CN | Chinese (China) | 乙胺丁醇 7.5 微克/毫升: Synonyms: 7.5 ug/mL C10H24N2O2 ug μg 分离物; |
56025-0 Ethambutol 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15625-4 Ethambutol
Ethambutol is a bacteriostatic antimycobacterial drug prescribed to treat tuberculosis (Mycobacterium tuberculosis). It is usually given in combination with other tuberculosis drugs. It is sold under the name Myambutol. Bacteriostatic against actively growing TB bacilli, it inhibits RNA synthesis and bacterial growth.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ethambutol (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ethambutol 8.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ethambutol 8 ug/mL Islt SlowMyco
- Display Name
- Ethambutol 8 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ethambutol 8 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.29
- Last Updated
- Version 2.32
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ethambutol 8,0 µg/mL: |
| es-ES | Spanish (Spain) | Etambutol 8 ug/mL: |
| es-MX | Spanish (Mexico) | Etambutol 8.0 ug / mL: |
| fr-CA | French (Canada) | Éthambutol, 8,0 mg/L: |
| fr-BE | French (Belgium) | Éthambutol 8,0 mg/L: |
| fr-FR | French (France) | Éthambutol 8mg/L: |
| it-IT | Italian (Italy) | Etambutolo, 8,0 ug/mL: Synonyms: 8 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | ethambutol 8,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Etambutol 8.0 ug/mL: Synonyms: Ethamb; |
| tr-TR | Turkish (Turkey) | Etambutol 8.0 ug/mL: |
| zh-CN | Chinese (China) | 乙胺丁醇 8.0 微克/毫升: Synonyms: 8 ug/mL; |
25195-9 Ethambutol 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15625-4 Ethambutol
Ethambutol is a bacteriostatic antimycobacterial drug prescribed to treat tuberculosis (Mycobacterium tuberculosis). It is usually given in combination with other tuberculosis drugs. It is sold under the name Myambutol. Bacteriostatic against actively growing TB bacilli, it inhibits RNA synthesis and bacterial growth.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ethambutol (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ethambutol 10.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ethambutol 10 ug/mL Islt SlowMyco
- Display Name
- Ethambutol 10 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ethambutol 10 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 14647
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41174-0 | Ethambutol 10.0 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ethambutol 10,0 µg/mL: |
| es-ES | Spanish (Spain) | Etambutol 10 ug/mL: |
| es-AR | Spanish (Argentina) | etambutol 10,0 ug/ml: |
| es-MX | Spanish (Mexico) | Etambutol 10.0 ug / mL: |
| fr-CA | French (Canada) | Éthambutol, 10,0 mg/L: |
| fr-BE | French (Belgium) | Éthambutol 10,0 mg/L: |
| fr-FR | French (France) | Éthambutol 10mg/L: |
| it-IT | Italian (Italy) | Etambutolo 10,0 ug/mL: Synonyms: 10 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 에탐부톨 10.0ug/mL: |
| nl-NL | Dutch (Netherlands) | ethambutol 10,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Etambutol 10.0 ug/mL: Synonyms: Ethamb; |
| tr-TR | Turkish (Turkey) | Etambutol 10.0 ug/mL: |
| zh-CN | Chinese (China) | 乙胺丁醇 10.0 微克/毫升: Synonyms: 10 ug/mL; |
55154-9 Ethambutol+rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ethambutol+rifAMPin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ethambutol+rifAMPin Islt SlowMyco
- Display Name
- Ethambutol+rifAMPin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ethambutol+rifAMPin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.27
- Last Updated
- Version 2.27
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG40999-1 | Ethambutol+RifampinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ethambutol+Rifampicin: |
| es-ES | Spanish (Spain) | Etambutol+Rifampicina: |
| es-MX | Spanish (Mexico) | Etambutol + rifAMPina: |
| fr-CA | French (Canada) | Éthambutol+Rifampicine: Synonyms: #REF! |
| fr-BE | French (Belgium) | Éthambutol+Rifampicine: |
| fr-FR | French (France) | Éthambutol+rifampicine: |
| it-IT | Italian (Italy) | Etambutolo+Rifampicina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | ethambutol + rifampicine: |
| pt-BR | Portuguese (Brazil) | Etambutol+Rifampina: Synonyms: RIF; |
| tr-TR | Turkish (Turkey) | Etambutol+Rifampin: |
| zh-CN | Chinese (China) | 乙胺丁醇+利福平: Synonyms: C10H24N2O2 RIF; |
20382-8 Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP17271-5 Ethionamide
Ethionamide (2-ethylthioisonicotinamide, Trecator SC®) is an antibiotic used in the treatment of tuberculosis.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ethionamide (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ethionamide
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ethionamide Islt SlowMyco
- Display Name
- Ethionamide Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ethionamide
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0m
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG40994-2 | EthionamideSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ethionamid: |
| es-ES | Spanish (Spain) | Etionamida: |
| es-AR | Spanish (Argentina) | micobacterias.lentas: |
| es-MX | Spanish (Mexico) | Etionamida: |
| fr-CA | French (Canada) | Éthionamide: |
| fr-BE | French (Belgium) | Éthionamide: |
| fr-FR | French (France) | Éthionamide: |
| it-IT | Italian (Italy) | Etionamide: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 에티오나미드: |
| nl-NL | Dutch (Netherlands) | ethionamide: |
| pt-BR | Portuguese (Brazil) | Etionamida: Synonyms: Trecator; |
| tr-TR | Turkish (Turkey) | Etionamid: |
| zh-CN | Chinese (China) | 乙硫异烟胺: Synonyms: 分离物; |
25196-7 Ethionamide 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP17271-5 Ethionamide
Ethionamide (2-ethylthioisonicotinamide, Trecator SC®) is an antibiotic used in the treatment of tuberculosis.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ethionamide (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ethionamide 5.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ethionamide 5 ug/mL Islt SlowMyco
- Display Name
- Ethionamide 5 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ethionamide 5 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 14506
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41175-7 | Ethionamide 5.0 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ethionamid 5,0 µg/mL: |
| es-ES | Spanish (Spain) | Etionamida 5 ug/mL: |
| es-AR | Spanish (Argentina) | etionamida 5 ug/ml: |
| es-MX | Spanish (Mexico) | Etionamida 5,0 ug / mL: |
| fr-CA | French (Canada) | Éthionamide, 5,0 mg/L: |
| fr-BE | French (Belgium) | Éthionamide 5,0 mg/L: |
| fr-FR | French (France) | Éthionamide 5mg/L: |
| it-IT | Italian (Italy) | Etionamide, 5,0 ug/mL: Synonyms: 5 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 에티오나미드 5.0ug/mL: |
| nl-NL | Dutch (Netherlands) | ethionamide 5,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Etionamida 5.0 ug/mL: Synonyms: Trecator; |
| tr-TR | Turkish (Turkey) | Etionamid 5.0 ug/mL: |
| zh-CN | Chinese (China) | 乙硫异烟胺 5.0 微克/毫升: Synonyms: 5 ug/mL; |
25231-2 Ethionamide 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP17271-5 Ethionamide
Ethionamide (2-ethylthioisonicotinamide, Trecator SC®) is an antibiotic used in the treatment of tuberculosis.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ethionamide (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ethionamide 10.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ethionamide 10 ug/mL Islt SlowMyco
- Display Name
- Ethionamide 10 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ethionamide 10 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 19510
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41209-4 | Ethionamide 10.0 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ethionamid 10,0 µg/mL: |
| es-ES | Spanish (Spain) | Etionamida 10 ug/mL: |
| es-AR | Spanish (Argentina) | etionamida 10 ug/ml: |
| es-MX | Spanish (Mexico) | Etionamida 10,0 ug / mL: |
| fr-CA | French (Canada) | Éthionamide, 10,0 mg/L: |
| fr-BE | French (Belgium) | Éthionamide 10,0 mg/L: |
| fr-FR | French (France) | Éthionamide 10mg/L: |
| it-IT | Italian (Italy) | Etionamide 10,0 ug/mL: Synonyms: 10 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 에티오나미드 10.0ug/mL: |
| nl-NL | Dutch (Netherlands) | ethionamide 10,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Etionamida 10.0 ug/mL: Synonyms: Trecator; |
| tr-TR | Turkish (Turkey) | Etionamid 10.0 ug/mL: |
| zh-CN | Chinese (China) | 乙硫异烟胺 10.0 微克/毫升: Synonyms: 10 ug/mL; |
25183-5 Ethionamide 11 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP17271-5 Ethionamide
Ethionamide (2-ethylthioisonicotinamide, Trecator SC®) is an antibiotic used in the treatment of tuberculosis.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ethionamide (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ethionamide 11.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ethionamide 11 ug/mL Islt SlowMyco
- Display Name
- Ethionamide 11 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ethionamide 11 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ethionamid 11,0 µg/mL: |
| es-ES | Spanish (Spain) | Etionamida 11 ug/mL: |
| es-AR | Spanish (Argentina) | etionamida 11 ug/ml: |
| es-MX | Spanish (Mexico) | Etionamida 11,0 ug / mL: |
| fr-CA | French (Canada) | Éthionamide, 11,0 mg/L: |
| fr-BE | French (Belgium) | Éthionamide 11 mg/L: |
| fr-FR | French (France) | Éthionamide 11mg/L: |
| it-IT | Italian (Italy) | Etionamide 11,0 ug/mL: Synonyms: 11 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 에티오나미드 11.0ug/mL: |
| nl-NL | Dutch (Netherlands) | ethionamide 11,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Etionamida 11.0 ug/mL: Synonyms: Trecator; |
| tr-TR | Turkish (Turkey) | Etionamid 11.0 ug/mL: |
| zh-CN | Chinese (China) | 乙硫异烟胺 11.0 微克/毫升: Synonyms: 11 ug/mL; |
25198-3 Ethionamide 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP17271-5 Ethionamide
Ethionamide (2-ethylthioisonicotinamide, Trecator SC®) is an antibiotic used in the treatment of tuberculosis.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ethionamide (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ethionamide 15.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ethionamide 15 ug/mL Islt SlowMyco
- Display Name
- Ethionamide 15 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ethionamide 15 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 16648
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ethionamid 15,0 µg/mL: |
| es-ES | Spanish (Spain) | Etionamida 15 ug/mL: |
| es-AR | Spanish (Argentina) | etionamida 15 ug/ml: |
| es-MX | Spanish (Mexico) | Etionamida 15.0 ug / mL: |
| fr-CA | French (Canada) | Éthionamide, 15,0 mg/L: |
| fr-BE | French (Belgium) | Éthionamide 15 mg/L: |
| fr-FR | French (France) | Éthionamide 15mg/L: |
| it-IT | Italian (Italy) | Etionamide 15,0 ug/mL: Synonyms: 15 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 에티오나미드 15.0ug/mL: |
| nl-NL | Dutch (Netherlands) | ethionamide 15,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Etionamida 15.0 ug/mL: Synonyms: Trecator; |
| tr-TR | Turkish (Turkey) | Etionamid 15.0 ug/mL: |
| zh-CN | Chinese (China) | 乙硫异烟胺 15.0 微克/毫升: Synonyms: 15 ug/mL; |
41494-6 Gatifloxacin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP28719-0 Gatifloxacin
Gatifloxacin sold under the brand names Gatiflo, Tequin and Zymar, is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Bristol-Myers Squibb introduced Gatifloxacin in 1999 under the proprietary name Tequin for the treatment of respiratory tract infections, having licensed the medication from Kyorin Pharmaceutical Company of Japan. Allergan produces an eye-drop formulation called Zymar.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Gatifloxacin
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Gatifloxacin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Gatifloxacin Islt SlowMyco
- Display Name
- Gatifloxacin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Gatifloxacin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.16
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41273-0 | GatifloxacinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Gatifloxacin: |
| es-ES | Spanish (Spain) | Gatifloxacino: |
| es-MX | Spanish (Mexico) | Gatifloxacina: |
| fr-CA | French (Canada) | Gatifloxacine: |
| fr-BE | French (Belgium) | Gatifloxacine: |
| fr-FR | French (France) | Gatifloxacine: |
| it-IT | Italian (Italy) | Gatifloxacina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 개티플록사신: |
| nl-NL | Dutch (Netherlands) | gatifloxacine: |
| pt-BR | Portuguese (Brazil) | Gatifloxacina: Synonyms: Tequin; |
| tr-TR | Turkish (Turkey) | Gatiflokzasin: |
| zh-CN | Chinese (China) | 加替沙星: Synonyms: 分离物; |
50630-3 Gentamicin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15747-6 Gentamicin
Gentamicin is an aminoglycoside antibiotic, which has a bactericidal mode of action binding to the ribosome and various ribozymes to inhibit protein synthesis. Gentamicin is a hydrophilic molecule and is considered to have limited capacity to penetrate eukaryotic cells. Administered intravenously or intramuscularly, gentamicin is used to treat many bacterial infections, particularly gram-negative organisms such as meningitis, and infections of the blood, abdomen, lungs, skin, bones, joints and urinary tract, and is often used to treat severe cases of tularemia and the plague. The effect of gentamicin is mediated through the production of reactive oxygen species (ROS), which causes destablization of iron-sulfur (Fe-S) clusters and generates toxic, bactericidal compounds through the Fenton reaction. Gentamicin may cause kidney, nerve and severe hearing problems. More common side effects include nausea, headache, fever, rash and hoarseness. PMID: 26503658 [MedlinePlus Drug:a682275]
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Gentamicin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Gentamicin Islt SlowMyco
- Display Name
- Gentamicin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Gentamicin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.22
- Last Updated
- Version 2.26
- Order vs. Observation
- Both
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41057-7 | GentamicinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Gentamicin: |
| es-ES | Spanish (Spain) | Gentamicina: |
| es-MX | Spanish (Mexico) | Gentamicina: |
| fr-CA | French (Canada) | Gentamicine: |
| fr-BE | French (Belgium) | Gentamicine: |
| fr-FR | French (France) | Gentamicine: |
| it-IT | Italian (Italy) | Gentamicina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | gentamicine: |
| pt-BR | Portuguese (Brazil) | Gentamicina: Synonyms: c213; |
| tr-TR | Turkish (Turkey) | Gentamisin: |
| zh-CN | Chinese (China) | 庆大霉素: Synonyms: 分离物; |
23613-3 Imipenem [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15795-5 Imipenem
Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with cilastatin, a renal dipeptidase inhibitor.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Imipenem
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Imipenem Islt SlowMyco
- Display Name
- Imipenem Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Imipenem
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0n
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 15674
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41061-9 | ImipenemSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Imipenem: |
| es-ES | Spanish (Spain) | Imipenem: |
| es-AR | Spanish (Argentina) | imipenem: |
| es-MX | Spanish (Mexico) | Imipenem: |
| fr-BE | French (Belgium) | Imipénem: |
| fr-CA | French (Canada) | Imipénem: |
| fr-FR | French (France) | Imipénème: |
| it-IT | Italian (Italy) | Imipenem: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 이미페넴: |
| nl-NL | Dutch (Netherlands) | imipenem: |
| pt-BR | Portuguese (Brazil) | Imipenem: Synonyms: Imp; |
| tr-TR | Turkish (Turkey) | İmipenem: |
| zh-CN | Chinese (China) | 亚胺培南: Synonyms: 分离物; |
25221-3 Imipenem 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15795-5 Imipenem
Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with cilastatin, a renal dipeptidase inhibitor.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Imipenem 10.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Imipenem 10 ug/mL Islt SlowMyco
- Display Name
- Imipenem 10 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Imipenem 10 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Imipenem 10,0 µg/mL: |
| es-ES | Spanish (Spain) | Imipenem 10 ug/mL: |
| es-AR | Spanish (Argentina) | imipenem 10 ug/ml: |
| es-MX | Spanish (Mexico) | Imipenem 10,0 ug / ml: |
| fr-CA | French (Canada) | Imipénem, 10,0 mg/L: |
| fr-BE | French (Belgium) | Imipénem 10,0 mg/L: |
| fr-FR | French (France) | Imipénème 10mg/L: |
| it-IT | Italian (Italy) | Imipenem 10,0 ug/mL: Synonyms: 10 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 이미페넴 10.0ug/mL: |
| nl-NL | Dutch (Netherlands) | imipenem 10,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Imipenem 10.0 ug/mL: Synonyms: Imp; |
| tr-TR | Turkish (Turkey) | İmipenem 10.0 ug/mL: |
| zh-CN | Chinese (China) | 亚胺培南 10.0 微克/毫升: Synonyms: 10 ug/mL; |
20383-6 Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15831-8 Isoniazid
Isoniazid (also called isonicotinyl hydrazine or isonicotinic acid hydrazide) is often abbreviated INH. Isoniazid is a first-line antituberculous medication used in the prevention and treatment of tuberculosis. It is available in tablet, syrup, and injectable forms (given intramuscularly or intravenously), available world-wide, inexpensive to produce and is generally well tolerated.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Isoniazid (Wikipedia)
LP15831-8 Isoniazid
Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Isoniazid
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Isoniazid Islt SlowMyco
- Display Name
- Isoniazid Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Isoniazid
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0m
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41063-5 | IsoniazidSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Isoniazid: |
| es-ES | Spanish (Spain) | Isoniazida: |
| es-AR | Spanish (Argentina) | micobacterias.lentas: |
| es-MX | Spanish (Mexico) | Isoniazida: |
| fr-CA | French (Canada) | Isoniazide: |
| fr-BE | French (Belgium) | Isoniazide: Synonyms: INH |
| fr-FR | French (France) | Isoniazide: |
| it-IT | Italian (Italy) | Isoniazide: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 이소니아지드: |
| nl-NL | Dutch (Netherlands) | isoniazide: |
| pt-BR | Portuguese (Brazil) | Isoniazida: Synonyms: Isoniaz; |
| tr-TR | Turkish (Turkey) | İzoniazid: |
| zh-CN | Chinese (China) | 异烟肼: Synonyms: C6H7N3O; |
25217-1 Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15831-8 Isoniazid
Isoniazid (also called isonicotinyl hydrazine or isonicotinic acid hydrazide) is often abbreviated INH. Isoniazid is a first-line antituberculous medication used in the prevention and treatment of tuberculosis. It is available in tablet, syrup, and injectable forms (given intramuscularly or intravenously), available world-wide, inexpensive to produce and is generally well tolerated.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Isoniazid (Wikipedia)
LP15831-8 Isoniazid
Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Isoniazid 0.1 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Isoniazid 0.1 ug/mL Islt SlowMyco
- Display Name
- Isoniazid 0.1 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Isoniazid 0.1 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 10462
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41195-5 | Isoniazid 0.1 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Isoniazid 0,1 µg/mL: |
| es-ES | Spanish (Spain) | Isoniazida 0.1 ug/mL: |
| es-AR | Spanish (Argentina) | isoniazida 0.1 ug/ml: |
| es-MX | Spanish (Mexico) | Isoniazida 0,1 ug / mL: |
| fr-CA | French (Canada) | Isoniazide, 0,1 mg/L: |
| fr-BE | French (Belgium) | Isoniazide 0,1 mg/L: Synonyms: INH |
| fr-FR | French (France) | Isoniazide 0,1mg/L: |
| it-IT | Italian (Italy) | Isoniazide, 0,1 ug/mL: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 이소니아지드 0.1ug/mL: |
| nl-NL | Dutch (Netherlands) | isoniazide 0,1 ug/mL: |
| pt-BR | Portuguese (Brazil) | Isoniazida 0.1 ug/mL: Synonyms: Isoniaz; |
| tr-TR | Turkish (Turkey) | İzoniazid 0.1 ug/mL: |
| zh-CN | Chinese (China) | 异烟肼 0.1 微克/毫升: Synonyms: 0.1 ug/mL C6H7N3O; |
25218-9 Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15831-8 Isoniazid
Isoniazid (also called isonicotinyl hydrazine or isonicotinic acid hydrazide) is often abbreviated INH. Isoniazid is a first-line antituberculous medication used in the prevention and treatment of tuberculosis. It is available in tablet, syrup, and injectable forms (given intramuscularly or intravenously), available world-wide, inexpensive to produce and is generally well tolerated.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Isoniazid (Wikipedia)
LP15831-8 Isoniazid
Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Isoniazid 0.2 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Isoniazid 0.2 ug/mL Islt SlowMyco
- Display Name
- Isoniazid 0.2 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Isoniazid 0.2 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 14838
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41196-3 | Isoniazid 0.2 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Isoniazid 0,2 µg/mL: |
| es-ES | Spanish (Spain) | Isoniazida 0.2 ug/mL: |
| es-AR | Spanish (Argentina) | isoniazida 0.2 ug/ml: |
| es-MX | Spanish (Mexico) | Isoniazida 0,2 ug / mL: |
| fr-CA | French (Canada) | Isoniazide, 0,2 mg/L: |
| fr-BE | French (Belgium) | Isoniazide 0,2 mg/L: Synonyms: INH |
| fr-FR | French (France) | Isoniazide 0,2mg/L: |
| it-IT | Italian (Italy) | Isoniazide, 0,2 ug/mL: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 이소니아지드 0.2ug/mL: |
| nl-NL | Dutch (Netherlands) | isoniazide 0,2 ug/mL: |
| pt-BR | Portuguese (Brazil) | Isoniazida 0.2 ug/mL: Synonyms: Isoniaz; |
| tr-TR | Turkish (Turkey) | İzoniazid 0.2 ug/mL: |
| zh-CN | Chinese (China) | 异烟肼 0.2 微克/毫升: Synonyms: 0.2 ug/mL C6H7N3O; |
29315-9 Isoniazid 0.4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15831-8 Isoniazid
Isoniazid (also called isonicotinyl hydrazine or isonicotinic acid hydrazide) is often abbreviated INH. Isoniazid is a first-line antituberculous medication used in the prevention and treatment of tuberculosis. It is available in tablet, syrup, and injectable forms (given intramuscularly or intravenously), available world-wide, inexpensive to produce and is generally well tolerated.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Isoniazid (Wikipedia)
LP15831-8 Isoniazid
Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Isoniazid 0.4 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Isoniazid 0.4 ug/mL Islt SlowMyco
- Display Name
- Isoniazid 0.4 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Isoniazid 0.4 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.03
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 11935
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41214-4 | Isoniazid 0.4 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Isoniazid 0,4 µg/mL: |
| es-ES | Spanish (Spain) | Isoniazida 0.4 ug/mL: |
| es-AR | Spanish (Argentina) | isoniazida 0.4 ug/ml: |
| es-MX | Spanish (Mexico) | Isoniazida 0,4 ug / ml: |
| fr-CA | French (Canada) | Isoniazide, 0,4 mg/L: |
| fr-BE | French (Belgium) | Isoniazide 0,4 mg/mL: Synonyms: INH |
| fr-FR | French (France) | Isoniazide 0,4mg/L: |
| it-IT | Italian (Italy) | Isoniazide 0,4 ug/mL: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 이소니아지드 0.4ug/mL: |
| nl-NL | Dutch (Netherlands) | isoniazide 0,4 ug/mL: |
| pt-BR | Portuguese (Brazil) | Isoniazida 0.4 ug/mL: Synonyms: Isoniaz; |
| tr-TR | Turkish (Turkey) | İzoniazid 0.4 ug/mL: |
| zh-CN | Chinese (China) | 异烟肼 0.4 微克/毫升: Synonyms: 0.4 ug/mL C6H7N3O; |
25219-7 Isoniazid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15831-8 Isoniazid
Isoniazid (also called isonicotinyl hydrazine or isonicotinic acid hydrazide) is often abbreviated INH. Isoniazid is a first-line antituberculous medication used in the prevention and treatment of tuberculosis. It is available in tablet, syrup, and injectable forms (given intramuscularly or intravenously), available world-wide, inexpensive to produce and is generally well tolerated.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Isoniazid (Wikipedia)
LP15831-8 Isoniazid
Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Isoniazid 1.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Isoniazid 1 ug/mL Islt SlowMyco
- Display Name
- Isoniazid 1 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Isoniazid 1 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 15845
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41197-1 | Isoniazid 1.0 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Isoniazid 1,0 µg/mL: |
| es-ES | Spanish (Spain) | Isoniazida 1 ug/mL: |
| es-AR | Spanish (Argentina) | isoniazida 1 ug/ml: |
| es-MX | Spanish (Mexico) | Isoniazida 1,0 ug / mL: |
| fr-CA | French (Canada) | Isoniazide, 1,0 mg/L: |
| fr-BE | French (Belgium) | Isoniazide 1,0 mg/L: Synonyms: INH |
| fr-FR | French (France) | Isoniazide 1mg/L: |
| it-IT | Italian (Italy) | Isoniazide 1,0 ug/mL: Synonyms: 1 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 이소니아지드 1.0ug/mL: |
| nl-NL | Dutch (Netherlands) | isoniazide 1,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Isoniazida 1.0 ug/mL: Synonyms: Isoniaz; |
| tr-TR | Turkish (Turkey) | İzoniazid 1.0 ug/mL: |
| zh-CN | Chinese (China) | 异烟肼 1.0 微克/毫升: Synonyms: 1 ug/mL; |
45215-1 Isoniazid 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15831-8 Isoniazid
Isoniazid (also called isonicotinyl hydrazine or isonicotinic acid hydrazide) is often abbreviated INH. Isoniazid is a first-line antituberculous medication used in the prevention and treatment of tuberculosis. It is available in tablet, syrup, and injectable forms (given intramuscularly or intravenously), available world-wide, inexpensive to produce and is generally well tolerated.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Isoniazid (Wikipedia)
LP15831-8 Isoniazid
Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Isoniazid 2.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Isoniazid 2 ug/mL Islt SlowMyco
- Display Name
- Isoniazid 2 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Isoniazid 2 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.17
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Isoniazid 2,0 µg/mL: |
| es-ES | Spanish (Spain) | Isoniazida 2 ug/mL: |
| es-MX | Spanish (Mexico) | Isoniazida 2,0 ug / mL: |
| fr-CA | French (Canada) | Isoniazide, 2,0 mg/L: |
| fr-BE | French (Belgium) | Isoniazide 2,0 mg/L: Synonyms: INH |
| fr-FR | French (France) | Isoniazide 2mg/L: |
| it-IT | Italian (Italy) | Isoniazide, 2,0 ug/mL: Synonyms: 2 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | isoniazide 2,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Isoniazida 2.0 ug/mL: Synonyms: Isoniaz; |
| tr-TR | Turkish (Turkey) | İzoniazid 2.0 ug/mL: |
| zh-CN | Chinese (China) | 异烟肼 2.0 微克/毫升: Synonyms: 2 ug/mL; |
42651-0 Isoniazid 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15831-8 Isoniazid
Isoniazid (also called isonicotinyl hydrazine or isonicotinic acid hydrazide) is often abbreviated INH. Isoniazid is a first-line antituberculous medication used in the prevention and treatment of tuberculosis. It is available in tablet, syrup, and injectable forms (given intramuscularly or intravenously), available world-wide, inexpensive to produce and is generally well tolerated.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Isoniazid (Wikipedia)
LP15831-8 Isoniazid
Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Isoniazid 5.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Isoniazid 5 ug/mL Islt SlowMyco
- Display Name
- Isoniazid 5 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Isoniazid 5 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.16
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Isoniazid 5,0 µg/mL: |
| es-ES | Spanish (Spain) | Isoniazida 5 ug/mL: |
| es-MX | Spanish (Mexico) | Isoniazida 5,0 ug / mL: |
| fr-CA | French (Canada) | Isoniazide, 5,0 mg/L: |
| fr-BE | French (Belgium) | Isoniazide 5,0 mg/L: Synonyms: INH |
| fr-FR | French (France) | Isoniazide 5mg/L: |
| it-IT | Italian (Italy) | Isoniazide, 5,0 ug/mL: Synonyms: 5 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 이소니아지드 5.0ug/mL: |
| nl-NL | Dutch (Netherlands) | isoniazide 5,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Isoniazida 5.0 ug/mL: Synonyms: Isoniaz; |
| tr-TR | Turkish (Turkey) | İzoniazid 5.0 ug/mL: |
| zh-CN | Chinese (China) | 异烟肼 5.0 微克/毫升: Synonyms: 5 ug/mL; |
55685-2 Isoniazid 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15831-8 Isoniazid
Isoniazid (also called isonicotinyl hydrazine or isonicotinic acid hydrazide) is often abbreviated INH. Isoniazid is a first-line antituberculous medication used in the prevention and treatment of tuberculosis. It is available in tablet, syrup, and injectable forms (given intramuscularly or intravenously), available world-wide, inexpensive to produce and is generally well tolerated.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Isoniazid (Wikipedia)
LP15831-8 Isoniazid
Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Isoniazid 10.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Isoniazid 10 ug/mL Islt SlowMyco
- Display Name
- Isoniazid 10 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Isoniazid 10 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.27
- Last Updated
- Version 2.27
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Isoniazid 10,0 µg/mL: |
| es-ES | Spanish (Spain) | Isoniazida 10 ug/mL: |
| es-MX | Spanish (Mexico) | Isoniazida 10,0 ug / mL: |
| fr-CA | French (Canada) | Isoniazide, 10,0 mg/L: |
| fr-BE | French (Belgium) | Isoniazide 10,0 mg/L: Synonyms: INH |
| fr-FR | French (France) | Isoniazide 10mg/L: |
| it-IT | Italian (Italy) | Isoniazide 10,0 ug/mL: Synonyms: 10 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | isoniazide 10,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Isoniazida 10.0 ug/mL: Synonyms: Isoniaz; |
| tr-TR | Turkish (Turkey) | İzoniazid 10.0 ug/mL: |
| zh-CN | Chinese (China) | 异烟肼 10.0 微克/毫升: Synonyms: 10 ug/mL; |
23609-1 Kanamycin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP14342-7 Kanamycin
Kanamycin is an aminoglycoside antibiotic that is isolated from the bacterium Streptomyces kanamyceticus. It binds to the bacterial 30S ribosomal subunit which cause a faulty reading of t-RNA that blocks the synthesis of proteins necessary for growth. Aminoglycosides are used to treat aerobic bacteria, Gram-negative bacteria including Pseudomona, Acinetobacter, Enterobacter and some mycobacteria, including Mycobacterium tuberculosis. The aminoglycosides are not effective treatments for anaerobic bacteria, fungi or viruses.[https://www.drugbank.ca/drugs/DB01172]
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Kanamycin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Kanamycin Islt SlowMyco
- Display Name
- Kanamycin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Kanamycin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0n
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41064-3 | KanamycinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Kanamycin: |
| es-MX | Spanish (Mexico) | Kanamicina: |
| es-ES | Spanish (Spain) | Kanamicina: |
| es-AR | Spanish (Argentina) | kanamicina: |
| fr-BE | French (Belgium) | Kanamycine: |
| fr-CA | French (Canada) | Kanamycine: |
| fr-FR | French (France) | Kanamycine: |
| it-IT | Italian (Italy) | Kanamicina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 카나마이신: |
| nl-NL | Dutch (Netherlands) | kanamycine: |
| pt-BR | Portuguese (Brazil) | Canamicina: Synonyms: Kantrex; |
| tr-TR | Turkish (Turkey) | Kanamisin: |
| zh-CN | Chinese (China) | 卡那霉素: Synonyms: 分离物; |
49080-5 Kanamycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP14342-7 Kanamycin
Kanamycin is an aminoglycoside antibiotic that is isolated from the bacterium Streptomyces kanamyceticus. It binds to the bacterial 30S ribosomal subunit which cause a faulty reading of t-RNA that blocks the synthesis of proteins necessary for growth. Aminoglycosides are used to treat aerobic bacteria, Gram-negative bacteria including Pseudomona, Acinetobacter, Enterobacter and some mycobacteria, including Mycobacterium tuberculosis. The aminoglycosides are not effective treatments for anaerobic bacteria, fungi or viruses.[https://www.drugbank.ca/drugs/DB01172]
Source: Regenstrief LOINC
LP228779-7 Kanamycin 1.0 ug/mL
Kanamycin is an aminoglycoside antibiotic that is isolated from the bacterium Streptomyces kanamyceticus. It binds to the bacterial 30S ribosomal subunit which cause a faulty reading of t-RNA that blocks the synthesis of proteins necessary for growth. Aminoglycosides are used to treat aerobic bacteria, Gram-negative bacteria including Pseudomona, Acinetobacter, Enterobacter and some mycobacteria, including Mycobacterium tuberculosis. The aminoglycosides are not effective treatments for anaerobic bacteria, fungi or viruses.[https://www.drugbank.ca/drugs/DB01172]
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Kanamycin 1.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Kanamycin 1 ug/mL Islt SlowMyco
- Display Name
- Kanamycin 1 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Kanamycin 1 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.21
- Last Updated
- Version 2.32
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Kanamycin 1,0 µg/mL: |
| es-ES | Spanish (Spain) | Kanamicina 1 ug/mL: |
| es-MX | Spanish (Mexico) | Kanamicina 1.0 ug / mL: |
| fr-CA | French (Canada) | Kanamycine, 1,0 mg/L: |
| fr-BE | French (Belgium) | Kanamycine 1,0 mg/L: |
| fr-FR | French (France) | Kanamycine 1mg/L: |
| it-IT | Italian (Italy) | Kanamicina 1,0 ug/mL: Synonyms: 1 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | kanamycine 1,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Canamicina 1.0 ug/ml: Synonyms: Kantrex; |
| tr-TR | Turkish (Turkey) | Kanamisin 1.0 ug/mL: |
| zh-CN | Chinese (China) | 卡那霉素 1.0 微克/毫升: Synonyms: 1 ug/mL; |
25182-7 Kanamycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP14342-7 Kanamycin
Kanamycin is an aminoglycoside antibiotic that is isolated from the bacterium Streptomyces kanamyceticus. It binds to the bacterial 30S ribosomal subunit which cause a faulty reading of t-RNA that blocks the synthesis of proteins necessary for growth. Aminoglycosides are used to treat aerobic bacteria, Gram-negative bacteria including Pseudomona, Acinetobacter, Enterobacter and some mycobacteria, including Mycobacterium tuberculosis. The aminoglycosides are not effective treatments for anaerobic bacteria, fungi or viruses.[https://www.drugbank.ca/drugs/DB01172]
Source: Regenstrief LOINC
LP228781-3 Kanamycin 5.0 ug/mL
Kanamycin is an aminoglycoside antibiotic that is isolated from the bacterium Streptomyces kanamyceticus. It binds to the bacterial 30S ribosomal subunit which cause a faulty reading of t-RNA that blocks the synthesis of proteins necessary for growth. Aminoglycosides are used to treat aerobic bacteria, Gram-negative bacteria including Pseudomona, Acinetobacter, Enterobacter and some mycobacteria, including Mycobacterium tuberculosis. The aminoglycosides are not effective treatments for anaerobic bacteria, fungi or viruses.[https://www.drugbank.ca/drugs/DB01172]
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Kanamycin 5.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Kanamycin 5 ug/mL Islt SlowMyco
- Display Name
- Kanamycin 5 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Kanamycin 5 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 19469
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41162-5 | Kanamycin 5.0 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Kanamycin 5,0 µg/mL: |
| es-ES | Spanish (Spain) | Kanamicina 5 ug/mL: |
| es-AR | Spanish (Argentina) | kanamicina 5 ug/ml: |
| es-MX | Spanish (Mexico) | Kanamicina 5,0 ug / mL: |
| fr-CA | French (Canada) | Kanamycine, 5,0 mg/L: |
| fr-BE | French (Belgium) | Kanamycine 5,0 mg/L: |
| fr-FR | French (France) | Kanamycine 5mg/L: |
| it-IT | Italian (Italy) | Kanamicina, 5,0 ug/mL: Synonyms: 5 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 카나마이신 5.0ug/mL: |
| nl-NL | Dutch (Netherlands) | kanamycine 5,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Canamicina 5.0 ug/ml: Synonyms: Kantrex; |
| tr-TR | Turkish (Turkey) | Kanamisin 5.0 ug/mL: |
| zh-CN | Chinese (China) | 卡那霉素 5.0 微克/毫升: Synonyms: 5 ug/mL; |
25213-0 Kanamycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP14342-7 Kanamycin
Kanamycin is an aminoglycoside antibiotic that is isolated from the bacterium Streptomyces kanamyceticus. It binds to the bacterial 30S ribosomal subunit which cause a faulty reading of t-RNA that blocks the synthesis of proteins necessary for growth. Aminoglycosides are used to treat aerobic bacteria, Gram-negative bacteria including Pseudomona, Acinetobacter, Enterobacter and some mycobacteria, including Mycobacterium tuberculosis. The aminoglycosides are not effective treatments for anaerobic bacteria, fungi or viruses.[https://www.drugbank.ca/drugs/DB01172]
Source: Regenstrief LOINC
LP228782-1 Kanamycin 6.0 ug/mL
Kanamycin is an aminoglycoside antibiotic that is isolated from the bacterium Streptomyces kanamyceticus. It binds to the bacterial 30S ribosomal subunit which cause a faulty reading of t-RNA that blocks the synthesis of proteins necessary for growth. Aminoglycosides are used to treat aerobic bacteria, Gram-negative bacteria including Pseudomona, Acinetobacter, Enterobacter and some mycobacteria, including Mycobacterium tuberculosis. The aminoglycosides are not effective treatments for anaerobic bacteria, fungi or viruses.[https://www.drugbank.ca/drugs/DB01172]
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Kanamycin 6.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Kanamycin 6 ug/mL Islt SlowMyco
- Display Name
- Kanamycin 6 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Kanamycin 6 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Kanamycin 6,0 µg/mL: |
| es-ES | Spanish (Spain) | Kanamicina 6 ug/mL: |
| es-AR | Spanish (Argentina) | kanamicina 6 ug/ml: |
| es-MX | Spanish (Mexico) | Kanamicina 6.0 ug / mL: |
| fr-CA | French (Canada) | Kanamycine, 6,0 mg/L: |
| fr-BE | French (Belgium) | Kanamycine 6,0 mg/L: |
| fr-FR | French (France) | Kanamycine 6mg/L: |
| it-IT | Italian (Italy) | Kanamicina 6,0 ug/mL: Synonyms: 6 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 카나마이신 6.0ug/mL: |
| nl-NL | Dutch (Netherlands) | kanamycine 6,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Canamicina 6.0 ug/ml: Synonyms: Kantrex; |
| tr-TR | Turkish (Turkey) | Kanamisin 6.0 ug/mL: |
| zh-CN | Chinese (China) | 卡那霉素 6.0 微克/毫升: Synonyms: 6 ug/mL; |
25214-8 Kanamycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP14342-7 Kanamycin
Kanamycin is an aminoglycoside antibiotic that is isolated from the bacterium Streptomyces kanamyceticus. It binds to the bacterial 30S ribosomal subunit which cause a faulty reading of t-RNA that blocks the synthesis of proteins necessary for growth. Aminoglycosides are used to treat aerobic bacteria, Gram-negative bacteria including Pseudomona, Acinetobacter, Enterobacter and some mycobacteria, including Mycobacterium tuberculosis. The aminoglycosides are not effective treatments for anaerobic bacteria, fungi or viruses.[https://www.drugbank.ca/drugs/DB01172]
Source: Regenstrief LOINC
LP228780-5 Kanamycin 30.0 ug/mL
Kanamycin is an aminoglycoside antibiotic that is isolated from the bacterium Streptomyces kanamyceticus. It binds to the bacterial 30S ribosomal subunit which cause a faulty reading of t-RNA that blocks the synthesis of proteins necessary for growth. Aminoglycosides are used to treat aerobic bacteria, Gram-negative bacteria including Pseudomona, Acinetobacter, Enterobacter and some mycobacteria, including Mycobacterium tuberculosis. The aminoglycosides are not effective treatments for anaerobic bacteria, fungi or viruses.[https://www.drugbank.ca/drugs/DB01172]
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Kanamycin 30.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Kanamycin 30 ug/mL Islt SlowMyco
- Display Name
- Kanamycin 30 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Kanamycin 30 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Kanamycin 30,0 µg/mL: |
| es-ES | Spanish (Spain) | Kanamicina 30 ug/mL: |
| es-AR | Spanish (Argentina) | kanamicina 30 ug/ml: |
| es-MX | Spanish (Mexico) | Kanamicina 30,0 ug / mL: |
| fr-CA | French (Canada) | Kanamycine, 30,0 mg/L: |
| fr-BE | French (Belgium) | Kanamycine 30,0 mg/L: |
| fr-FR | French (France) | Kanamycine 30mg/L: |
| it-IT | Italian (Italy) | Kanamicina 30,0 ug/mL: Synonyms: 30 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 카나마이신 30.0ug/mL: |
| nl-NL | Dutch (Netherlands) | kanamycine 30,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Canamicina 30.0 ug/ml: Synonyms: Kantrex; |
| tr-TR | Turkish (Turkey) | Kanamisin 30.0 ug/mL: |
| zh-CN | Chinese (China) | 卡那霉素 30.0 微克/毫升: Synonyms: 30 ug/mL; |
53716-7 levoFLOXacin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP17276-4 levoFLOXacin
Levofloxacin is a bacteriacidal fluoroquinolone antibiotic that is effective against gram-positive and gram-negative organisms as well as other infectious agents, including Mycobacterium tuberculosis. It is used to treat a broad range of infections, including pneumonia, multi-drug resistant tuberculosis, and urinary tract infections. Levofloxacin increases the risk of tendinitis and tendon rupture, and is not recommended for children under the age of 18. [MedlinePlus Drug: a697040]
Source: Regenstrief LOINC, MedlinePlus Drug: Levofloxacin
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- levoFLOXacin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- levoFLOXacin Islt SlowMyco
- Display Name
- levoFLOXacin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to levoFLOXacin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.26
- Last Updated
- Version 2.26
- Order vs. Observation
- Both
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41134-4 | LevofloxacinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Levofloxacin: |
| es-ES | Spanish (Spain) | Levofloxacino: |
| es-MX | Spanish (Mexico) | levoFLOXacina: |
| fr-CA | French (Canada) | lévoFLOXacin: |
| fr-BE | French (Belgium) | Lévofloxacine: |
| fr-FR | French (France) | Lévofloxacine: |
| it-IT | Italian (Italy) | Levofloxacina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | levofloxacine: |
| pt-BR | Portuguese (Brazil) | Levofloxacina: Synonyms: Susceptibility; |
| tr-TR | Turkish (Turkey) | Levoflokzasin: |
| zh-CN | Chinese (China) | 左氧氟沙星: Synonyms: 三环类氟喹诺酮类抗菌药; |
53716-7 levoFLOXacin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP17276-4 levoFLOXacin
Levofloxacin is a bacteriacidal fluoroquinolone antibiotic that is effective against gram-positive and gram-negative organisms as well as other infectious agents, including Mycobacterium tuberculosis. It is used to treat a broad range of infections, including pneumonia, multi-drug resistant tuberculosis, and urinary tract infections. Levofloxacin increases the risk of tendinitis and tendon rupture, and is not recommended for children under the age of 18. [MedlinePlus Drug: a697040]
Source: Regenstrief LOINC, MedlinePlus Drug: Levofloxacin
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- levoFLOXacin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- levoFLOXacin Islt SlowMyco
- Display Name
- levoFLOXacin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to levoFLOXacin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.26
- Last Updated
- Version 2.26
- Order vs. Observation
- Both
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41134-4 | LevofloxacinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Levofloxacin: |
| es-ES | Spanish (Spain) | Levofloxacino: |
| es-MX | Spanish (Mexico) | levoFLOXacina: |
| fr-CA | French (Canada) | lévoFLOXacin: |
| fr-BE | French (Belgium) | Lévofloxacine: |
| fr-FR | French (France) | Lévofloxacine: |
| it-IT | Italian (Italy) | Levofloxacina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | levofloxacine: |
| pt-BR | Portuguese (Brazil) | Levofloxacina: Synonyms: Susceptibility; |
| tr-TR | Turkish (Turkey) | Levoflokzasin: |
| zh-CN | Chinese (China) | 左氧氟沙星: Synonyms: 三环类氟喹诺酮类抗菌药; |
76040-5 levoFLOXacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP17276-4 levoFLOXacin
Levofloxacin is a bacteriacidal fluoroquinolone antibiotic that is effective against gram-positive and gram-negative organisms as well as other infectious agents, including Mycobacterium tuberculosis. It is used to treat a broad range of infections, including pneumonia, multi-drug resistant tuberculosis, and urinary tract infections. Levofloxacin increases the risk of tendinitis and tendon rupture, and is not recommended for children under the age of 18. [MedlinePlus Drug: a697040]
Source: Regenstrief LOINC, MedlinePlus Drug: Levofloxacin
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- levoFLOXacin 1.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- levoFLOXacin 1 ug/mL Islt SlowMyco
- Display Name
- levoFLOXacin 1 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to levoFLOXacin 1 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.50
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Levofloxacin 1,0 µg/mL: |
| es-ES | Spanish (Spain) | Levofloxacino 1 ug/mL: |
| es-MX | Spanish (Mexico) | levoFLOXacina 1.0 ug / mL: |
| fr-CA | French (Canada) | lévoFLOXacin, 1,0 mg/L: |
| fr-BE | French (Belgium) | Lévofloxacine 1,0 mg/L: |
| fr-FR | French (France) | Lévofloxacine 1mg/L: |
| it-IT | Italian (Italy) | Levofloxacina 1,0 ug/mL: Synonyms: 1 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | levofloxacine 1,0 ug/mL: |
| tr-TR | Turkish (Turkey) | Levoflokzasin 1.0 ug/mL: |
| zh-CN | Chinese (China) | 左氧氟沙星 1.0 微克/毫升: Synonyms: 1 ug/mL; |
48173-9 levoFLOXacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP17276-4 levoFLOXacin
Levofloxacin is a bacteriacidal fluoroquinolone antibiotic that is effective against gram-positive and gram-negative organisms as well as other infectious agents, including Mycobacterium tuberculosis. It is used to treat a broad range of infections, including pneumonia, multi-drug resistant tuberculosis, and urinary tract infections. Levofloxacin increases the risk of tendinitis and tendon rupture, and is not recommended for children under the age of 18. [MedlinePlus Drug: a697040]
Source: Regenstrief LOINC, MedlinePlus Drug: Levofloxacin
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- levoFLOXacin 1.5 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- levoFLOXacin 1.5 ug/mL Islt SlowMyco
- Display Name
- levoFLOXacin 1.5 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to levoFLOXacin 1.5 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.21
- Last Updated
- Version 2.26
- Order vs. Observation
- Both
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Levofloxacin 1,5 µg/mL: |
| es-ES | Spanish (Spain) | Levofloxacino 1.5 ug/mL: |
| es-MX | Spanish (Mexico) | levoFLOXacina 1,5 ug / mL: |
| fr-CA | French (Canada) | lévoFLOXacin, 1,5 mg/L: |
| fr-BE | French (Belgium) | Lévofloxacine 1,5 mg/L: |
| fr-FR | French (France) | Lévofloxacine 1,5mg/L: |
| it-IT | Italian (Italy) | Levofloxacina 1,5 ug/mL: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | levofloxacine 1,5 ug/mL: |
| pt-BR | Portuguese (Brazil) | Levofloxacina 1.5 ug/mL: Synonyms: Susceptibility; |
| tr-TR | Turkish (Turkey) | Levoflokzasin 1.5 ug/mL: |
| zh-CN | Chinese (China) | 左氧氟沙星 1.5 微克/毫升: Synonyms: 1.5 ug/mL ug μg 三环类氟喹诺酮类抗菌药; |
76041-3 levoFLOXacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP17276-4 levoFLOXacin
Levofloxacin is a bacteriacidal fluoroquinolone antibiotic that is effective against gram-positive and gram-negative organisms as well as other infectious agents, including Mycobacterium tuberculosis. It is used to treat a broad range of infections, including pneumonia, multi-drug resistant tuberculosis, and urinary tract infections. Levofloxacin increases the risk of tendinitis and tendon rupture, and is not recommended for children under the age of 18. [MedlinePlus Drug: a697040]
Source: Regenstrief LOINC, MedlinePlus Drug: Levofloxacin
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- levoFLOXacin 2.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- levoFLOXacin 2 ug/mL Islt SlowMyco
- Display Name
- levoFLOXacin 2 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to levoFLOXacin 2 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.50
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Levofloxacin 2,0 µg/mL: |
| es-ES | Spanish (Spain) | Levofloxacino 2 ug/mL: |
| es-MX | Spanish (Mexico) | levoFLOXacina 2,0 ug / mL: |
| fr-CA | French (Canada) | lévoFLOXacin, 2,0 mg/L: |
| fr-BE | French (Belgium) | Lévofloxacine 2,0 mg/L: |
| fr-FR | French (France) | Lévofloxacine 2mg/L: |
| it-IT | Italian (Italy) | Levofloxacina, 2,0 ug/mL: Synonyms: 2 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | levofloxacine 2,0 ug/mL: |
| tr-TR | Turkish (Turkey) | Levoflokzasin 2.0 ug/mL: |
| zh-CN | Chinese (China) | 左氧氟沙星 2.0 微克/毫升: Synonyms: 2 ug/mL; |
76042-1 levoFLOXacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP17276-4 levoFLOXacin
Levofloxacin is a bacteriacidal fluoroquinolone antibiotic that is effective against gram-positive and gram-negative organisms as well as other infectious agents, including Mycobacterium tuberculosis. It is used to treat a broad range of infections, including pneumonia, multi-drug resistant tuberculosis, and urinary tract infections. Levofloxacin increases the risk of tendinitis and tendon rupture, and is not recommended for children under the age of 18. [MedlinePlus Drug: a697040]
Source: Regenstrief LOINC, MedlinePlus Drug: Levofloxacin
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- levoFLOXacin 4.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- levoFLOXacin 4 ug/mL Islt SlowMyco
- Display Name
- levoFLOXacin 4 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to levoFLOXacin 4 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.50
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Levofloxacin 4,0 µg/mL: |
| es-ES | Spanish (Spain) | Levofloxacino 4 ug/mL: |
| es-MX | Spanish (Mexico) | levoFLOXacina 4.0 ug / mL: |
| fr-CA | French (Canada) | lévoFLOXacin, 4,0 mg/L: |
| fr-BE | French (Belgium) | Lévofloxacine 4,0 mg/L: |
| fr-FR | French (France) | Lévofloxacine 4mg/L: |
| it-IT | Italian (Italy) | Levofloxacina, 4,0 ug/mL: Synonyms: 4 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | levofloxacine 4,0 ug/mL: |
| tr-TR | Turkish (Turkey) | Levoflokzasin 4.0 ug/mL: |
| zh-CN | Chinese (China) | 左氧氟沙星 4.0 微克/毫升: Synonyms: 4 ug/mL; |
41500-0 Linezolid [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP21256-0 Linezolid
Linezolid is a synthetic antibiotic that belongs to the oxazolidinone class. It is used to treat bacterial infections that are resistant to multiple antimicrobial drugs including streptococcus and methicillin-resistant Staphylococcus aureus (MRSA). Linezolid prevents bacteria from initiating bacterial protein synthesis.[https://www.drugbank.ca/drugs/DB00601]For patients with tuberculosis infection that is resistant to both isoniazid and rifampicin, the use of linezolid has shown to improve the rate of sputum culture conversion. However, for patients with drug-resistant tuberculosis, linezolid has proven to be difficult to tolerate due to its cumulative dose-related toxicity. PMID: 26870767
Source: Regenstrief LOINC
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Linezolid
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Linezolid Islt SlowMyco
- Display Name
- Linezolid Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Linezolid
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.16
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41213-6 | LinezolidSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Linezolid: |
| es-ES | Spanish (Spain) | Linezolid: |
| es-MX | Spanish (Mexico) | Linezolid: |
| fr-CA | French (Canada) | Linézolide: |
| fr-BE | French (Belgium) | Linézolide: |
| fr-FR | French (France) | Linézolide: |
| it-IT | Italian (Italy) | Linezolid: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 리네졸리드: |
| nl-NL | Dutch (Netherlands) | linezolid: |
| pt-BR | Portuguese (Brazil) | Linezolida: Synonyms: Zyvox; |
| tr-TR | Turkish (Turkey) | Linezolid: |
| zh-CN | Chinese (China) | 利奈唑胺: Synonyms: (S)-N-((3-(3-氟-4-(4-吗啉基)苯基)-2-氧代-5-噁唑烷基)甲基)乙酰胺; |
55156-4 Minocycline [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16031-4 Minocycline
A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Minocycline
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Minocycline Islt SlowMyco
- Display Name
- Minocycline Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Minocycline
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.27
- Last Updated
- Version 2.27
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41077-5 | MinocyclineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Minocyclin: |
| es-ES | Spanish (Spain) | Minociclina: |
| es-MX | Spanish (Mexico) | Minociclina: |
| fr-CA | French (Canada) | Minocycline: |
| fr-BE | French (Belgium) | Minocycline: |
| fr-FR | French (France) | Minocycline: |
| it-IT | Italian (Italy) | Minociclina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | minocycline: |
| pt-BR | Portuguese (Brazil) | Minociclina: Synonyms: Aknemin; |
| tr-TR | Turkish (Turkey) | Minosiklin: |
| zh-CN | Chinese (China) | 二甲胺四环素: Synonyms: 分离物; |
55156-4 Minocycline [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16031-4 Minocycline
A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Minocycline
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Minocycline Islt SlowMyco
- Display Name
- Minocycline Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Minocycline
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.27
- Last Updated
- Version 2.27
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41077-5 | MinocyclineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Minocyclin: |
| es-ES | Spanish (Spain) | Minociclina: |
| es-MX | Spanish (Mexico) | Minociclina: |
| fr-CA | French (Canada) | Minocycline: |
| fr-BE | French (Belgium) | Minocycline: |
| fr-FR | French (France) | Minocycline: |
| it-IT | Italian (Italy) | Minociclina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | minocycline: |
| pt-BR | Portuguese (Brazil) | Minociclina: Synonyms: Aknemin; |
| tr-TR | Turkish (Turkey) | Minosiklin: |
| zh-CN | Chinese (China) | 二甲胺四环素: Synonyms: 分离物; |
25225-4 Minocycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16031-4 Minocycline
A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Minocycline 30.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Minocycline 30 ug/mL Islt SlowMyco
- Display Name
- Minocycline 30 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Minocycline 30 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Minocyclin 30,0 µg/mL: |
| es-ES | Spanish (Spain) | Minociclina 30 ug/mL: |
| es-AR | Spanish (Argentina) | minociclina 30 ug/ml: |
| es-MX | Spanish (Mexico) | Minociclina 30,0 ug / mL: |
| fr-CA | French (Canada) | Minocycline, 30,0 mg/L: |
| fr-BE | French (Belgium) | Minocycline 30,0 mg/L: |
| fr-FR | French (France) | Minocycline 30mg/L: |
| it-IT | Italian (Italy) | Minociclina 30,0 ug/mL: Synonyms: 30 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | Minocycline 30.0 ug/mL: |
| nl-NL | Dutch (Netherlands) | minocycline 30,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Minociclina 30.0 ug/mL: Synonyms: Aknemin; |
| tr-TR | Turkish (Turkey) | Minosiklin 30.0 ug/mL: |
| zh-CN | Chinese (China) | 二甲胺四环素 30.0 微克/毫升: Synonyms: 30 ug/mL; |
41502-6 Moxifloxacin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP28720-8 Moxifloxacin
Moxifloxacin is a bacteriacidal fluoroquinolone antibiotic that is effective against gram-positive and gram-negative organisms as well as other infectious agents, including Mycobacterium tuberculosis. It is used to treat a broad range of infections, including pneumonia, multi-drug resistant tuberculosis, and endocarditis. Moxifloxacin increases the risk of tendinitis and tendon rupture, and is not recommended for children under the age of 18. [MedlinePlus Drug: a600002]
Source: Regenstrief LOINC, MedlinePlus Drug: Moxifloxacin
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Moxifloxacin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Moxifloxacin Islt SlowMyco
- Display Name
- Moxifloxacin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Moxifloxacin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.16
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41274-8 | MoxifloxacinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Moxifloxacin: |
| es-ES | Spanish (Spain) | Moxifloxacino: |
| es-MX | Spanish (Mexico) | Moxifloxacino: |
| fr-CA | French (Canada) | Moxifloxacine: |
| fr-BE | French (Belgium) | Moxifloxacine: |
| fr-FR | French (France) | Moxifloxacine: |
| it-IT | Italian (Italy) | Moxifloxacina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 목시플록사신: |
| nl-NL | Dutch (Netherlands) | moxifloxacine: |
| pt-BR | Portuguese (Brazil) | Moxifloxacina: Synonyms: Avelox; |
| tr-TR | Turkish (Turkey) | Moksiflokzasin: |
| zh-CN | Chinese (China) | 莫西沙星: Synonyms: 分离物; |
76043-9 Moxifloxacin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP229026-2 Moxifloxacin 0.5 ug/mL
Moxifloxacin is a bacteriacidal fluoroquinolone antibiotic that is effective against gram-positive and gram-negative organisms as well as other infectious agents, including Mycobacterium tuberculosis. It is used to treat a broad range of infections, including pneumonia, multi-drug resistant tuberculosis, and endocarditis. Moxifloxacin increases the risk of tendinitis and tendon rupture, and is not recommended for children under the age of 18. [MedlinePlus Drug: a600002]
Source: Regenstrief LOINC, MedlinePlus Drug: Moxifloxacin
LP28720-8 Moxifloxacin
Moxifloxacin is a bacteriacidal fluoroquinolone antibiotic that is effective against gram-positive and gram-negative organisms as well as other infectious agents, including Mycobacterium tuberculosis. It is used to treat a broad range of infections, including pneumonia, multi-drug resistant tuberculosis, and endocarditis. Moxifloxacin increases the risk of tendinitis and tendon rupture, and is not recommended for children under the age of 18. [MedlinePlus Drug: a600002]
Source: Regenstrief LOINC, MedlinePlus Drug: Moxifloxacin
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Moxifloxacin 0.5 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Moxifloxacin 0.5 ug/mL Islt SlowMyco
- Display Name
- Moxifloxacin 0.5 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Moxifloxacin 0.5 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.50
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Moxifloxacin 0,5 µg/mL: |
| es-ES | Spanish (Spain) | Moxifloxacino 0.5 ug/mL: |
| es-MX | Spanish (Mexico) | Moxifloxacina 0,5 ug / mL: |
| fr-CA | French (Canada) | Moxifloxacine, 0,5 mg/L: |
| fr-BE | French (Belgium) | Moxifloxacine 0,5 ug/mL: |
| fr-FR | French (France) | Moxifloxacine 0,5mg/L: |
| it-IT | Italian (Italy) | Moxifloxacina 0,5 ug/mL: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | moxifloxacine 0,5 ug/mL: |
| tr-TR | Turkish (Turkey) | Moksiflokzasin 0.5 ug/mL: |
| zh-CN | Chinese (China) | 莫西沙星 0.5 微克/毫升: Synonyms: 0.5 ug/mL ug μg 分离物; |
76044-7 Moxifloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP229027-0 Moxifloxacin 1.0 ug/mL
Moxifloxacin is a bacteriacidal fluoroquinolone antibiotic that is effective against gram-positive and gram-negative organisms as well as other infectious agents, including Mycobacterium tuberculosis. It is used to treat a broad range of infections, including pneumonia, multi-drug resistant tuberculosis, and endocarditis. Moxifloxacin increases the risk of tendinitis and tendon rupture, and is not recommended for children under the age of 18. [MedlinePlus Drug: a600002]
Source: Regenstrief LOINC, MedlinePlus Drug: Moxifloxacin
LP28720-8 Moxifloxacin
Moxifloxacin is a bacteriacidal fluoroquinolone antibiotic that is effective against gram-positive and gram-negative organisms as well as other infectious agents, including Mycobacterium tuberculosis. It is used to treat a broad range of infections, including pneumonia, multi-drug resistant tuberculosis, and endocarditis. Moxifloxacin increases the risk of tendinitis and tendon rupture, and is not recommended for children under the age of 18. [MedlinePlus Drug: a600002]
Source: Regenstrief LOINC, MedlinePlus Drug: Moxifloxacin
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Moxifloxacin 1.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Moxifloxacin 1 ug/mL Islt SlowMyco
- Display Name
- Moxifloxacin 1 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Moxifloxacin 1 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.50
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Moxifloxacin 1,0 µg/mL: |
| es-ES | Spanish (Spain) | Moxifloxacino 1 ug/mL: |
| es-MX | Spanish (Mexico) | Moxifloxacina 1.0 ug / mL: |
| fr-CA | French (Canada) | Moxifloxacine, 1,0 mg/L: |
| fr-BE | French (Belgium) | Moxifloxacine 1,0 mg/L: |
| fr-FR | French (France) | Moxifloxacine 1mg/L: |
| it-IT | Italian (Italy) | Moxifloxacina 1,0 ug/mL: Synonyms: 1 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | moxifloxacine 1,0 ug/mL: |
| tr-TR | Turkish (Turkey) | Moksiflokzasin 1.0 ug/mL: |
| zh-CN | Chinese (China) | 莫西沙星 1.0 微克/毫升: Synonyms: 1 ug/mL; |
76045-4 Moxifloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP229028-8 Moxifloxacin 2.0 ug/mL
Moxifloxacin is a bacteriacidal fluoroquinolone antibiotic that is effective against gram-positive and gram-negative organisms as well as other infectious agents, including Mycobacterium tuberculosis. It is used to treat a broad range of infections, including pneumonia, multi-drug resistant tuberculosis, and endocarditis. Moxifloxacin increases the risk of tendinitis and tendon rupture, and is not recommended for children under the age of 18. [MedlinePlus Drug: a600002]
Source: Regenstrief LOINC, MedlinePlus Drug: Moxifloxacin
LP28720-8 Moxifloxacin
Moxifloxacin is a bacteriacidal fluoroquinolone antibiotic that is effective against gram-positive and gram-negative organisms as well as other infectious agents, including Mycobacterium tuberculosis. It is used to treat a broad range of infections, including pneumonia, multi-drug resistant tuberculosis, and endocarditis. Moxifloxacin increases the risk of tendinitis and tendon rupture, and is not recommended for children under the age of 18. [MedlinePlus Drug: a600002]
Source: Regenstrief LOINC, MedlinePlus Drug: Moxifloxacin
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Moxifloxacin 2.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Moxifloxacin 2 ug/mL Islt SlowMyco
- Display Name
- Moxifloxacin 2 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Moxifloxacin 2 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.50
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Moxifloxacin 2,0 µg/mL: |
| es-ES | Spanish (Spain) | Moxifloxacino 2 ug/mL: |
| es-MX | Spanish (Mexico) | Moxifloxacina 2,0 ug / mL: |
| fr-CA | French (Canada) | Moxifloxacine, 2,0 mg/L: |
| fr-BE | French (Belgium) | Moxifloxacine 2,0 mg/L: |
| fr-FR | French (France) | Moxifloxacine 2mg/L: |
| it-IT | Italian (Italy) | Moxifloxacina, 2,0 ug/mL: Synonyms: 2 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | moxifloxacine 2,0 ug/mL: |
| tr-TR | Turkish (Turkey) | Moksiflokzasin 2.0 ug/mL: |
| zh-CN | Chinese (China) | 莫西沙星 2.0 微克/毫升: Synonyms: 2 ug/mL; |
41504-2 Norfloxacin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16156-9 Norfloxacin
Norfloxacin is an oral broad-spectrum quinolone antibacterial agent used in the treatment of urinary tract infections. Action::The mechanism of action of norfloxacin involves inhibition of the A subunit of bacterial DNA gyrase, an enzyme which is essential for DNA replication.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Norfloxacin (Wikipedia)
LP16156-9 Norfloxacin
A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Norfloxacin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Norfloxacin Islt SlowMyco
- Display Name
- Norfloxacin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Norfloxacin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.16
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41085-8 | NorfloxacinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Norfloxacin: |
| es-ES | Spanish (Spain) | Norfloxacina: |
| es-MX | Spanish (Mexico) | Norfloxacina: |
| fr-CA | French (Canada) | Norfloxacine: |
| fr-BE | French (Belgium) | Norfloxacine: |
| fr-FR | French (France) | Norfloxacine: |
| it-IT | Italian (Italy) | Norfloxacina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 노플로삭신: |
| nl-NL | Dutch (Netherlands) | norfloxacine: |
| pt-BR | Portuguese (Brazil) | Norfloxacina: Synonyms: Noroxin; |
| tr-TR | Turkish (Turkey) | Norflokzasin: |
| zh-CN | Chinese (China) | 诺氟沙星: Synonyms: 分离物; |
20384-4 Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16182-5 Ofloxacin
Ofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class considered to be a second-generation fluoroquinolone. The original brand, Floxin, has been discontinued by the manufacturer in the United States in 2009, though generic equivalents continue to be available.
Oral and I.V. Floxin is not licensed by the FDA for use in children due to the risk of serious reversible and irreversible injury to the musculoskeletal system. Ofloxacin (and its derivatives) has also been associated with a few isolated reports of unexplained pediatric fatalities. Children (those under 18) are also at an increased risk of bone, joint, or tendon toxicities.
In the adult population ofloxacin is limited to the treatment of proven serious and life threatening bacterial infections such as:
Acute bacterial exacerbations of chronic bronchitis
Community-acquired pneumonia
Uncomplicated skin and skin structure infections
Nongonococcal urethritis and cervicitis
Mixed Infections of the urethra and cervix
Acute pelvic inflammatory disease
Uncomplicated cystitis
Complicated urinary tract infections
Prostatitis
Acute, uncomplicated urethral and cervical gonorrhea
Mycobacterial infections
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ofloxacin (Wikipedia)
LP16182-5 Ofloxacin
A synthetic fluoroquinolone (FLUOROQUINOLONES) antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ofloxacin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ofloxacin Islt SlowMyco
- Display Name
- Ofloxacin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ofloxacin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0m
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41088-2 | OfloxacinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ofloxacin: |
| es-ES | Spanish (Spain) | Ofloxacina: |
| es-AR | Spanish (Argentina) | micobacterias.lentas: |
| es-MX | Spanish (Mexico) | Ofloxacina: |
| fr-CA | French (Canada) | Ofloxacine: |
| fr-BE | French (Belgium) | Ofloxacine: |
| fr-FR | French (France) | Ofloxacine: |
| it-IT | Italian (Italy) | Ofloxacina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 오플록사신: |
| nl-NL | Dutch (Netherlands) | ofloxacine: |
| pt-BR | Portuguese (Brazil) | Ofloxacina: Synonyms: Floxin; |
| tr-TR | Turkish (Turkey) | Oflokzasin: |
| zh-CN | Chinese (China) | 氧氟沙星: Synonyms: 分离物; |
41408-6 Ofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16182-5 Ofloxacin
Ofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class considered to be a second-generation fluoroquinolone. The original brand, Floxin, has been discontinued by the manufacturer in the United States in 2009, though generic equivalents continue to be available.
Oral and I.V. Floxin is not licensed by the FDA for use in children due to the risk of serious reversible and irreversible injury to the musculoskeletal system. Ofloxacin (and its derivatives) has also been associated with a few isolated reports of unexplained pediatric fatalities. Children (those under 18) are also at an increased risk of bone, joint, or tendon toxicities.
In the adult population ofloxacin is limited to the treatment of proven serious and life threatening bacterial infections such as:
Acute bacterial exacerbations of chronic bronchitis
Community-acquired pneumonia
Uncomplicated skin and skin structure infections
Nongonococcal urethritis and cervicitis
Mixed Infections of the urethra and cervix
Acute pelvic inflammatory disease
Uncomplicated cystitis
Complicated urinary tract infections
Prostatitis
Acute, uncomplicated urethral and cervical gonorrhea
Mycobacterial infections
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ofloxacin (Wikipedia)
LP16182-5 Ofloxacin
A synthetic fluoroquinolone (FLUOROQUINOLONES) antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ofloxacin 1.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ofloxacin 1 ug/mL Islt SlowMyco
- Display Name
- Ofloxacin 1 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ofloxacin 1 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.16
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ofloxacin 1,0 µg/mL: |
| es-ES | Spanish (Spain) | Ofloxacina 1 ug/mL: |
| es-MX | Spanish (Mexico) | Ofloxacina 1,0 ug / mL: |
| fr-CA | French (Canada) | Ofloxacine, 1,0 mg/L: |
| fr-BE | French (Belgium) | Ofloxacine 1,0 mg/L: |
| fr-FR | French (France) | Ofloxacine 1mg/L: |
| it-IT | Italian (Italy) | Ofloxacina 1,0 ug/mL: Synonyms: 1 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 오플록사신 1.0ug/mL: |
| nl-NL | Dutch (Netherlands) | ofloxacine 1,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Ofloxacina 1.0 ug/mL: Synonyms: Floxin; |
| tr-TR | Turkish (Turkey) | Oflokzasin 1.0 ug/mL: |
| zh-CN | Chinese (China) | 氧氟沙星 1.0 微克/毫升: Synonyms: 1 ug/mL; |
41409-4 Ofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16182-5 Ofloxacin
Ofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class considered to be a second-generation fluoroquinolone. The original brand, Floxin, has been discontinued by the manufacturer in the United States in 2009, though generic equivalents continue to be available.
Oral and I.V. Floxin is not licensed by the FDA for use in children due to the risk of serious reversible and irreversible injury to the musculoskeletal system. Ofloxacin (and its derivatives) has also been associated with a few isolated reports of unexplained pediatric fatalities. Children (those under 18) are also at an increased risk of bone, joint, or tendon toxicities.
In the adult population ofloxacin is limited to the treatment of proven serious and life threatening bacterial infections such as:
Acute bacterial exacerbations of chronic bronchitis
Community-acquired pneumonia
Uncomplicated skin and skin structure infections
Nongonococcal urethritis and cervicitis
Mixed Infections of the urethra and cervix
Acute pelvic inflammatory disease
Uncomplicated cystitis
Complicated urinary tract infections
Prostatitis
Acute, uncomplicated urethral and cervical gonorrhea
Mycobacterial infections
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ofloxacin (Wikipedia)
LP16182-5 Ofloxacin
A synthetic fluoroquinolone (FLUOROQUINOLONES) antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ofloxacin 2.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ofloxacin 2 ug/mL Islt SlowMyco
- Display Name
- Ofloxacin 2 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ofloxacin 2 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.16
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41271-4 | Ofloxacin 2.0 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ofloxacin 2,0 µg/mL: |
| es-ES | Spanish (Spain) | Ofloxacina 2 ug/mL: |
| es-MX | Spanish (Mexico) | Ofloxacina 2,0 ug / mL: |
| fr-CA | French (Canada) | Ofloxacine, 2,0 mg/L: |
| fr-BE | French (Belgium) | Ofloxacine 2,0 mg/L: |
| fr-FR | French (France) | Ofloxacine 2mg/L: |
| it-IT | Italian (Italy) | Ofloxacina, 2,0 ug/mL: Synonyms: 2 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 오플록사신 2.0ug/mL: |
| nl-NL | Dutch (Netherlands) | ofloxacine 2,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Ofloxacina 2.0 ug/mL: Synonyms: Floxin; |
| tr-TR | Turkish (Turkey) | Oflokzasin 2.0 ug/mL: |
| zh-CN | Chinese (China) | 氧氟沙星 2.0 微克/毫升: Synonyms: 2 ug/mL; |
41410-2 Ofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16182-5 Ofloxacin
Ofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class considered to be a second-generation fluoroquinolone. The original brand, Floxin, has been discontinued by the manufacturer in the United States in 2009, though generic equivalents continue to be available.
Oral and I.V. Floxin is not licensed by the FDA for use in children due to the risk of serious reversible and irreversible injury to the musculoskeletal system. Ofloxacin (and its derivatives) has also been associated with a few isolated reports of unexplained pediatric fatalities. Children (those under 18) are also at an increased risk of bone, joint, or tendon toxicities.
In the adult population ofloxacin is limited to the treatment of proven serious and life threatening bacterial infections such as:
Acute bacterial exacerbations of chronic bronchitis
Community-acquired pneumonia
Uncomplicated skin and skin structure infections
Nongonococcal urethritis and cervicitis
Mixed Infections of the urethra and cervix
Acute pelvic inflammatory disease
Uncomplicated cystitis
Complicated urinary tract infections
Prostatitis
Acute, uncomplicated urethral and cervical gonorrhea
Mycobacterial infections
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ofloxacin (Wikipedia)
LP16182-5 Ofloxacin
A synthetic fluoroquinolone (FLUOROQUINOLONES) antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Ofloxacin 4.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Ofloxacin 4 ug/mL Islt SlowMyco
- Display Name
- Ofloxacin 4 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ofloxacin 4 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.16
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ofloxacin 4,0 µg/mL: |
| es-ES | Spanish (Spain) | Ofloxacina 4 ug/mL: |
| es-MX | Spanish (Mexico) | Ofloxacina 4.0 ug / mL: |
| fr-CA | French (Canada) | Ofloxacine, 4,0 mg/L: |
| fr-BE | French (Belgium) | Ofloxacine 4,0 mg/L: |
| fr-FR | French (France) | Ofloxacine 4mg/L: |
| it-IT | Italian (Italy) | Ofloxacina, 4,0 ug/mL: Synonyms: 4 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 오플록사신 4.0ug/mL: |
| nl-NL | Dutch (Netherlands) | ofloxacine 4,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Ofloxacina 4.0 ug/mL: Synonyms: Floxin; |
| tr-TR | Turkish (Turkey) | Oflokzasin 4.0 ug/mL: |
| zh-CN | Chinese (China) | 氧氟沙星 4.0 微克/毫升: Synonyms: 4 ug/mL; |
25216-3 Para aminosalicylate 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP18625-1 Para aminosalicylate
4-Aminosalicylic acid, commonly known as PAS, is an antibiotic used to treat tuberculosis. This organic compound has been use since the 1940s for the treatment of inflammatory bowel diseases (IBDs), where it has shown greater potency in Ulcerative Colitis and Crohn's disease. It is thought to act via NF-κB (nuclear factor-kappa B) inhibition and free radical scavenging. 5-Aminosalicylic acid, sold under the name mesalazine, is a closely related compound that also has medical uses.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Para aminosalicylate
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Para aminosalicylate 8.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- PAS 8 ug/mL Islt SlowMyco
- Display Name
- Para aminosalicylate 8 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Para aminosalicylate 8 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Para-Aminosalicylat 8,0 µg/mL: Synonyms: 4-Amino-2-Hydroxybenzoat |
| es-ES | Spanish (Spain) | Para-amino salicilato 8 ug/mL: |
| es-AR | Spanish (Argentina) | paraminosalicilato 8 ug/ml: |
| es-MX | Spanish (Mexico) | Para aminosalicilato 8.0 ug / mL: |
| fr-CA | French (Canada) | Para-aminosalicylate, 8,0 mg/L: |
| fr-BE | French (Belgium) | Para-aminosalicylate 8,0 mg/L: |
| fr-FR | French (France) | Para aminosalicylate 8mg/L: |
| it-IT | Italian (Italy) | Para aminosalicilato, 8,0 ug/mL: Synonyms: 8 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | Para aminosalicylate 8.0 ug/mL: |
| nl-NL | Dutch (Netherlands) | para-aminosalicylaat 8,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Para aminosalicilato 8.0 ug/mL: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Para aminosalisilat 8.0 ug/mL: |
| zh-CN | Chinese (China) | p-氨基水杨酸 8.0 微克/毫升: Synonyms: 8 ug/mL; |
25215-5 Para aminosalicylate 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP18625-1 Para aminosalicylate
4-Aminosalicylic acid, commonly known as PAS, is an antibiotic used to treat tuberculosis. This organic compound has been use since the 1940s for the treatment of inflammatory bowel diseases (IBDs), where it has shown greater potency in Ulcerative Colitis and Crohn's disease. It is thought to act via NF-κB (nuclear factor-kappa B) inhibition and free radical scavenging. 5-Aminosalicylic acid, sold under the name mesalazine, is a closely related compound that also has medical uses.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Para aminosalicylate
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Para aminosalicylate 2.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- PAS 2 ug/mL Islt SlowMyco
- Display Name
- Para aminosalicylate 2 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Para aminosalicylate 2 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41193-0 | Para aminosalicylate 2.0 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Para-Aminosalicylat 2,0 µg/mL: Synonyms: 4-Amino-2-Hydroxybenzoat |
| es-ES | Spanish (Spain) | Para-amino salicilato 2 ug/mL: |
| es-AR | Spanish (Argentina) | paraminosalicilato 2 ug/ml: |
| es-MX | Spanish (Mexico) | Para aminosalicilato 2,0 ug / mL: |
| fr-CA | French (Canada) | Para-aminosalicylate, 2,0 mg/L: |
| fr-BE | French (Belgium) | Para-aminosalicylate 2,0 mg/L: |
| fr-FR | French (France) | Para aminosalicylate 2mg/L: |
| it-IT | Italian (Italy) | Para aminosalicilato, 2,0 ug/mL: Synonyms: 2 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | Para aminosalicylate 2.0 ug/mL: |
| nl-NL | Dutch (Netherlands) | para-aminosalicylaat 2,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Para aminosalicilato 2.0 ug/mL: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Para aminosalisilat 2.0 ug/mL: |
| zh-CN | Chinese (China) | p-氨基水杨酸 2.0 微克/毫升: Synonyms: 2 ug/mL; |
48685-2 Para aminosalicylate 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP18625-1 Para aminosalicylate
4-Aminosalicylic acid, commonly known as PAS, is an antibiotic used to treat tuberculosis. This organic compound has been use since the 1940s for the treatment of inflammatory bowel diseases (IBDs), where it has shown greater potency in Ulcerative Colitis and Crohn's disease. It is thought to act via NF-κB (nuclear factor-kappa B) inhibition and free radical scavenging. 5-Aminosalicylic acid, sold under the name mesalazine, is a closely related compound that also has medical uses.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Para aminosalicylate
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Para aminosalicylate 10.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- PAS 10 ug/mL Islt SlowMyco
- Display Name
- Para aminosalicylate 10 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Para aminosalicylate 10 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.21
- Last Updated
- Version 2.26
- Order vs. Observation
- Both
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Para-Aminosalicylat 10,0 µg/mL: Synonyms: 4-Amino-2-Hydroxybenzoat |
| es-ES | Spanish (Spain) | Para-amino salicilato 10 ug/mL: |
| es-MX | Spanish (Mexico) | Para aminosalicilato 10.0 ug / mL: |
| fr-CA | French (Canada) | Para-aminosalicylate, 10,0 mg/L: |
| fr-BE | French (Belgium) | Para-aminosalicylate 10,0 mg/L: |
| fr-FR | French (France) | Para aminosalicylate 10mg/L: |
| it-IT | Italian (Italy) | Para aminosalicilato 10,0 ug/mL: Synonyms: 10 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | para-aminosalicylaat 10,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Para aminosalicilato 10.0 ug/mL: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Para aminosalisilat 10.0 ug/mL: |
| zh-CN | Chinese (China) | p-氨基水杨酸 10.0 微克/毫升: Synonyms: 10 ug/mL; |
23611-7 Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP18625-1 Para aminosalicylate
4-Aminosalicylic acid, commonly known as PAS, is an antibiotic used to treat tuberculosis. This organic compound has been use since the 1940s for the treatment of inflammatory bowel diseases (IBDs), where it has shown greater potency in Ulcerative Colitis and Crohn's disease. It is thought to act via NF-κB (nuclear factor-kappa B) inhibition and free radical scavenging. 5-Aminosalicylic acid, sold under the name mesalazine, is a closely related compound that also has medical uses.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Para aminosalicylate
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Para aminosalicylate
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- PAS Islt SlowMyco
- Display Name
- Para aminosalicylate Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Para aminosalicylate
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0n
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 8973
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG40990-0 | Para aminosalicylateSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Para-Aminosalicylat: Synonyms: 4-Amino-2-Hydroxybenzoat |
| es-ES | Spanish (Spain) | Para-amino salicilato: |
| es-AR | Spanish (Argentina) | paraminosalicilato: |
| es-MX | Spanish (Mexico) | Para aminosalicilato: |
| fr-BE | French (Belgium) | Para-aminosalicylate: |
| fr-CA | French (Canada) | Para-aminosalicylate: |
| fr-FR | French (France) | Para aminosalicylate: |
| it-IT | Italian (Italy) | Para aminosalicilato: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | Para aminosalicylate: |
| nl-NL | Dutch (Netherlands) | para-aminosalicylaat: |
| pt-BR | Portuguese (Brazil) | Para aminosalicilato: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Para aminosalisilat: |
| zh-CN | Chinese (China) | p-氨基水杨酸: Synonyms: ASA; |
20461-0 Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15007-5 Pyrazinamide
Pyrazinamide is a drug used to treat tuberculosis in afflicted patients. The drug is largely bacteriostatic, but can be bacteriocidal on actively replicating tuberculosis bacteria.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Pyrazinamide (Wikipedia)
LP15007-5 Pyrazinamide
A pyrazine that is used therapeutically as an antitubercular agent.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Pyrazinamide
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- PZA Islt SlowMyco
- Display Name
- Pyrazinamide Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Pyrazinamide
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0m
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 15372
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41102-1 | PyrazinamideSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Pyrazinamid: |
| es-ES | Spanish (Spain) | Pirazinamida: |
| es-AR | Spanish (Argentina) | micobacterias.lentas: |
| es-MX | Spanish (Mexico) | Pirazinamida: |
| fr-BE | French (Belgium) | Pyrazinamide: |
| fr-CA | French (Canada) | Pyrazinamide: |
| fr-FR | French (France) | Pyrazinamide: |
| it-IT | Italian (Italy) | Pirazinamide: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 피라진아미드: |
| nl-NL | Dutch (Netherlands) | pyrazinamide: |
| pt-BR | Portuguese (Brazil) | Pirazinamida: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Pirazinamid: |
| zh-CN | Chinese (China) | 吡嗪酰胺: Synonyms: PZA; |
25186-8 Pyrazinamide 25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15007-5 Pyrazinamide
Pyrazinamide is a drug used to treat tuberculosis in afflicted patients. The drug is largely bacteriostatic, but can be bacteriocidal on actively replicating tuberculosis bacteria.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Pyrazinamide (Wikipedia)
LP15007-5 Pyrazinamide
A pyrazine that is used therapeutically as an antitubercular agent.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Pyrazinamide 25.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- PZA 25 ug/mL Islt SlowMyco
- Display Name
- Pyrazinamide 25 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Pyrazinamide 25 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 18050
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Pyrazinamid 25,0 µg/mL: |
| es-ES | Spanish (Spain) | Pirazinamida 25 ug/mL: |
| es-AR | Spanish (Argentina) | pirazinamida 25.0 ug/ml: |
| es-MX | Spanish (Mexico) | Pirazinamida 25,0 ug / mL: |
| fr-CA | French (Canada) | Pyrazinamide, 25,0 mg/L: |
| fr-BE | French (Belgium) | Pyrazinamide 25,0 mg/L: |
| fr-FR | French (France) | Pyrazinamide 25mg/L: |
| it-IT | Italian (Italy) | Pirazinamide 25,0 ug/mL: Synonyms: 25 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 피라진아미드 25.0ug/mL: |
| nl-NL | Dutch (Netherlands) | pyrazinamide 25,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Pirazinamida 25.0 ug/mL: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Pirazinamid 25.0 ug/mL: |
| zh-CN | Chinese (China) | 吡嗪酰胺 25.0 微克/毫升: Synonyms: 25 ug/mL; |
25229-6 Pyrazinamide 100 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15007-5 Pyrazinamide
Pyrazinamide is a drug used to treat tuberculosis in afflicted patients. The drug is largely bacteriostatic, but can be bacteriocidal on actively replicating tuberculosis bacteria.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Pyrazinamide (Wikipedia)
LP15007-5 Pyrazinamide
A pyrazine that is used therapeutically as an antitubercular agent.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Pyrazinamide 100.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- PZA 100 ug/mL Islt SlowMyco
- Display Name
- Pyrazinamide 100 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Pyrazinamide 100 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 11806
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41207-8 | Pyrazinamide 100.0 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Pyrazinamid 100,0 µg/mL: |
| es-ES | Spanish (Spain) | Pirazinamida 100 ug/mL: |
| es-AR | Spanish (Argentina) | pirazinamida 100.0 ug/ml: |
| es-MX | Spanish (Mexico) | Pirazinamida 100,0 ug / mL: |
| fr-CA | French (Canada) | Pyrazinamide, 100,0 mg/L: |
| fr-BE | French (Belgium) | Pyrazinamide 100,0 mg/L: |
| fr-FR | French (France) | Pyrazinamide 100mg/L: |
| it-IT | Italian (Italy) | Pirazinamide, 100,0 ug/mL: Synonyms: 100 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 피라진아미드 100.0ug/mL: |
| nl-NL | Dutch (Netherlands) | pyrazinamide 100,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Pirazinamida 100.0 ug/mL: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Pirazinamid 100.0 ug/mL: |
| zh-CN | Chinese (China) | 吡嗪酰胺 100.0 微克/毫升: Synonyms: 100 ug/mL; |
55711-6 Pyrazinamide 200 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15007-5 Pyrazinamide
Pyrazinamide is a drug used to treat tuberculosis in afflicted patients. The drug is largely bacteriostatic, but can be bacteriocidal on actively replicating tuberculosis bacteria.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Pyrazinamide (Wikipedia)
LP15007-5 Pyrazinamide
A pyrazine that is used therapeutically as an antitubercular agent.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Pyrazinamide 200.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- PZA 200 ug/mL Islt SlowMyco
- Display Name
- Pyrazinamide 200 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Pyrazinamide 200 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.27
- Last Updated
- Version 2.27
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Pyrazinamid 200,0 µg/mL: |
| es-ES | Spanish (Spain) | Pirazinamida 200.0 ug/ml: |
| es-MX | Spanish (Mexico) | Pirazinamida 200,0 ug / mL: |
| fr-CA | French (Canada) | Pyrazinamide, 200,0 mg/L: |
| fr-BE | French (Belgium) | Pyrazinamide 200,0 mg/L: |
| fr-FR | French (France) | Pyrazinamide 200mg/L: |
| it-IT | Italian (Italy) | Pirazinamide 200,0 ug/mL: Synonyms: 200 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | pyrazinamide 200,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Pirazinamida 200.0 ug/mL: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Pirazinamid 200.0 ug/mL: |
| zh-CN | Chinese (China) | 吡嗪酰胺 200.0 微克/毫升: Synonyms: 200 ug/mL; |
56026-8 Pyrazinamide 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15007-5 Pyrazinamide
Pyrazinamide is a drug used to treat tuberculosis in afflicted patients. The drug is largely bacteriostatic, but can be bacteriocidal on actively replicating tuberculosis bacteria.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Pyrazinamide (Wikipedia)
LP15007-5 Pyrazinamide
A pyrazine that is used therapeutically as an antitubercular agent.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Pyrazinamide 300.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- PZA 300 ug/mL Islt SlowMyco
- Display Name
- Pyrazinamide 300 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Pyrazinamide 300 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.29
- Last Updated
- Version 2.32
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Pyrazinamid 300,0 µg/mL: |
| es-ES | Spanish (Spain) | Pirazinamida 300 ug/mL: |
| es-MX | Spanish (Mexico) | Pirazinamida 300,0 ug / mL: |
| fr-CA | French (Canada) | Pyrazinamide, 300,0 mg/L: |
| fr-BE | French (Belgium) | Pyrazinamide 300,0 mg/L: |
| fr-FR | French (France) | Pyrazinamide 300mg/L: |
| it-IT | Italian (Italy) | Pirazinamide 300,0 ug/mL: Synonyms: 300 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | pyrazinamide 300,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Pirazinamida 300.0 ug/mL: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Pirazinamid 300.0 ug/mL: |
| zh-CN | Chinese (China) | 吡嗪酰胺 300.0 微克/毫升: Synonyms: 100 微克/毫升; |
20386-9 Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP14435-9 Rifabutin
Rifabutin is a bactericidal antibiotic drug primarily used in the treatment of tuberculosis. The drug is a semi-synthetic derivative of rifamycin S. Its effect is based on blocking the DNA-dependend RNA-polymerase of the bacteria. It is effective against Gram-positive and some Gram-negative bacteria, but also against the highly resistant Mycobacteria, e.g. Mycobacterium tuberculosis, M. leprae and M. avium intracellulare.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Rifabutin (Wikipedia)
LP14435-9 Rifabutin
A broad-spectrum antibiotic that is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Rifabutin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Rifabutin Islt SlowMyco
- Display Name
- Rifabutin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Rifabutin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0m
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG40996-7 | RifabutinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Rifabutin: |
| es-ES | Spanish (Spain) | Rifabutin: |
| es-AR | Spanish (Argentina) | micobacterias.lentas: |
| es-MX | Spanish (Mexico) | Rifabutina: |
| fr-CA | French (Canada) | Rifabutin: |
| fr-BE | French (Belgium) | Rifabutin: |
| fr-FR | French (France) | Rifabutine: |
| it-IT | Italian (Italy) | Rifabutina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 리파부틴: |
| nl-NL | Dutch (Netherlands) | rifabutine: |
| pt-BR | Portuguese (Brazil) | Rifabutina: Synonyms: Mycobutin; |
| tr-TR | Turkish (Turkey) | Rifabutin: |
| zh-CN | Chinese (China) | 利福布汀: Synonyms: 分支布汀; |
42655-1 Rifabutin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP14435-9 Rifabutin
Rifabutin is a bactericidal antibiotic drug primarily used in the treatment of tuberculosis. The drug is a semi-synthetic derivative of rifamycin S. Its effect is based on blocking the DNA-dependend RNA-polymerase of the bacteria. It is effective against Gram-positive and some Gram-negative bacteria, but also against the highly resistant Mycobacteria, e.g. Mycobacterium tuberculosis, M. leprae and M. avium intracellulare.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Rifabutin (Wikipedia)
LP14435-9 Rifabutin
A broad-spectrum antibiotic that is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Rifabutin 0.5 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Rifabutin 0.5 ug/mL Islt SlowMyco
- Display Name
- Rifabutin 0.5 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Rifabutin 0.5 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.16
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Rifabutin 0,5 µg/mL: |
| es-ES | Spanish (Spain) | Rifabutin 0.5 ug/mL: |
| es-MX | Spanish (Mexico) | Rifabutina 0,5 ug / mL: |
| fr-CA | French (Canada) | Rifabutin, 0,5 mg/L: |
| fr-BE | French (Belgium) | Rifabutin 0,5 ug/mL: |
| fr-FR | French (France) | Rifabutine 0,5mg/L: |
| it-IT | Italian (Italy) | Rifabutina 0,5 ug/mL: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 리파부틴 0.5ug/mL: |
| nl-NL | Dutch (Netherlands) | rifabutine 0,5 ug/mL: |
| pt-BR | Portuguese (Brazil) | Rifabutina 0.5 ug/mL: Synonyms: Mycobutin; |
| tr-TR | Turkish (Turkey) | Rifabutin 0.5 ug/mL: |
| zh-CN | Chinese (China) | 利福布汀 0.5 微克/毫升: Synonyms: 0.5 ug/mL ug μg 分支布汀; |
25199-1 Rifabutin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP14435-9 Rifabutin
Rifabutin is a bactericidal antibiotic drug primarily used in the treatment of tuberculosis. The drug is a semi-synthetic derivative of rifamycin S. Its effect is based on blocking the DNA-dependend RNA-polymerase of the bacteria. It is effective against Gram-positive and some Gram-negative bacteria, but also against the highly resistant Mycobacteria, e.g. Mycobacterium tuberculosis, M. leprae and M. avium intracellulare.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Rifabutin (Wikipedia)
LP14435-9 Rifabutin
A broad-spectrum antibiotic that is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Rifabutin 1.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Rifabutin 1 ug/mL Islt SlowMyco
- Display Name
- Rifabutin 1 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Rifabutin 1 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 15976
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Rifabutin 1,0 µg/mL: |
| es-ES | Spanish (Spain) | Rifabutin 1 ug/mL: |
| es-AR | Spanish (Argentina) | rifabutina 1 ug/ml: |
| es-MX | Spanish (Mexico) | Rifabutina 1.0 ug / mL: |
| fr-CA | French (Canada) | Rifabutin, 1,0 mg/L: |
| fr-BE | French (Belgium) | Rifabutin 1,0 mg/L: |
| fr-FR | French (France) | Rifabutine 1mg/L: |
| it-IT | Italian (Italy) | Rifabutina 1,0 ug/mL: Synonyms: 1 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 리파부틴 1.0ug/mL: |
| nl-NL | Dutch (Netherlands) | rifabutine 1,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Rifabutina 1.0 ug/mL: Synonyms: Mycobutin; |
| tr-TR | Turkish (Turkey) | Rifabutin 1.0 ug/mL: |
| zh-CN | Chinese (China) | 利福布汀 1.0 微克/毫升: Synonyms: 1 ug/mL; |
25200-7 Rifabutin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP14435-9 Rifabutin
Rifabutin is a bactericidal antibiotic drug primarily used in the treatment of tuberculosis. The drug is a semi-synthetic derivative of rifamycin S. Its effect is based on blocking the DNA-dependend RNA-polymerase of the bacteria. It is effective against Gram-positive and some Gram-negative bacteria, but also against the highly resistant Mycobacteria, e.g. Mycobacterium tuberculosis, M. leprae and M. avium intracellulare.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Rifabutin (Wikipedia)
LP14435-9 Rifabutin
A broad-spectrum antibiotic that is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Rifabutin 2.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Rifabutin 2 ug/mL Islt SlowMyco
- Display Name
- Rifabutin 2 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Rifabutin 2 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 19122
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41178-1 | Rifabutin 2.0 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Rifabutin 2,0 µg/mL: |
| es-ES | Spanish (Spain) | Rifabutin 2 ug/mL: |
| es-AR | Spanish (Argentina) | rifabutina 2 ug/ml: |
| es-MX | Spanish (Mexico) | Rifabutina 2,0 ug / mL: |
| fr-CA | French (Canada) | Rifabutin, 2,0 mg/L: |
| fr-BE | French (Belgium) | Rifabutin 2,0 mg/L: |
| fr-FR | French (France) | Rifabutine 2mg/L: |
| it-IT | Italian (Italy) | Rifabutina, 2,0 ug/mL: Synonyms: 2 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 리파부틴 2.0ug/mL: |
| nl-NL | Dutch (Netherlands) | rifabutine 2,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Rifabutina 2.0 ug/mL: Synonyms: Mycobutin; |
| tr-TR | Turkish (Turkey) | Rifabutin 2.0 ug/mL: |
| zh-CN | Chinese (China) | 利福布汀 2.0 微克/毫升: Synonyms: 2 ug/mL; |
25201-5 Rifabutin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP14435-9 Rifabutin
Rifabutin is a bactericidal antibiotic drug primarily used in the treatment of tuberculosis. The drug is a semi-synthetic derivative of rifamycin S. Its effect is based on blocking the DNA-dependend RNA-polymerase of the bacteria. It is effective against Gram-positive and some Gram-negative bacteria, but also against the highly resistant Mycobacteria, e.g. Mycobacterium tuberculosis, M. leprae and M. avium intracellulare.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Rifabutin (Wikipedia)
LP14435-9 Rifabutin
A broad-spectrum antibiotic that is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Rifabutin 4.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Rifabutin 4 ug/mL Islt SlowMyco
- Display Name
- Rifabutin 4 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Rifabutin 4 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 19833
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Rifabutin 4,0 µg/mL: |
| es-ES | Spanish (Spain) | Rifabutin 4 ug/mL: |
| es-AR | Spanish (Argentina) | rifabutina 4 ug/ml: |
| es-MX | Spanish (Mexico) | Rifabutina 4.0 ug / mL: |
| fr-CA | French (Canada) | Rifabutin, 4,0 mg/L: |
| fr-BE | French (Belgium) | Rifabutin 4,0 mg/L: |
| fr-FR | French (France) | Rifabutine 4mg/L: |
| it-IT | Italian (Italy) | Rifabutina, 4,0 ug/mL: Synonyms: 4 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 리파부틴 4.0ug/mL: |
| nl-NL | Dutch (Netherlands) | rifabutine 4,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Rifabutina 4.0 ug/mL: Synonyms: Mycobutin; |
| tr-TR | Turkish (Turkey) | Rifabutin 4.0 ug/mL: |
| zh-CN | Chinese (China) | 利福布汀 4.0 微克/毫升: Synonyms: 4 ug/mL; |
20385-1 rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- rifAMPin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- rifAMPin Islt SlowMyco
- Display Name
- rifAMPin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to rifAMPin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0m
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41103-9 | RifampinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Rifampicin: |
| es-ES | Spanish (Spain) | Rifampicina: |
| es-AR | Spanish (Argentina) | micobacterias.lentas: |
| es-MX | Spanish (Mexico) | rifAMPin: |
| fr-CA | French (Canada) | Rifampicine: Synonyms: #REF! |
| fr-BE | French (Belgium) | Rifampicine: |
| fr-FR | French (France) | Rifampicine: |
| it-IT | Italian (Italy) | Rifampicina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 리팜핀: |
| nl-NL | Dutch (Netherlands) | rifampicine: |
| pt-BR | Portuguese (Brazil) | Rifampicina: Synonyms: RIF; |
| tr-TR | Turkish (Turkey) | Rifampin: |
| zh-CN | Chinese (China) | 利福平: Synonyms: RIF; |
25202-3 rifAMPin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- rifAMPin 1.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- rifAMPin 1 ug/mL Islt SlowMyco
- Display Name
- rifAMPin 1 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to rifAMPin 1 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 10347
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41180-7 | Rifampin 1.0 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Rifampicin 1,0 µg/mL: |
| es-ES | Spanish (Spain) | Rifampicina 1 ug/mL: |
| es-AR | Spanish (Argentina) | rifampicina 1 ug/ml: |
| es-MX | Spanish (Mexico) | rifAMPin 1.0 ug / mL: |
| fr-CA | French (Canada) | Rifampicine, 1,0 mg/L: Synonyms: #REF! |
| fr-BE | French (Belgium) | Rifampicine 1,0 mg/L: |
| fr-FR | French (France) | Rifampicine 1mg/L: |
| it-IT | Italian (Italy) | Rifampicina 1,0 ug/mL: Synonyms: 1 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 리팜핀 1.0ug/mL: |
| nl-NL | Dutch (Netherlands) | rifampicine 1,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Rifampina 1.0 ug/mL: Synonyms: RIF; |
| tr-TR | Turkish (Turkey) | Rifampin 1.0 ug/mL: |
| zh-CN | Chinese (China) | 利福平 1.0 微克/毫升: Synonyms: 1 ug/mL; |
25203-1 rifAMPin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- rifAMPin 2.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- rifAMPin 2 ug/mL Islt SlowMyco
- Display Name
- rifAMPin 2 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to rifAMPin 2 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 19409
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Rifampicin 2,0 µg/mL: |
| es-ES | Spanish (Spain) | Rifampicina 2 ug/mL: |
| es-AR | Spanish (Argentina) | rifampicina 2 ug/ml: |
| es-MX | Spanish (Mexico) | rifAMPin 2.0 ug / mL: |
| fr-CA | French (Canada) | Rifampicine, 2,0 mg/L: Synonyms: #REF! |
| fr-BE | French (Belgium) | Rifampicine 2,0 mg/L: |
| fr-FR | French (France) | Rifampicine 2mg/L: |
| it-IT | Italian (Italy) | Rifampicina, 2,0 ug/mL: Synonyms: 2 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 리팜핀 2.0ug/mL: |
| nl-NL | Dutch (Netherlands) | rifampicine 2,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Rifampina 2.0 ug/mL: Synonyms: RIF; |
| tr-TR | Turkish (Turkey) | Rifampin 2.0 ug/mL: |
| zh-CN | Chinese (China) | 利福平 2.0 微克/毫升: Synonyms: 2 ug/mL; |
25204-9 rifAMPin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- rifAMPin 5.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- rifAMPin 5 ug/mL Islt SlowMyco
- Display Name
- rifAMPin 5 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to rifAMPin 5 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 14974
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Rifampicin 5,0 µg/mL: |
| es-ES | Spanish (Spain) | Rifampicina 5 ug/mL: |
| es-AR | Spanish (Argentina) | rifampicina 5 ug/ml: |
| es-MX | Spanish (Mexico) | rifAMPin 5.0 ug / mL: |
| fr-CA | French (Canada) | Rifampicine, 5,0 mg/L: Synonyms: #REF! |
| fr-BE | French (Belgium) | Rifampicine 5,0 mg/L: |
| fr-FR | French (France) | Rifampicine 5mg/L: |
| it-IT | Italian (Italy) | Rifampicina, 5,0 ug/mL: Synonyms: 5 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 리팜핀 5.0ug/mL: |
| nl-NL | Dutch (Netherlands) | rifampicine 5,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Rifampina 5.0 ug/mL: Synonyms: RIF; |
| tr-TR | Turkish (Turkey) | Rifampin 5.0 ug/mL: |
| zh-CN | Chinese (China) | 利福平 5.0 微克/毫升: Synonyms: 5 ug/mL; |
25184-3 rifAMPin 14 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- rifAMPin 14.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- rifAMPin 14 ug/mL Islt SlowMyco
- Display Name
- rifAMPin 14 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to rifAMPin 14 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Rifampicin 14,0 µg/mL: |
| es-ES | Spanish (Spain) | Rifampicina 14 ug/mL: |
| es-AR | Spanish (Argentina) | rifampicina 14 ug/ml: |
| es-MX | Spanish (Mexico) | rifAMPin 14.0 ug / mL: |
| fr-CA | French (Canada) | Rifampicine, 14,0 mg/L: Synonyms: #REF! |
| fr-BE | French (Belgium) | Rifampicine 14,0 mg/L: |
| fr-FR | French (France) | Rifampicine 14mg/L: |
| it-IT | Italian (Italy) | Rifampicina 14,0 ug/mL: Synonyms: 14 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 리팜핀 14.0ug/mL: |
| nl-NL | Dutch (Netherlands) | rifampicine 14,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Rifampina 14.0 ug/mL: Synonyms: RIF; |
| tr-TR | Turkish (Turkey) | Rifampin 14.0 ug/mL: |
| zh-CN | Chinese (China) | 利福平 14.0 微克/毫升: Synonyms: 14 ug/mL; |
55712-4 rifAMPin 40 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- rifAMPin 40.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- rifAMPin 40 ug/mL Islt SlowMyco
- Display Name
- rifAMPin 40 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to rifAMPin 40 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.27
- Last Updated
- Version 2.27
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Rifampicin 40,0 µg/mL: |
| es-ES | Spanish (Spain) | Rifampicina 40.0 ug/ml: |
| es-MX | Spanish (Mexico) | rifAMPin 40,0 ug / mL: |
| fr-CA | French (Canada) | Rifampicine, 40,0 mg/L: Synonyms: #REF! |
| fr-BE | French (Belgium) | Rifampicine 40,0 mg/L: |
| fr-FR | French (France) | Rifampicine 40mg/L: |
| it-IT | Italian (Italy) | Rifampicina, 40,0 ug/mL: Synonyms: 40 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | rifampicine 40,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Rifampina 40.0 ug/mL: Synonyms: RIF; |
| tr-TR | Turkish (Turkey) | Rifampin 40.0 ug/mL: |
| zh-CN | Chinese (China) | 利福平 40.0 微克/毫升: Synonyms: 40 ug/mL; |
23610-9 Sparfloxacin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP17280-6 Sparfloxacin
Sparfloxacin (spar FLOX a sin), trade names Zagam and Zagam Respipac, is a fluoroquinolone antibiotic used in the treatment of bacterial infections. It has a controversial safety profile.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Sparfloxacin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Sparfloxacin Islt SlowMyco
- Display Name
- Sparfloxacin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Sparfloxacin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0n
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41135-1 | SparfloxacinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Sparfloxacin: |
| es-ES | Spanish (Spain) | Sparfloxacino: |
| es-AR | Spanish (Argentina) | esparfloxacina: |
| es-MX | Spanish (Mexico) | Esparfloxacino: |
| fr-BE | French (Belgium) | Sparfloxacine: |
| fr-CA | French (Canada) | Sparfloxacine: |
| fr-FR | French (France) | Sparfloxacine: |
| it-IT | Italian (Italy) | Sparfloxacina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | Sparfloxacin: |
| nl-NL | Dutch (Netherlands) | sparfloxacine: |
| pt-BR | Portuguese (Brazil) | Esparfloxacina: Synonyms: Zagam; |
| tr-TR | Turkish (Turkey) | Sparflokzasin: |
| zh-CN | Chinese (China) | 司氟沙星: Synonyms: 分离物; |
20462-8 Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16282-3 Streptomycin
Streptomycin is an antibiotic drug, the first of a class of drugs called aminoglycosides to be discovered, and was the first antibiotic remedy for tuberculosis. It is derived from the actinobacterium Streptomyces griseus. Streptomycin stops bacterial growth by damaging cell membranes and inhibiting protein synthesis. Specifically, it binds to the 23S rRNA molecule of the bacterial ribosome, which prevents the release of the growing protein (polypeptide chain). Humans have structurally different ribosomes than bacteria, thereby allowing the selectivity of this antibiotic for bacteria. Streptomycin cannot be given orally, but must be administered by regular intramuscular injection. An adverse effect of this medicine is ototoxicity. It can result in permanent hearing loss. History:It was first isolated on October 19, 1943 in the laboratory of Selman Abraham Waksman at Rutgers University by Albert Schatz, a graduate student in his laboratory.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Streptomycin (Wikipedia)
LP16282-3 Streptomycin
An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Streptomycin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Streptomycin Islt SlowMyco
- Display Name
- Streptomycin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Streptomycin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0m
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 5520
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41111-2 | StreptomycinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Streptomycin: |
| es-ES | Spanish (Spain) | Estreptomicina: |
| es-AR | Spanish (Argentina) | micobacterias.lentas: |
| es-MX | Spanish (Mexico) | Estreptomicina: |
| fr-BE | French (Belgium) | Streptomycine: |
| fr-CA | French (Canada) | Streptomycine: |
| fr-FR | French (France) | Streptomycine: |
| it-IT | Italian (Italy) | Streptomicina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 스트렙토마이신: |
| nl-NL | Dutch (Netherlands) | streptomycine: |
| pt-BR | Portuguese (Brazil) | Estreptomicina: Synonyms: Streptomyc; |
| tr-TR | Turkish (Turkey) | Streptomisin: |
| zh-CN | Chinese (China) | 链霉素: Synonyms: C21H39O12N7 分离物; |
48177-0 Streptomycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16282-3 Streptomycin
Streptomycin is an antibiotic drug, the first of a class of drugs called aminoglycosides to be discovered, and was the first antibiotic remedy for tuberculosis. It is derived from the actinobacterium Streptomyces griseus. Streptomycin stops bacterial growth by damaging cell membranes and inhibiting protein synthesis. Specifically, it binds to the 23S rRNA molecule of the bacterial ribosome, which prevents the release of the growing protein (polypeptide chain). Humans have structurally different ribosomes than bacteria, thereby allowing the selectivity of this antibiotic for bacteria. Streptomycin cannot be given orally, but must be administered by regular intramuscular injection. An adverse effect of this medicine is ototoxicity. It can result in permanent hearing loss. History:It was first isolated on October 19, 1943 in the laboratory of Selman Abraham Waksman at Rutgers University by Albert Schatz, a graduate student in his laboratory.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Streptomycin (Wikipedia)
LP16282-3 Streptomycin
An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Streptomycin 1.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Streptomycin 1 ug/mL Islt SlowMyco
- Display Name
- Streptomycin 1 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Streptomycin 1 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.21
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 12239
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Streptomycin 1,0 µg/mL: |
| es-ES | Spanish (Spain) | Estreptomicina 1 ug/mL: |
| es-MX | Spanish (Mexico) | Estreptomicina 1.0 ug / mL: |
| fr-CA | French (Canada) | Streptomycine, 1,0 mg/L: |
| fr-BE | French (Belgium) | Streptomycine 1,0 mg/L: |
| fr-FR | French (France) | Streptomycine 1mg/L: |
| it-IT | Italian (Italy) | Streptomicina 1,0 ug/mL: Synonyms: 1 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | streptomycine 1,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Estreptomicina 1.0 ug/ml: Synonyms: Streptomyc; |
| tr-TR | Turkish (Turkey) | Streptomisin 1.0 ug/mL: |
| zh-CN | Chinese (China) | 链霉素 1.0 微克/毫升: Synonyms: 1 ug/mL; |
25205-6 Streptomycin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16282-3 Streptomycin
Streptomycin is an antibiotic drug, the first of a class of drugs called aminoglycosides to be discovered, and was the first antibiotic remedy for tuberculosis. It is derived from the actinobacterium Streptomyces griseus. Streptomycin stops bacterial growth by damaging cell membranes and inhibiting protein synthesis. Specifically, it binds to the 23S rRNA molecule of the bacterial ribosome, which prevents the release of the growing protein (polypeptide chain). Humans have structurally different ribosomes than bacteria, thereby allowing the selectivity of this antibiotic for bacteria. Streptomycin cannot be given orally, but must be administered by regular intramuscular injection. An adverse effect of this medicine is ototoxicity. It can result in permanent hearing loss. History:It was first isolated on October 19, 1943 in the laboratory of Selman Abraham Waksman at Rutgers University by Albert Schatz, a graduate student in his laboratory.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Streptomycin (Wikipedia)
LP16282-3 Streptomycin
An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Streptomycin 2.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Streptomycin 2 ug/mL Islt SlowMyco
- Display Name
- Streptomycin 2 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Streptomycin 2 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 10037
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41183-1 | Streptomycin 2.0 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Streptomycin 2,0 µg/mL: |
| es-ES | Spanish (Spain) | Estreptomicina 2 ug/mL: |
| es-AR | Spanish (Argentina) | estreptomicina 2 ug/ml: |
| es-MX | Spanish (Mexico) | Estreptomicina 2,0 ug / mL: |
| fr-CA | French (Canada) | Streptomycine, 2,0 mg/L: |
| fr-BE | French (Belgium) | Streptomycine 2,0 mg/L: |
| fr-FR | French (France) | Streptomycine 2mg/L: |
| it-IT | Italian (Italy) | Streptomicina, 2,0 ug/mL: Synonyms: 2 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 스트렙토마이신 2.0ug/mL: |
| nl-NL | Dutch (Netherlands) | streptomycine 2,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Estreptomicina 2.0 ug/ml: Synonyms: Streptomyc; |
| tr-TR | Turkish (Turkey) | Streptomisin 2.0 ug/mL: |
| zh-CN | Chinese (China) | 链霉素 2.0 微克/毫升: Synonyms: 2 ug/mL; |
46719-1 Streptomycin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16282-3 Streptomycin
Streptomycin is an antibiotic drug, the first of a class of drugs called aminoglycosides to be discovered, and was the first antibiotic remedy for tuberculosis. It is derived from the actinobacterium Streptomyces griseus. Streptomycin stops bacterial growth by damaging cell membranes and inhibiting protein synthesis. Specifically, it binds to the 23S rRNA molecule of the bacterial ribosome, which prevents the release of the growing protein (polypeptide chain). Humans have structurally different ribosomes than bacteria, thereby allowing the selectivity of this antibiotic for bacteria. Streptomycin cannot be given orally, but must be administered by regular intramuscular injection. An adverse effect of this medicine is ototoxicity. It can result in permanent hearing loss. History:It was first isolated on October 19, 1943 in the laboratory of Selman Abraham Waksman at Rutgers University by Albert Schatz, a graduate student in his laboratory.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Streptomycin (Wikipedia)
LP16282-3 Streptomycin
An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Streptomycin 4.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Streptomycin 4 ug/mL Islt SlowMyco
- Display Name
- Streptomycin 4 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Streptomycin 4 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.19
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Streptomycin 4,0 µg/mL: |
| es-ES | Spanish (Spain) | Estreptomicina 4 ug/mL: |
| es-MX | Spanish (Mexico) | Estreptomicina 4.0 ug / mL: |
| fr-CA | French (Canada) | Streptomycine, 4,0 mg/L: |
| fr-BE | French (Belgium) | Streptomycine 4,0 mg/L: |
| fr-FR | French (France) | Streptomycine 4mg/L: |
| it-IT | Italian (Italy) | Streptomicina, 4,0 ug/mL: Synonyms: 4 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | streptomycine 4,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Estreptomicina 4.0 ug/ml: Synonyms: Streptomyc; |
| tr-TR | Turkish (Turkey) | Streptomisin 4.0 ug/mL: |
| zh-CN | Chinese (China) | 链霉素 4.0 微克/毫升: Synonyms: 4 ug/mL; |
25185-0 Streptomycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16282-3 Streptomycin
Streptomycin is an antibiotic drug, the first of a class of drugs called aminoglycosides to be discovered, and was the first antibiotic remedy for tuberculosis. It is derived from the actinobacterium Streptomyces griseus. Streptomycin stops bacterial growth by damaging cell membranes and inhibiting protein synthesis. Specifically, it binds to the 23S rRNA molecule of the bacterial ribosome, which prevents the release of the growing protein (polypeptide chain). Humans have structurally different ribosomes than bacteria, thereby allowing the selectivity of this antibiotic for bacteria. Streptomycin cannot be given orally, but must be administered by regular intramuscular injection. An adverse effect of this medicine is ototoxicity. It can result in permanent hearing loss. History:It was first isolated on October 19, 1943 in the laboratory of Selman Abraham Waksman at Rutgers University by Albert Schatz, a graduate student in his laboratory.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Streptomycin (Wikipedia)
LP16282-3 Streptomycin
An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Streptomycin 6.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Streptomycin 6 ug/mL Islt SlowMyco
- Display Name
- Streptomycin 6 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Streptomycin 6 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 19917
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Streptomycin 6,0 µg/mL: |
| es-ES | Spanish (Spain) | Estreptomicina 6 ug/mL: |
| es-AR | Spanish (Argentina) | estreptomicina 6 ug/ml: |
| es-MX | Spanish (Mexico) | Estreptomicina 6.0 ug / mL: |
| fr-CA | French (Canada) | Streptomycine, 6,0 mg/L: |
| fr-BE | French (Belgium) | Streptomycine 6,0 mg/L: |
| fr-FR | French (France) | Streptomycine 6mg/L: |
| it-IT | Italian (Italy) | Streptomicina 6,0 ug/mL: Synonyms: 6 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 스트렙토마이신 6.0ug/mL: |
| nl-NL | Dutch (Netherlands) | streptomycine 6,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Estreptomicina 6.0 ug/ml: Synonyms: Streptomyc; |
| tr-TR | Turkish (Turkey) | Streptomisin 6.0 ug/mL: |
| zh-CN | Chinese (China) | 链霉素 6.0 微克/毫升: Synonyms: 6 ug/mL; |
25206-4 Streptomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16282-3 Streptomycin
Streptomycin is an antibiotic drug, the first of a class of drugs called aminoglycosides to be discovered, and was the first antibiotic remedy for tuberculosis. It is derived from the actinobacterium Streptomyces griseus. Streptomycin stops bacterial growth by damaging cell membranes and inhibiting protein synthesis. Specifically, it binds to the 23S rRNA molecule of the bacterial ribosome, which prevents the release of the growing protein (polypeptide chain). Humans have structurally different ribosomes than bacteria, thereby allowing the selectivity of this antibiotic for bacteria. Streptomycin cannot be given orally, but must be administered by regular intramuscular injection. An adverse effect of this medicine is ototoxicity. It can result in permanent hearing loss. History:It was first isolated on October 19, 1943 in the laboratory of Selman Abraham Waksman at Rutgers University by Albert Schatz, a graduate student in his laboratory.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Streptomycin (Wikipedia)
LP16282-3 Streptomycin
An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Streptomycin 10.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Streptomycin 10 ug/mL Islt SlowMyco
- Display Name
- Streptomycin 10 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Streptomycin 10 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 15740
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41184-9 | Streptomycin 10.0 ug/mLSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Streptomycin 10,0 µg/mL: |
| es-ES | Spanish (Spain) | Estreptomicina 10 ug/mL: |
| es-AR | Spanish (Argentina) | estreptomicina 10 ug/ml: |
| es-MX | Spanish (Mexico) | Estreptomicina 10,0 ug / mL: |
| fr-CA | French (Canada) | Streptomycine, 10,0 mg/L: |
| fr-BE | French (Belgium) | Streptomycine 10,0 mg/L: |
| fr-FR | French (France) | Streptomycine 10mg/L: |
| it-IT | Italian (Italy) | Streptomicina 10,0 ug/mL: Synonyms: 10 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 스트렙토마이신 10.0ug/mL: |
| nl-NL | Dutch (Netherlands) | streptomycine 10,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Estreptomicina 10.0 ug/ml: Synonyms: Streptomyc; |
| tr-TR | Turkish (Turkey) | Streptomisin 10.0 ug/mL: |
| zh-CN | Chinese (China) | 链霉素 10.0 微克/毫升: Synonyms: 10 ug/mL; |
25226-2 sulfiSOXAZOLE 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15603-1 sulfiSOXAZOLE
Sulphafurazole (INN, also known as sulfisoxazole) is a sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of Gram-negative and Gram-positive organisms. It is sometimes given in combination with erythromycin or phenazopyridine
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Sulfisoxazole (Wikipedia)
LP15603-1 sulfiSOXAZOLE
A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- sulfiSOXAZOLE 300.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Sulfisoxaz 300 ug/mL Islt SlowMyco
- Display Name
- sulfiSOXAZOLE 300 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to sulfiSOXAZOLE 300 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Sulfisoxazol 300,0 µg/mL: |
| es-ES | Spanish (Spain) | Sulfisoxazol 300 ug/mL: |
| es-AR | Spanish (Argentina) | sulfisoxazol 300 ug/ml: |
| es-MX | Spanish (Mexico) | sulfiSOXAZOLE 300.0 ug / mL: |
| fr-CA | French (Canada) | Sulfisoxazole, 300,0 mg/L: Synonyms: #REF! |
| fr-BE | French (Belgium) | Sulfisoxazole 300,0 mg/L: |
| fr-FR | French (France) | Sulfisoxazole 300mg/L: |
| it-IT | Italian (Italy) | Sulfisossazolo 300,0 ug/mL: Synonyms: 300 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 설피속사졸 300.0ug/mL: |
| nl-NL | Dutch (Netherlands) | sulfisoxazol 300,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Sulfisoxazol 300.0 ug/mL: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Sülfizoksazol 300.0 ug/mL: |
| zh-CN | Chinese (China) | 磺胺异嘧唑 300.0 微克/毫升: Synonyms: 100 微克/毫升; |
55158-0 Tigecycline [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP36048-4 Tigecycline
Tiglylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction: acyl-CoA + glycine < -- > CoA + N-acylglycine Tiglylglycine is an intermediate product of the catabolism of isoleucine. An elevated level of tiglylglycine is identified in urine of patients with beta-ketothiolase deficiency or with disorders of propionate metabolism PMID: 7923765.
Copyright Copyright ©2005-2009 Genome Alberta (Reference to original publication: Wishart DS, Knox C, Guo AC, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009 37(Database issue):D603-610.)
Source: Human Metabolome Database, Tiglylglycine
LP36048-4 Tigecycline
Tigecycline (INN) is a glycylcycline antibiotic marketed under the brand name Tygacil. It was given a U.S. Food and Drug Administration (FDA) fast-track approval and was approved on June 17, 2005. It was developed in response to the growing prevalence of antibiotic resistance in bacteria such as Staphylococcus aureus and Acinetobacter baumannii. The New Delhi metallo-β-Lactamase multidrug-resistant Enterobacteriaceae has also shown susceptibility to tigecycline.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Tigecycline
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Tigecycline Islt SlowMyco
- Display Name
- Tigecycline Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Tigecycline
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.27
- Last Updated
- Version 2.27
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41299-5 | TigecyclineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Tigecyclin: |
| es-ES | Spanish (Spain) | Tigeciclina: |
| es-MX | Spanish (Mexico) | Tigeciclina: |
| fr-CA | French (Canada) | Tigécycline: |
| fr-BE | French (Belgium) | Tigécycline: |
| fr-FR | French (France) | Tigécycline: |
| it-IT | Italian (Italy) | Tigeciclina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | tigecycline: |
| pt-BR | Portuguese (Brazil) | Tigeciclina: Synonyms: Tygecycline; |
| tr-TR | Turkish (Turkey) | Tigesiklin: |
| zh-CN | Chinese (China) | 替加环素: Synonyms: 分离物; |
55158-0 Tigecycline [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP36048-4 Tigecycline
Tiglylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction: acyl-CoA + glycine < -- > CoA + N-acylglycine Tiglylglycine is an intermediate product of the catabolism of isoleucine. An elevated level of tiglylglycine is identified in urine of patients with beta-ketothiolase deficiency or with disorders of propionate metabolism PMID: 7923765.
Copyright Copyright ©2005-2009 Genome Alberta (Reference to original publication: Wishart DS, Knox C, Guo AC, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009 37(Database issue):D603-610.)
Source: Human Metabolome Database, Tiglylglycine
LP36048-4 Tigecycline
Tigecycline (INN) is a glycylcycline antibiotic marketed under the brand name Tygacil. It was given a U.S. Food and Drug Administration (FDA) fast-track approval and was approved on June 17, 2005. It was developed in response to the growing prevalence of antibiotic resistance in bacteria such as Staphylococcus aureus and Acinetobacter baumannii. The New Delhi metallo-β-Lactamase multidrug-resistant Enterobacteriaceae has also shown susceptibility to tigecycline.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Tigecycline
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Tigecycline Islt SlowMyco
- Display Name
- Tigecycline Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Tigecycline
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.27
- Last Updated
- Version 2.27
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41299-5 | TigecyclineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Tigecyclin: |
| es-ES | Spanish (Spain) | Tigeciclina: |
| es-MX | Spanish (Mexico) | Tigeciclina: |
| fr-CA | French (Canada) | Tigécycline: |
| fr-BE | French (Belgium) | Tigécycline: |
| fr-FR | French (France) | Tigécycline: |
| it-IT | Italian (Italy) | Tigeciclina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | tigecycline: |
| pt-BR | Portuguese (Brazil) | Tigeciclina: Synonyms: Tygecycline; |
| tr-TR | Turkish (Turkey) | Tigesiklin: |
| zh-CN | Chinese (China) | 替加环素: Synonyms: 分离物; |
25800-4 Tobramycin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16294-8 Tobramycin
Tobramycin sulfate is an aminoglycoside antibiotic produced by Streptomyces tenebrarius used to treat various bacterial infections, particularly Gram-negative infections. It works by binding to a site on the bacterial ribosome, causing the genetic code to be misread. Like all aminoglycosides, tobramycin does not pass the gastro-intestinal tract, so for systemic use it can only be given intravenously or intramuscularly. This formulation for injection is branded Nebcin®. Patients with cystic fibrosis will often take an inhalational form (Tobi®) for suppression of Pseudomonas aeruginosa infections. Tobramycin is also combined with dexamethasone as an ophthalmic solution (TobraDex®). Bausch Lomb Pharmaceuticals, Inc. makes a sterile Tobramycin Ophthalmic Solution (eye-drops) with a tobramycin concentration of 0.3%. In the USA it is available by prescription only.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Tobramycin (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Tobramycin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Tobramycin Islt SlowMyco
- Display Name
- Tobramycin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Tobramycin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 15337
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41123-7 | TobramycinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Tobramycin: |
| es-ES | Spanish (Spain) | Tobramicina: |
| es-AR | Spanish (Argentina) | tobramicina: |
| es-MX | Spanish (Mexico) | Tobramicina: |
| fr-CA | French (Canada) | Tobramycine: |
| fr-BE | French (Belgium) | Tobramycine: |
| fr-FR | French (France) | Tobramycine: |
| it-IT | Italian (Italy) | Tobramicina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 토브라마이신: |
| nl-NL | Dutch (Netherlands) | tobramycine: |
| pt-BR | Portuguese (Brazil) | Tobramicina: Synonyms: NEBCIN; |
| tr-TR | Turkish (Turkey) | Tobramisin: |
| zh-CN | Chinese (China) | 妥布霉素: Synonyms: 分离物; |
25227-0 Tobramycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16294-8 Tobramycin
Tobramycin sulfate is an aminoglycoside antibiotic produced by Streptomyces tenebrarius used to treat various bacterial infections, particularly Gram-negative infections. It works by binding to a site on the bacterial ribosome, causing the genetic code to be misread. Like all aminoglycosides, tobramycin does not pass the gastro-intestinal tract, so for systemic use it can only be given intravenously or intramuscularly. This formulation for injection is branded Nebcin®. Patients with cystic fibrosis will often take an inhalational form (Tobi®) for suppression of Pseudomonas aeruginosa infections. Tobramycin is also combined with dexamethasone as an ophthalmic solution (TobraDex®). Bausch Lomb Pharmaceuticals, Inc. makes a sterile Tobramycin Ophthalmic Solution (eye-drops) with a tobramycin concentration of 0.3%. In the USA it is available by prescription only.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Tobramycin (Wikipedia)
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Tobramycin 10.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Tobramycin 10 ug/mL Islt SlowMyco
- Display Name
- Tobramycin 10 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Tobramycin 10 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Tobramycin 10,0 µg/mL: |
| es-ES | Spanish (Spain) | Tobramicina 10 ug/mL: |
| es-AR | Spanish (Argentina) | tobramicina 10 ug/ml: |
| es-MX | Spanish (Mexico) | Tobramicina 10,0 ug / mL: |
| fr-CA | French (Canada) | Tobramycine, 10,0 mg/L: |
| fr-BE | French (Belgium) | Tobramycine 10,0 mg/L: |
| fr-FR | French (France) | Tobramycine 10mg/L: |
| it-IT | Italian (Italy) | Tobramicina 10,0 ug/mL: Synonyms: 10 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 토브라마이신 10.0ug/mL: |
| nl-NL | Dutch (Netherlands) | tobramycine 10,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Tobramicina 10.0 ug/ml: Synonyms: NEBCIN; |
| tr-TR | Turkish (Turkey) | Tobramisin 10.0 ug/mL: |
| zh-CN | Chinese (China) | 妥布霉素 10.0 微克/毫升: Synonyms: 10 ug/mL; |
23614-1 Trimethoprim [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP15010-9 Trimethoprim
Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections. It belongs to the class of chemotherapeutic agents known as dihydrofolate reductase inhibitors. Trimethoprim is marketed under the trade name Primsol. In clinical use it is often abbreviated TRI or TMP; its common laboratory abbreviation is W.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Trimethoprim (Wikipedia)
LP15010-9 Trimethoprim
Trimethoprim is a synthetic (man-made) antibiotic that interferes with the production of tetrahydrofolic acid, a chemical necessary in protein production. The drug inhibits the enzyme responsible for making tetrahydrofolic acid from dihydrofolic acid. Trimethoprim inhibits the bacterial enzyme more than the corresponding human enzyme, so it has less effect on the production of tetrahydrofolic acid by humans. It is effective against a wide variety of bacteria. Information is from MedicineNet.com, accessed 2006 10 16.
Copyright Copyright © 1996-2008 MedicineNet, Inc. All rights reserved.
Source: MedicineNet.com
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Trimethoprim
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Trimethoprim Islt SlowMyco
- Display Name
- Trimethoprim Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Trimethoprim
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0n
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41124-5 | TrimethoprimSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Trimethoprim: |
| es-ES | Spanish (Spain) | Trimetoprim: |
| es-AR | Spanish (Argentina) | trimetoprima: |
| es-MX | Spanish (Mexico) | Trimetoprima: |
| fr-BE | French (Belgium) | Triméthoprime: |
| fr-CA | French (Canada) | Triméthoprime: |
| fr-FR | French (France) | Triméthoprime: |
| it-IT | Italian (Italy) | Trimetoprim: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 트리메토프림: |
| nl-NL | Dutch (Netherlands) | trimethoprim: |
| pt-BR | Portuguese (Brazil) | Trimetoprim: Synonyms: Trimpex; |
| tr-TR | Turkish (Turkey) | Trimetoprim: |
| zh-CN | Chinese (China) | 三甲氧苄二氨嘧啶: Synonyms: 三甲氧下二氨嘧啶; |
20387-7 Trimethoprim+Sulfamethoxazole [Susceptibility] by Method for Slow-growing mycobacteria
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Trimethoprim+Sulfamethoxazole
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- TMP SMX Islt SlowMyco
- Display Name
- Trimethoprim+Sulfamethoxazole Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Trimethoprim+Sulfamethoxazole
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0m
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 16146
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41125-2 | Trimethoprim+SulfamethoxazoleSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Trimethoprim+Sulfamethoxazol: Synonyms: Cotrimoxazol |
| es-ES | Spanish (Spain) | Trimetoprim + sulfametoxazol: |
| es-AR | Spanish (Argentina) | micobacterias.lentas: |
| es-MX | Spanish (Mexico) | Trimetoprim + Sulfametoxazol: |
| fr-CA | French (Canada) | Triméthoprime+Sulfaméthoxazole: |
| fr-BE | French (Belgium) | Triméthoprime+Sulfaméthoxazole: |
| fr-FR | French (France) | Triméthoprime+sulfaméthoxazole: |
| it-IT | Italian (Italy) | Trimetoprim+Sulfametossazolo: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 트리메토프림+술파메톡사졸: |
| nl-NL | Dutch (Netherlands) | trimethoprim + sulfamethoxazol: |
| pt-BR | Portuguese (Brazil) | Trimetoprim+Sulfametoxazol: Synonyms: ; |
| tr-TR | Turkish (Turkey) | Trimetoprim-Sulfametoksazol: |
| zh-CN | Chinese (China) | 三甲氧苄二氨嘧啶+磺胺甲噁唑: Synonyms: SMX; |
23615-8 Vancomycin [Susceptibility] by Method for Slow-growing mycobacteria
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Vancomycin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Vancomycin Islt SlowMyco
- Display Name
- Vancomycin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Vancomycin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0n
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41127-8 | VancomycinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Vancomycin: |
| es-ES | Spanish (Spain) | Vancomicina: |
| es-AR | Spanish (Argentina) | vancomicina: |
| es-MX | Spanish (Mexico) | Vancomicina: |
| fr-BE | French (Belgium) | Vancomycine: |
| fr-CA | French (Canada) | Vancomycine: |
| fr-FR | French (France) | Vancomycine: |
| it-IT | Italian (Italy) | Vancomicina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 반코마이신: |
| nl-NL | Dutch (Netherlands) | vancomycine: |
| pt-BR | Portuguese (Brazil) | Vancomicina: Synonyms: Vancocin; |
| tr-TR | Turkish (Turkey) | Vankomisin: |
| zh-CN | Chinese (China) | 万古霉素: Synonyms: 分离物; |
25228-8 Vancomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Vancomycin 30.0 ug/mL
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Vancomycin 30 ug/mL Islt SlowMyco
- Display Name
- Vancomycin 30 ug/mL Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Vancomycin 30 ug/mL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.00
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Vancomycin 30,0 µg/mL: |
| es-ES | Spanish (Spain) | Vancomicina 30 ug/mL: |
| es-AR | Spanish (Argentina) | vancomicina 30 ug/ml: |
| es-MX | Spanish (Mexico) | Vancomicina 30,0 ug / mL: |
| fr-CA | French (Canada) | Vancomycine, 30,0 mg/L: |
| fr-BE | French (Belgium) | Vancomycine 30,0 mg/L: |
| fr-FR | French (France) | Vancomycine 30mg/L: |
| it-IT | Italian (Italy) | Vancomicina 30,0 ug/mL: Synonyms: 30 ug/mL Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 반코마이신 30.0ug/mL: |
| nl-NL | Dutch (Netherlands) | vancomycine 30,0 ug/mL: |
| pt-BR | Portuguese (Brazil) | Vancomicina 30.0 ug/ml: Synonyms: Vancocin; |
| tr-TR | Turkish (Turkey) | Vankomisin 30.0 ug/mL: |
| zh-CN | Chinese (China) | 万古霉素 30.0 微克/毫升: Synonyms: 30 ug/mL; |
23616-6 Viomycin [Susceptibility] by Method for Slow-growing mycobacteria
Part Descriptions
LP16733-5 Viomycin
Viomycin sulfate (Viocin®) is an polypeptide antibiotic used in the treatment of tuberculosis. It is produced by the actinomycete Streptomyces puniceus, that binds to RNA and inhibits prokaryotic protein synthesis and certain forms of RNA splicing. Administration:Intramuscular injection.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Viomycin (Wikipedia)
LP16733-5 Viomycin
A strongly basic peptide, antibiotic complex from several strains of Streptomyces. It is allergenic and toxic to kidneys and the labyrinth. Viomycin is used in tuberculosis as several different salts and in combination with other agents.
Source: National Library of Medicine, MeSH 2006
Observation Required in Panel
Optional
Fully-Specified Name
- Component
- Viomycin
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Method for Slow-growing mycobacteria
Additional Names
- Panel Name
- Short Name
- Viomycin Islt SlowMyco
- Display Name
- Viomycin Method for Slow-growing mycobacteria [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Viomycin
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 1.0n
- Last Updated
- Version 2.26
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 29579-0 | Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41128-6 | ViomycinSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Viomycin: |
| es-ES | Spanish (Spain) | Viomicina: |
| es-AR | Spanish (Argentina) | viomicina: |
| es-MX | Spanish (Mexico) | Viomicina: |
| fr-BE | French (Belgium) | Viomycine: |
| fr-CA | French (Canada) | Viomycine: |
| fr-FR | French (France) | Viomycine: |
| it-IT | Italian (Italy) | Viomicina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| ko-KR | Korean (Korea, Republic Of) | 바이오마이신: |
| nl-NL | Dutch (Netherlands) | viomycine: |
| pt-BR | Portuguese (Brazil) | Viomicina: Synonyms: Tuberactinomycin b; |
| tr-TR | Turkish (Turkey) | Viomisin: |
| zh-CN | Chinese (China) | 紫霉素: Synonyms: 分离物; |